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                                         ABSTRACT 
 
Flies are a widely distributed pest insect that poses a significant threat to food security. Flight 
is essential for the dispersal of the adult flies to find new food sources and ideal breeding spots. 
The supply of metabolic fuel to power the flight muscles of insects is regulated by adipokinetic 
hormones (AKHs). The fruit fly, Drosophila melanogaster, the flesh fly, Sarcophaga 
crassipalpis, and the oriental fruit fly, Bactrocera dorsalis all have the same AKH that is 
present in the blowfly, Phormia terraenovae; this AKH has the code-name Phote-HrTH. 
Binding of the AKH to the extracellular binding site of a G protein-coupled receptor causes its 
activation. In this thesis, the structure of Phote-HrTH in SDS micelle solution was determined 
using NMR restrained molecular dynamics. The peptide was found to bind to the micelle and 
be reasonably rigid, with an S2 order parameter of 0.96. The translated protein sequence of the 
AKH receptor from the fruit fly, Drosophila melanogaster, the flesh fly, Sarcophaga 
crassipalpis, and the oriental fruit fly, Bactrocera dorsalis were used to construct two models 
for each receptor: Drome-AKHR, Sarcr-AKHR, and Bacdo-AKHR. It is proposed that these 
two models represent the active and inactive state of the receptor. The models based on the 
crystal structure of the β-2 adrenergic receptor were found to bind Phote-HrTH with a predicted 
binding free energy of –107 kJ mol–1 for Drome-AKHR, –102 kJ mol–1 for Sarcr-AKHR and 
–102 kJ mol–1 for Bacdo-AKHR. Under molecular dynamics simulation, in a POPC membrane, 
the β-2AR receptor-like complexes transformed to rhodopsin-like. The identification and 
characterisation of the ligand-binding site of each receptor provide novel information on 
ligand-receptor interactions, which could lead to the development of species-specific control 
substances to use discriminately against these pest flies. 
 
Keywords 
Adipokinetic hormones, Adipokinetic hormone-receptor, Beta2-adrenergic receptors, 
Docking, G-protein, coupled receptors, GROMACS, Homology modelling, Molecular 
dynamics simulation.







1.0  Background 
Insects are the most abundant and most diverse group of animals on this planet. It is not 
surprising, therefore, that insects account for many pests as seen from a human perspective. 
They compete for the same food (agricultural and stored food pests)1, and they act as vectors 
of numerous pathogens to both man and domesticated animals with severe consequences 
(medical pests and transmitters of disease)2,3. However, not all insects are pests, and this can 
be seen in the large insect order Diptera, which comprises about 152 000 described fly species 
4. A few examples of useful fly species are the pollinators of flowers to result in fruit and seed 
production, like hoverflies (Family: Syrphidae)5–7; flies that are used in wound care, like larvae 
of the family Calliphoridae that feed on necrotic tissues and are also a source of 
pharmacologically active substances such as antimicrobial, antiviral and antitumor compounds 
8–10 and fly larvae of the black soldier fly Hermetia illucens (Family: Stratiomyidae) that are 
used at an industrial level as organic waste removers and simultaneously as a source of 
economically valuable products, such as oils and dried protein feed for chicken and fish 11. 
Other fly species may have both beneficial and pest status and all insects play a role in the 
ecosystem 6,7. Adult flies, like many other insects, have wings that they use for aerial 




locomotion (flight) to find food sources, for dispersal or for finding a mate 12. Insect flight is 
always based on aerobic metabolism 13 and is dependent on efficient oxidation of carbohydrates 
and lipids in the flight muscles 14–17. Carbohydrates comprise the primary supply of fuel for 
short flights and are stored as glycogen in the fat body and trehalose in the haemolymph 15,18. 
At the start of a flight, trehalose is transported to the flight muscles where it is hydrolysed to 
glucose for use 15. Lipid reserves are critical for more prolonged and demanding flights and are 
stored in the fat body as triacylglycerol (TAG) 19,20. TAG needs to be transformed into 
stereospecific 1,2 diaclyglycerol (DG) having an SN-1,2-configuration 21–23, before being 
released into the haemolymph and transported to the flight muscles. Membrane-bound lipase 
enzymes catalyse the hydrolysis of DG to produce fatty acids, and the successive oxidation 
leads to energy release 24. Mobilisation of stored metabolites from the fat body into the 
haemolymph is regulated by members of a neuropeptide family, generically known as the 
adipokinetic hormone family (see Section 1.3.0 for further understanding) 15–17. Adipokinetic 
hormones (AKHs) are synthesised and stored in intrinsic neurons of the corpus cardiacum (CC) 
in the head of insects, released into the hemolymph as required, and act as extracellular 
messengers by binding to their cognate G-protein coupled receptor (GPCR) on fat body cells. 
14–17 Binding of the AKH to the extracellular domain of its cognate AKH-receptor (the so-called 
AKHR) elicits an intracellular signal transduction cascade that ends in the activation of critical 
enzymes for substrate mobilisation, like glycogen phosphorylase and lipases 15,25–28. Given the 
importance of the AKH signalling system in insect metabolism and the fact that similar 
endocrine pathways are selected by pharmacology as targets of drug treatment of human 
diseases, it is no wonder that insect hormonal systems are being looked at with great interest 
as potential targets for specific pest control 29–33. Thus, the AKH-AKHR system of insects is 
being considered as a potential target for novel pest control agents (Marco and Gäde, 2020).   




There is an ever-louder call for such alternatives to the current chemical pesticides that are 
being used globally. Apart from adverse effects on the environment and human health 34–36, the 
unspecific action of commercial chemical pesticides has resulted in “superbugs”, i.e. pest insect 
populations that are resistant to the pesticide compounds 37,38, and are also implicated in the 
observed decline in insect biomass and biodiversity 35,39,40. It has become necessary, therefore, 
to consider all the ecological services offered by different insect species, including being part 
of the natural food chain that sustains other animals, like birds and fish, and to steer away from 
the indiscriminate conventional way of combatting insects towards bio-rational pest 
management. This has spurred on the search for “green insecticides”, i.e. species- (or group-) 
specific control agents (peptide mimetics that are based on the insect’s hormones) to target and 
control pest insect numbers with little or no adverse effect on beneficial insects, other 
organisms and the environment. One idea for developing a so-called green insecticide is to 
target the GPCRs of pest insects29–33,41,42 in the hope that these are species-specific. For this to 
be successful and applicable, research into ligand-receptor interactions is needed for both pest 
and beneficial insects to ascertain significant differences/similarities in the signalling 
components and to identify those components that are specific to pest insects which may be 
further investigated for drug development.  
In this context, the current thesis was developed to focus on the AKH-AKHR interactions in 
three different fly species: Drosophila melanogaster (vinegar/fruit fly), Bactrocera dorsalis 
(oriental fruit fly) and Sarcophaga crassipalpis (flesh fly). All three fly species produce the 
same AKH in the corpora cardiaca, viz. an octapeptide (pGlu-Leu-Thr-Phe-Ser-Pro-Asp-Trp-
NH2) that was discovered in the blowfly, Phormia terraenovae and is thus, code-named Phote-
HrTH, and the respective AKHR is known from each species 43–45. This provides us with an 
ideal experimental system in which we can investigate how an endogenous ligand (Phote-
HrTH) may interact with its endogenous AKH receptor in beneficial, and pest fly species.  The 




resulting models will shed light on whether the same amino acids are involved with ligand 
binding and whether the same conformation is maintained in all species. Hence, insight can 
ultimately be gained into whether a species-specific effect can be predicted between the three 
fly species and possibly others who also produce Phote-HrTH as a potential lead for peptide 
mimetics. Computational techniques were employed here to study AKH-AKHR interactions. 
Via nuclear magnetic resonance (NMR) restrained molecular dynamic (MD), the solution 
structure of the ligand (Phote-HrTH) was elucidated. Homology modelling techniques were 
used to construct two 3D models for each of the fly species, using β2AR and rhodopsin crystal 
structures as templates. The two receptor models built for each species differ in a few critical 
features, the most important of which is that the β2AR-based models have an open 
conformation, while the rhodopsin-based models have a closed structure46. To enable us to 
imitate the receptor’s precise nature, long MD simulations (100 ns) were conducted in a model 
membrane to determine stability and conformational changes during agonist binding. 
In order to validate the model built of the fruit fly AKH-receptor (Drome-AKHR), in-silico 
structure-activity studies were conducted and compared with biological activity data.   
1.2.0 Biology of Diptera (true flies)  
“True flies” (order Diptera) are distinctly different from other insects that are colloquially 
known as a type of “fly.” However, belonging to another order, such as butterflies (order 
Lepidoptera), scorpionflies (order Mecoptera), dragonflies (order Odonata), stoneflies (order 
Plecoptera) and mayflies (Ephemeroptera). Whereas other winged insects have four wings (2 
pairs of wings), dipterans are distinct in that they have only two wings (1 pair of wings) – an 
ancestral pair of hindwings have evolved into small structures called halteres, which serve as 
sensory organs that detect rotation of the body during flight and provides positional feedback 
to the flight muscles via the nervous system) 47. Diptera’s diverse order includes mosquitoes, 




midges, crane flies, marsh flies, flesh flies, fruit flies, house flies, robber flies, and tsetse flies, 
to mention but a few. Dipterans have a holometabolous lifecycle (in other words, a complete 
metamorphosis that includes four life stages, i.e., egg, larva, pupa, and imago or adult). The 
larval and adult forms of a fly species may be classified as pests or beneficial according to their 
diet (blood, pollen/nectar, rotting organic matter, fruits and vegetables, and other insects). 
Beneficial services of flies include being part of the ecological food web as a food source for 
other animals, such as reptiles, fish, birds, and predatory insects; ecosystem engineering, by 
conditioning and enriching soil; accelerated removal and decomposition of biological matter, 
quality indicators of water bodies, pollinators of many plants, medical intervention in wound 
healing and source of antibiotics 48,49. Additionally, certain fly species are used in forensic 
entomology as markers for estimating corpse death, used as model organisms for insect 
physiology, biochemistry, and genetics. 50–52 
The insect pests can be divided into medical and agricultural pests. Some fly species, especially 
blood-sucking flies, pose a significant threat to man’s health. In feeding, they can transmit 
severe diseases such as trypanosomiasis (sleeping sleekness), malaria, cholera, and yellow 
fever 2,47. The agricultural pests are adult and larvae feeding on fruits and vegetables even 
before they are fully ripe 1. Adult flies transmit disease vectors to other animals, e.g., equine 
infectious anaemia anthrax in cattle and sheep 3. The line between good and wrong concerning 
the status (beneficial or pest) of an insect is not always as clearly and finally delineated as 
expressed above. Therefore, to avoid future ecological problems arising from the drastic 
alteration of species composition, we should not apply broad-spectrum pesticides that kill 
invertebrates indiscriminately.  
This thesis focuses on three different fly species with different economic importance attached 
to each but with the same endogenous mature AKH peptide and a structurally similar (but not 
identical) AKHR for their metabolic processes. The selected dipteran species are shown in 




Figure 1.1: the vinegar/fruit fly, Drosophila melanogaster, has both beneficial and pest insect 
status (agricultural pest and genetic model for developmental studies) 53; the oriental fruit fly, 
Bactrocera dorsalis, is a significant and invasive pest of fruit orchards 54, and the flesh fly, 
Sarcophaga crassipalpis, is a common laboratory animal used in the study of gene expression 
and the study of diapause in insects 55, thus, a beneficial insect. 
 
Figure 1. 1: a) Dorsal view of adult female Sarcophaga crassipalpis taken from Bänziger and Pape, 2004 56. b) side view 
of adult D. melanogaster, taken from Mansourian et al., 2018 57. c) Dorsal view of adult Bactrocera dorsalis taken from 
Schutze et al., 2015 58.  
1.3.0 Adipokinetic Hormones (AKHs) in Diptera 
Foraging flies are active fliers, and for this, they require large amounts of energy. The supply 
of fuel metabolites for oxidation in insects’ flight muscles is regulated by a neuropeptide family 
generically referred to as the adipokinetic hormone (AKH) family. AKHs are synthesised in 
intrinsic neurons of the corpora cardiaca (CC, a pair of retro-cerebral glands).  In dipterans, 
the CC form part of the ring gland which is a complex structure formed of the larval prothoracic 
gland fused with the CC and the corpora allata during development and located in the anterior 
thorax in the adult stage59.  




The first AKH was isolated from the locust, Locusta migratoria 60, while the first dipteran 
AKHs were sequenced from the horse fly, Tabanus atratus in 1989 61. Since the first AKH 
sequence, over 80 AKH sequences are now known from insects 62. The distinctive features of 
insect AKHs are that they are either octa-, nona- or decapeptides with blocked termini (a 
pyroglutamate at the N-terminus) and an amidated C-terminus; a Phe or Tyr in position 4, Trp 
in position 8 and Gly in position 9 63. In 1990, an octapeptide AKH with the primary sequence 
pGlu–Leu–Thr–Phe–Ser–Pro–Asp–Trp–NH2 was isolated and sequenced from the blowfly 
Phormia terraenovae. It was shown to have an aspartic acid in position 7, which resulted in the 
peptide having an overall negative charge 64. This is the first identified charged member of the 
AKH family, and because it demonstrated hypertrehalosaemic activity in vivo in P. 
terraenovae, it was, thus, named Phote-HrTH 64,65. The same peptide is produced in fruit flies, 
e.g., D. melanogaster45,66 and B. dorsalis44, the flesh fly (S. crassipalpis) 41,43, as well as in a 
variety of other fly pest species67,68. Phote-HrTH has been called Drome-AKH in D. 
melanogaster 45 and Bacdo-AKH in B. dorsalis 44.    
Whereas some insects produce more than one AKH, for example, two AKHs are synthesised 
in the malaria mosquito Anopheles gambiae 69 and tsetse flies70, and the crane fly Tipula 
paludosa makes three AKHs, most other Diptera have only one AKH 71. In Diptera, AKHs 
may function as hypertrehalosaemic hormones (mobilising carbohydrates), hyperlipidaemia 
hormones (mobilising lipids), or as hyperprolinaemic hormones (mobilising proline as fuel 
metabolite) (Gäde and Marco, 2013). AKHs work by binding to a GPCR 16,28,72–74 situated in 
the plasma membrane of adipocytes. The binding of the peptide ligand leads to the activation 
of intracellular pathways that trigger the mobilisation of carbohydrate or lipid reserve, and 
proline in some insects 25,26,28,75–77.   
 




1.4.0 G-protein coupled receptors (GPCRs) 
1.4.1 Secondary Structure and Function 
GPCRs are known as seven transmembrane receptors (7TM receptors), the most diverse and 
significant group of membrane receptors 78 and considered the major superfamily of 
membrane-bound proteins 76,79–83. GPCRs share a similar overall tertiary structure: 7TM α -
helices, with alternating intracellular and extracellular loops connecting the helices, and a G 
protein that associates with the intracellular region of the C-terminus of the receptor protein 
27,43,45,69,83–87. Figure 1.2 is a schematic diagram of the β-2-adrenergic receptor (β2AR) 
showing the structural domains commonly found in most GPCRs.   
 
 
Figure 1. 2: Schematic 2D diagram showing the overall transmembrane topology of the β-2-adrenergic receptor 
(β2AR). TM1-TM7 represents transmembrane helices 1-7.  The core region is represented in light grey and the two 
water-lipid interface regions of the lipid in dark grey. The conserved residues in each of the 7 transmembranes are in 
black88. 




Each of the 7 TM helices possesses the conserved residue motifs patterns found in most class 
A GPCRs, namely Asn in TM1, Asp in TM2, Arg in TM3, Trp in TM4, Pro in TM5, Pro in 
TM6, and Pro in TM7 (see Figure 1.2). 89–92. GPCRs are also characterised by the presence of 
disulphide bonds linking the first two extracellular cell loops (ECL I and -II); these loops help 
in the stabilisation of the transmembrane helices and also take part in ligand-receptor binding 
46,93–97. The Rhodopsin receptor has one disulphide bond between Cys110 and Cys187, while 
the β2AR receptor has two disulphide bonds between Cys106/Cys191 and Cys184/Cys190. 
Both receptor molecules contain a palmitoylation site in the intracellular region. For the 
Rhodopsin molecule, the site is between Cys322 and Cys323 while for the β2AR molecule the 
palmitoylation site is Cys341 96,98–101. 
GPCR ligands comprise neurotransmitters which include, Ca2+ ions, proteins, amines, and 
hormones 102–106. The binding of a ligand to the extracellular region of a GPCR causes a 
conformational change in the 7 TM regions, which activates the receptor 106–111. Senses, such 
as taste, smell, vision, pain, along with secretion, metabolism and neurotransmission are 
biological processes where GPCRs play intermediary roles 112. Because of the physiological 
importance of GPCRs, receptor-ligand interactions have been targeted successfully with 
therapeutic drugs in medicine33,46,113,114, and are being considered as suitable targets for insect 
control agents 29–33,41,114–116.  
Most ligands bind as antagonists (inhibitors of receptor activity, antagonists mimic ligands that 
bind to a receptor and prevent receptor activation by a natural ligand). Moreover, some ligands 
bind as agonists (are mimetic of the natural ligand and produces a similar biological effect as 
the natural ligand when it binds to the receptor) to the GPCR 117–120. At the same time, some 
ligands are allosteric modulators (change the receptor’s response to stimulus by increasing or 
decreasing the strength of the signal a receptor sends into the cell) for GCPRs 88,121–123.   




1.4.2 Classification of GPCRs 
GPCRs are categorised into six prominent families based on sequence homology and functional 
similarity 117,124–126. These are Class1 or A (Rhodopsin-like family), Class 2 or B (Secretin 
receptor family), Class 3 or C (Pheromone /Metabotropic glutamate), Class 4 or D (Fungal 
mating Pheromone receptors), Class 5 or E (Cyclic AMP or Taste-like receptors), and Class 6 
or F (Frizzled / smoothened) GPCRs. Amongst these GPCR families, class 1 or A has the most 
significant number of identified/known structures. The first GCPR structure determined from 
this family was rhodopsin 127,128. Most type A GPCR structures were elucidated based on 
homology with the rhodopsin structure. Amongst the GPCRs built from rhodopsin is beta-2 
Adrenergic receptor (β2AR) in the year 2007, after which other GCPRs have been elucidated 
using either rhodopsin or β2AR as a template 125,129,130. As of May 2019, the ChEMBL database 
had documented 772 GPCRs, amongst which only 30 crystal structures have been recorded. 
ChEMBL_20 contains 688 Class A,  44 Class B, 35 Class C, and 1 of each Class D, E and F 
sequences131–134. 
1.4.3 Adipokinetic hormone Receptor (AKHR) of the dipteran species 
studied in this thesis. 
The AKHR is a fundamental part of the AKH signal transduction pathway. The AKHR was 
first sequenced in D. melanogaster and Bombyx mori (silkworm) and identified as belonging 
to the class A GPCR superfamily 45,135. The AKHRs were discovered to be evolutionarily and 
structurally related to the gonadotropin-releasing hormone receptor from vertebrates 45. Other 
dipteran AKHRs were cloned and characterised from malaria and yellow fever mosquitoes, A. 
gambiae and Aedes aegypti 69,136 from G. morsitans morsitans 137, S. crassipalpis 43 and B. 
dorsalis 44. With the increase in whole-genome sequencing of animals, many more AKH and 
AKHR genes are annotated, and sequences can be predicted for Diptera and other insects (see 




for example Flybase – an online bioinformatics database: https://flybase.org and Vectorbase – 
bioinformatics resources for invertebrate vectors of human pathogens: https://vectorbase.org).  
An alignment of the primary amino acid sequence of the S. crassipalpis AKHR 43, D. 
melanogaster AKHR 43, and the B. dorsalis AKHR 44 are presented in Figure 1.3. 
 
Figure 1. 3: Multiple primary amino acid sequence alignment of adipokinetic hormone receptors (AKHRs). The flies 
are represented with Genbank database accession numbers.  The flesh fly S. crassipalpis (AOA1B2RVC93), the fruit 
fly D. melanogaster (AAN10047.1), and the oriental fruit fly B. dorsalis AQX83416 43–45.  
Figure 1.3, the primary amino acid sequence length of the flesh AKHRs, is between 424 and 
455 amino acids with high identity (over 70%) to each other 43,44. These fly AKH receptors 
have the seven-transmembrane topology that is characteristic of the GPCR superfamily 43,44,76. 
Furthermore, the amino acid residues, patterns, and motifs generally found in the 7 TM helices 




of other Class A GPCRs are also found in all the AKHRs; see Table 1.1, where X signifies any 
amino acid residue. 
Table 1. 1. The highly conserved residues, patterns, and motifs found in AKHRs and Class A GPCRs and those 
identified in three fly AKHRs. X represents amino acid residues common to other Class A GPCRs.   
Helix  Residue/Motif/Patternsin 
GCPRs 
Residue/Motif/Patterns  
In the flesh fly  
Residue/Motif/Patterns  
In the fruit fly    
Residue/Motif/Patterns   
 In the oriental fruit fly   
1 N N N N 
2 LAxxD LAIAD LAIAD LAIAD 
3 (D/E)R(Y/H) DRY DRY DRY 
4 W W W W 
5 (F/Y)XXPXXXXXXXY YACPLITFIYCY YAFPLITFIYCY YAFPLITFIYCY 
6 (F/Y)XXXWXPYY FIICWTPYY FIICWTPYY FVICWTPYY 
7 (N/D)PXXY NPIVY NPLVY NPLVY 
 
These conserved residues play a vital role via helical interactions to stabilise the helices. Also, 
they are essential for receptor activation and ligand binding.  
AKHR was shown to be expressed in the fat body and specific nervous tissues of cockroach 
and tobacco hornworm, Manduca sexta 138,139. Also, the AKHR expression is found in the 
abdomen and thorax of A. aegypti and A. gambiae– presumably in the fat body 69,136. They were 
thus confirming the role of AKHs in mobilising stored metabolites from the fat body. During 
receptor activation (see Figure 1.4), insects which fully oxidise carbohydrates for flight (like 
cockroaches), or insects which oxidise carbohydrates in conjunction with lipids for flight (like 
the locusts) or insects which oxidise proline for flight (some beetles). Essential for this regard 
is that they possess the endogenous AKHs as a ligand which bind to the extracellular part of 
Gq-protein-coupled receptor, to activate a phospholipase C (PLC). The resulting inositol 
trisphosphate (IP3) releases Ca
2+ from internal stores. In addition, the influx of extracellular 




Ca2+ is amplified and, via a kinase cascade, glycogen phosphorylase is activated, which lead to 
the production of glucose-1-phosphate. glucose-1-phosphate is transformed into trehalose, 
which is discharged into the haemolymph. In insects which use lipids for prolonged flight (like 
the locust) or proline for flight (certain beetles), adenylate cyclase (AC) is activated after the 
AKHs bind to their respective Gs-protein-coupled receptor. Also, in locusts, when AC is 
activated, cyclic AMP is synthesised. The resulting cyclic AMP, together with the messengers 
both intracellular and extracellular Ca2+, activate a triacylglycerol lipase, which results in the 
production of 1,2 diacylglycerols (in locusts) or free fatty acids (in fruit beetle) (see Figure 
1.4) 16,140. 
 
Figure 1. 4: AKH controlled mobilisation of trehalose during high energy demanding flight in the fat body of insects 
(documented in L. migratoria, P. sinuata, and P. americana).  Abbreviations - CC: corpus cardiacum; AKH: 
adipokinetic hormone; R: AKH receptor; Gs/Gq: G-protein; PLC: phospholipase C; PIP2: phosphatidylinositol 
bisphosphate; DAG: diacylglycerol; IP3: inositol triphosphate; ER: endoplasmic reticulum; AC: adenylate cyclase; 
cAMP: cyclic AMP; PKC2: protein kinase C and black-boxed AC and cAMP represent a specific pathway in L. 
migratoria. It was adapted from16,140.  
 




GPCRs are the largest family of cell surface receptors. They are essential targets for drug 
pharmacology in humans, as bioactive peptides and proteins signal via GPCRs. If one interferes 
with this ligand-receptor binding, one could potentially influence or disrupt critical 
physiological processes in the body. This was effectively achieved with the development of a 
group of drugs, generically known as β-blockers, and used to treat a variety of cardiac ailments, 
hypertension, migraine and anxiety 63. In the same vein, it is thought that the GPCRs of pest 
invertebrates, including the AKHRs of insects, maybe suitable targets for new insect control 
agents with a more significant deal of species specificity than the conventional chemical 
pesticides. One of the steps towards achieving this goal is to know the AKHR binding site, the 
3D structure of both ligand and receptor. Unfortunately only very few 3D structures of most 
GPCR/AKHRs are available. 63.  
1.4.4 GPCRs class A activation 
Ligand binding stimulates the activation of class A GPCRs from the extracellular side of the 
receptor through conformational changes apparent in the α-helices 29,90,139,141,142. Opsins (colour 
pigments and rhodopsin) are photosensitive GPCRs that differ from other Class A 
GPCRs/AKHRs as photons of light activate them 143. The rhodopsin ligand (chromophore, 11-
cis-retinal), which is protonated by a Schiff base, is covalently bonded to a Lys residue in 
Helix7 89,101,144–147. Within femtoseconds on exposure to light, the receptor-ligand changes its 
conformation from 11-cis to all-trans 29,89,100,101,148. The activation of the rhodopsin GCPR 
receptor involves neutralisation of the Schiff’s base counterion, which in turn leads to a 
conformal change of the molecule, particularly from the intracellular region that is related to 
the protonation of two cytoplasmic acidic residues 90. Experimental studies back the photo-
activation leading to the movements of TM3 and TM6, causing a break in the DRY ionic lock 
90.  




Molecular studies have shown that the binding cavity of some small agonists, viz; adenosine, 
3-peptide thyrotropin-releasing hormone, biogenic amines, and nucleotides are between TM3, 
TM4, TM5, TM6, and TM7149–152. Also, site-directed mutagenesis experiments indicated that 
some residues in ECL2 are essential for the binding of antagonists and agonists 153. The 
existence of a disulfide bond between ECL2 and ECL3 is known to covalently link the loop 
close to the binding site 153, making the ECL2 form a lid over the bonded ligand to prevent it 
from being released. Also, from mutagenesis of serotonin, it was suggested that ECL2 and 
ECL1 play an essential role in receptor conformal change 154 or even create a channel for ligand 
penetration into the binding cavity90. The same hypothesis of ligand channelling has also been 
postulated for rhodopsin 155,156. The participation of the extracellular domains in the binding of 
large peptide ligands has been documented in mutational studies of GPCRs, and it has been 
shown that the residues in the extracellular loop and N-terminus interrelate directly 157–161. 
Thyrotropin-releasing hormone (TRH), angiotensin II, neuropeptide Y (NPY), gonadotropin-
releasing hormone (GnRH) and chemokines are amongst the receptors reported with such 
findings 162–166. Experimental data have shown that residues found in the upper parts of TM2, 
TM3, TM5, TM6, and TM7 interact directly with particular neuropeptides, which include δ 
opioid, ETB endothelin and Y1NPY in humans 167–169. Only recently, the importance of the 
extracellular domains during ligand/receptor binding in molecular docking calculations 
relating to the insect neuropeptide binding to the pheromone biosynthesis and activating AKH-
receptor was reported 170–172. In biogenic amine receptors, identified binding cavities are 
different from the crucial positions assumed to interact with ligands 158. 
AKHRs / GPCRs are generally recognised to exist in equilibrium between the active and 
inactive states. Upon ligand binding, there exists a molecular inter-switch between both states. 
When bound to an agonist, the activated state is favoured, leading to the formation of the 
agonist-activated receptor-AKH/ G-protein complex 86,98,173. Similarly, antagonists bind to the 




receptor with a superior affinity for the inactive state when compared to the active state 33,174,175. 
However, neutral antagonists bind with an equivalent affinity for both inactive and activated 
states and do not have any effect on the constitutive activity. 
1.4.5 Signal transduction and G-proteins 
AKHR/GPCRs act on heterotrimeric G-proteins in the form of guanosine diphosphate (GDP) 
and guanosine triphosphate (GTP). The heterotrimeric subunits are denoted the α subunit, the 
β subunit, and the γ subunit 90,158. The α- and β subunits are attached to the plasma membrane. 
For a receptor to be activated, the ligand first binds to the identified cavity with the best pose, 
leading to a change in conformation of the GCPR. The conformal changes allow the GPCR to 
act as a guanine nucleotide exchange factor (GEF), and the G-α subunit then binds to either 
GDP (to become inactive) or GTP ( to become active). When becoming inactive, the two G 
protein subunits disconnect into two parts: the GTP-bound G-α subunit and a β-γ subunit dimer 
90,158,176–178. The separate units at this stage are no longer active but remain fixed to the plasma 
membrane. This will enable them to diffuse and interact with other G-proteins 179–181. To 
reactivate the system again, GTP is first hydrolysed back to GDP, which causes a revival of α 
-GDP and βγ-subunits once again, causing the receptor to assume the active heterotrimer state 
90.  
1.4.6 GPCRs structure 
GPCRs proteins with seven-transmembrane (7TM) α-helices in an anticlockwise arrangement, 
when observed from the N-terminus (extracellular region) (see Figure 1.5). 182–187.  Three loops 
connect the helices on the extracellular region, making up the N-terminus and another three 
loops connect the helices on the intracellular region, making up the C-terminus182. From one 
GPCR to another, the loops differ in length. GCPRs contain conserved residues that influence 




the discrimination of ligand from the extracellular side, whereas the conserved residues in the 
cytoplasmic region affect G-protein coupling selectivity187–189. 
 
Figure 1. 5: (a) Schematic diagram showing amino acid sequence and  (b) 3D structure of human β2 adrenergic receptor 
(PDB ID 3D4S). (c)  Schematic diagram showing amino acid sequence and (d) 3D structure of bovine Rhodopsin (PDB 
ID 1U19).  The black amino acid residues signify the end of the stable structural segment and the beginning of the next 
stable structural layer in the sequence. The seven α-helices of both GCPR representations are labelled H1-H7. The 
extracellular loops are denoted E1, E2, E3, while the cytoplasmic (intracellular loops) are C1, C2, C3. A small tail-like 
helix usually found in most GCPRs at the C terminal is denoted H8 adapted from Gruber 2010 123. 
The putative binding site for glycoprotein hormones and the largest polypeptides are located at 
the N-terminus 190–192. The expected ligand binding sites of GPCRs are the N-terminus or the 




extracellular loops, predominantly ECL2 106,123,190,193–196. Recently, over 109 GPCRs have been 
used as targets for developing new drug 92,197. In all the 109 targeted GPCRs, the extracellular 
part of the receptor has been identified as the most preferred ligand-binding site. To enable 
sufficient elucidation of the signal transduction pathway, efficient selectivity of ligands by 
GPCRs is of supreme importance for both side effects and correction of drug-drug interaction 
198,199. 
Binding affinity and molecular docking studies have proposed that related sequence motifs 
could identify ligands with similar chemical features and same biological space 186,187,200,201. 
However, in the binding site and the residues, physicochemical properties can be compared. 
Thus, in-class A GPCRs, the presence of conserved residues in the transmembrane regions, is 
vital in receptor activations. Also, ECL2 is essential to most GPCRs as it provides stability to 
the system, 120,195,202,203. The stability of the system is possible because of the presence of 
cysteine residue in the ECL2 and conserved CWxP motif in transmembrane six (TM6) 
193,204,205. The cysteine forms an ionic lock 202. The presence of this ionic lock helps to preserve 
the position of helices three and six together to maintain the protein structure 129,195. 
In the subfamily of opioid and chemokine receptors, the second extracellular loop forms a β-
hairpin conformation111. It is an excellent example because they make a common peptidic-
binding motif found in GPCRs. Sequence identity across the five families of GPCRs is low 
(below 25%), even though they both share the same 7 TM topology in humans, and there exists 
variation in the N terminal domain 111,206. Though, among subfamilies, the structural sequence 
resemblance is better between subtypes186,207. Hence, within subtypes, templates that permit 
predictions can be used by comparative modelling, which is precise enough for some 
applications. 




         
 
Figure 1. 6: (a) Crystal structure of corticotropin-releasing factor receptor 1 (CRF1) (PDB ID 4K5Y) within a 
membrane. (b) Crystal structure of glucagon receptor  (PDB ID 4L6R) within a membrane. (C) An overlay of the 
glucagon and CRF1 receptors 114. In purple sticks, the disulfide bond between TM3 and ECL2 is represented. The red 
arrow with a distance of 11Å between the Ca-atoms of glucagon receptor and that of the CRF1 receptor emphasise the 
structural difference between them. The alignment of both receptors indicated the binding site and showed the 
antagonist binding configuration around CP-376395, and a structural re-conformation around TM6 for both receptors 
adapted from Hollenstein 2014 124.       




1.4.7 GPCRs Three Dimensional (3D) Structures   
To get a proper understanding regarding the molecular functions of protein, and to enable the 
practical design of experiments especially molecular understanding of disease-related 
mutation, site-directed mutagenesis and structure-based design of specific inhibitors three 
dimensional (3D) structures of receptors are required 208,209.  
3D structures of GPCRs are limited despite their significance in physiological processes. The 
reason for this is most likely that the determination of 3D structures is very complicated. Also,  
experimental methods like X-ray crystallography and NMR cannot easily be applied for 3D 
structure determination, due to the flexibility of membrane-bound proteins outside a membrane 
and the difficulty in crystallising a membrane-bound molecule 29,128,141,190,210–212. The low 
solubility and relatively large molecular size of the receptors make it impractical to apply 
experimental techniques like NMR29,128,141,190,211–213. As a result, to date, the mammalian 
rhodopsin and the human Beta2-adrenergic receptor (β2AR)96,98,141 are the only resolved 
crystal structures of a GPCR 89,201,205. Even with these crystal structures, the highly mobile 
ICL3 has been removed. Due to the above-listed complexity of the experimental techniques 
and to reduce time and cost, the pharmaceutical industry has resorted to computational methods 
to obtain their molecular models of GPCRs. 
1.4.8 Crystal structures of Beta2- adrenergic receptors (β2AR) and Rhodopsin   
β2AR and rhodopsin possess comparable overall molecular structures 154 29,86,128,148,154. They 
both belong to Class A GPCRs 130,214,215, and rhodopsin belongs to a subfamily known as opsin, 
29,88,96,98,130 while β2AR belongs to the amine family 29,46,96,113,216. Both rhodopsin and β2AR 
experience similar conformational changes upon activation 46. 




1.4.9  Rhodopsin 
Rhodopsin is located in the retina of the eye and is stabilised structurally by a covalently 
bounded 11–cis retinal ligand 29,46,113,128,141,217–221. The first crystal structure 89, available with 
PDB ID 1F88A (see Figure 1.7 a &c ) had a resolution of 2.8Å. The resolved molecule had 
348 residues and a total of 194 TM residues. 
                   
Figure 1. 7: (a) Side view of the rhodopsin (PDB, 1F88A) crystal structure showing the α-helix (ribbon in green), and 
loops (purple). b) A view of the rhodopsin crystal structure from the extracellular region, demonstrating the closed 
conformation of the molecule. c)  Side view of the β-2 adrenergic receptor (PDB, 2rh1A) crystal structure showing the 
α-helix (ribbon in gold), and the loops (pink). d) A view of the β-2 adrenergic receptor from the extracellular region, 
demonstrating the open conformation of the helix bundle 156.  
The rhodopsin crystal structure, like any GPCR class A structure involves 7 TM helices with a 
tail like small helix parallel to the membrane inside the cell, it possesses 3 ICL and 3 ECL 
regions with a β sheet in ECL2. The molecule has an N-terminus which forms a cap-like 




structure over the molecule 29,98,222,223. The protein has the disulfide bond found in most 
GPCRs, between Cys110 of TM 3 and Cys187 in the second extracellular loop.   
Until 2007, the rhodopsin molecule (PDB, 2rh1A) was the only known GPCR crystal structure, 
and so was used as a template for building 3D molecules of most GPCR structures 156. Now, 
another crystal structure is available, which is (PDB code, 2X72) 224. 
1.4.10  Beta2-adrenergic receptor 
The β2AR crystal structure was published in 2007. The structure was achieved by replacing 
part of ECL3 with T4 lysozyme to reduce its flexibility. The resolution was 2.4Ǻ96,98,113 
(Figure 1.7 c & d), and is available in the PDB database (ID 2rh1A). The β2AR molecule has 
a broader range of signalling behaviour and can react to a spectrum of several diffusible ligands 
or peptides, coupled to more than one G-protein. Like the rhodopsin molecule, the binding site 
is the same 29,46,223. When compared to rhodopsin, β2AR has a more open structure when 
viewed from the extracellular region, and two disulfide bonds constrain its ECL2 to enable free 
access to the ligand-binding cavity 29,46.  
Modelling of large molecules, such as AKHR is dependant on available template structures. 
Template 3D structures constructed using computational techniques may slightly differ with 
3D structures constructed using an experimental technique (by NMR or x-ray crystallography). 
Nevertheless, the crystal structures of β2AR and rhodopsin provide valuable information 
regarding the structure and activity of Class A GPCRs, and has, consequently, simplified 
structure-based drug design.  
1.5.0 Research Motivation and Statement of the Problem 
Insect control via commercially available non-specific toxic chemicals has resulted, over the 
years, in some of the harmful insects gaining resistance to the widely used insecticides (Wang 
et al., 2018; Gould et al., 2018). Furthermore, a potential risk to food production may arise in 




the near future due to indiscriminate killing of pollinator insects (collateral damage) as a result 
of continued use of conventional broad-spectrum toxic chemicals225,226. Some of these 
chemicals are carcinogenic, and somehow, these chemicals find their way into the stomach 
leading to severe health problems 227,228. This has spurred on the search for “green insecticides” 
(a species-specific pesticide that is selective in its action. Negatively affecting the pest insect 
and causing no harm to the beneficial insect, other animals and the environment) that can serve 
as a viable and responsible alternative to current practices. One idea for developing a green 
insecticide is to target the GPCRs that are involved in endocrine signalling in insects. Because 
the regulation of metabolism is of such fundamental importance in insects, the adipokinetic 
hormone signalling is investigated in this thesis. For the AKH system to be seriously evaluated 
as a potential application in green pesticides, research into structure-based ligand-AKHR 
interactions is needed for pest and beneficial insects to find those that are specific to pest insects 
for further drug development. Essential in this regard, is the availability of 3D AKHR models. 
Even though the relationship between physiological process and 3D structures are vital, very 
limited 3D structures of insects AKHRs are available. The first models of an insect AKHR 
were published in 2011 for the receptor in the malaria mosquito A. gambiae 229; aside from this, 
there are no 3D models available for AKHRs of other dipterans.  
Literature has shown that about 50% of pharmaceutical industries target GPCRs, and the 
molecules are elucidated using homology models 128,170,172,214,221,230–238. From an accurate 
AKHR model, the binding cavity can be determined. With the aid of the insect AKH 
neuropeptide, structure-based design of non-peptide ligands (mimetics) that can act with high 
potency at the receptor as antagonists or agonists could be developed 239. Doing so could help 
in the production of insect-specific insecticides that could reduce the vector capacity of these 
insects by decreasing the amount of energy released during flight. Moreover, it could lead to 
the discovery of neuropeptide analogues that are selective in their activity and negatively 




influencing the targeted pest species without harm to beneficial insect species. Thus, enhancing 
the eradication of some of the damages caused by some of these insects. For this reason, this 
study focuses on the determination of the 3D structure and locating and comparing how one 
AKH, which is common to three fly species, binds to its cognate AKHR in each of the fly 
species. The AKH receptors of the three fly species are similar but not identical (see Chapter 
3, 4 and 5).  
1.6.0 Aim and Objectives 
1.6.1 Aim 
To explain via modelling how a single adipokinetic hormone (Phote-HrTH) can activate 
receptors from three different insects, namely, the flesh fly Sarcophaga crassipalpis, the 
vinegar fly (also called fruit fly) Drosophila melanogaster and the oriental fruit fly Bactrocera 
dorsalis. 
1.6.2 Specific objectives and expected significance of the research 
• Determine the solution structure of Phote-HrTH using NMR constrained molecular 
dynamics. 
o Record NMR spectra of Phote-HrTH in DPC micelle solution. 
o Use the measured nOe’s to determine average internuclear distances.  
o Conduct NMR restrained molecular dynamics in water and DPC micelle 
solution.    
• Use each primary sequence of the adipokinetic hormone receptor for all three insects to 
build three-dimensional structures of each, using the crystal structures of rhodopsin and 
β2AR as templates.   
• Refine the structures using molecular dynamics in a membrane. 




• Identify the binding pockets of the adipokinetic hormone receptors using site finder 
program and confirming the result with site map program. 
• Validate the Drosophila melanogaster β2AR model using experimental ligand 
mutation data. 
• Perform molecular dynamics of the receptor/ligand complex in a membrane. 
 
• Compare and contrast the results for the different insect species at a molecular level. 
1.7.0 Questions to be addressed in this work 
1. Are the three constructed 3D structures of the AKHR, based on two different homology 
model targets, i.e. beta2-adrenergic receptor and rhodopsin molecules, the same? If not, 
is there any correlation between the structures? 
2. What structural and conformational changes occur during MD simulations of the 
constructed models when in a membrane?  
3. How do these results compare to experimental data of other GPCRs? 
4.  How does the binding cavity location in these constructed AKHRs compare to those 
in Beta2-adrenergic receptor and rhodopsin? How does each adipokinetic hormone bind 
to its cognate receptor differ from one another?  How does this position agree with 
experimental results from other peptide GPCRs?  
5. What are the binding energies of the AKH to each receptor?  
6. What structural and conformational changes occur during the MD simulation of the 
beta2-adrenergic-based model? 
7. What is the correlation between the experimental data and molecular data on structure-
activity?   






Construction of the Three-dimensional Structure of Phote-HrTH 
via NMR Restrained Molecular Dynamics 
 
 Summary 
In this chapter, we present the 3D structure of Phote-HrTH (pGlu-Leu-Thr-Phe-Ser-Pro-Asp-
Trp-NH2). The structure was elucidated using NMR restrained molecular dynamics simulations 
in both water and micelle solution.  
Elucidation of the Phote-HrTH peptide structure was conducted with the aid of Ccp-NMR.  Both 
one and two-dimensional NMR spectra were used to resolve the secondary structure and 
orientation in solution and DPC micelle solution 107,240.    
The three-dimensional structure of Phote-HrTH has a β-type I turn H-bonding stabilises that. 
The β-turn is due to Pro6 and is stabilised by a moderately strong, transient H-bond between 
Trp8(NH) and Thr3(CO) as well as many other H-bonds between the side chains and backbone. 





2.1.1 Introduction  
2.1.2 Overview of some NMR structure elucidation programs.   
Experimental determination of the solution structure of Phote-HrTH was accomplished using 
NMR. NMR is a valuable tool for the elucidation of solution structures of biological molecules 
241–250. The solution structure elucidation was accomplished using the collaborative computing 
project for NMR (CcpNmr Analysis), a graphics-based data analysis, NMR resonance assignment 
and spectrum visualisation program 240. The CcpNmr Analysis program helps in the assignment 
of NMR spectra and the generation of structural constraints. Distance constraints are derived by 
integration of the NOESY cross-peaks and relating these to internuclear distances.  DANGLE251 
is used to calculate torsion angles from chemical shifts.   These restraints can then be fed into 
ARIA (ambiguous restraints for iterative assignment) and CYANA (combined assignment and 
dynamics algorithm for NMR applications) to calculate possible structures of the molecule.  The 
success of such a strategy for structure calculation depends on a complete list of chemical shift 
assignments 252. An experienced spectroscopist can calculate structures manually for small 
molecules, but it is cumbersome and time-consuming. ARIA or CYANA function through several 
refining cycles of conformational computations to reach a structural model with the least deviation 
from the experimental data 240,253. The calculated structure with minimum energy has maximum 
compatibility with the experimental data. This iterative process utilises preliminary structures from 
earlier cycles to reduce the ambiguities of cross-peak assignments. Additional selection criteria for 
cross-peaks and NOE- assignments are added after each cycle, and it yields better structures in the 
process. Cycle one is thus the most crucial one since it is the first for which a previous structure is 
not available 240,253. The key conformational data-input are upper distance limits resulting from 
NOEs 240,254.  





2.1.3 Brief information relating to chemical shifts 
All nuclei resonate at a particular frequency, but the precise value of this frequency can vary for 
even the same type of nuclei, it all depends on the local environment.  This phenomenon is called 
the chemical shift. Chemical shifts arise from small changes in electron density around a specific 
nucleus, and the electronic environment influences the difference in shifts seen for different nuclei. 
That is to say; the electrons induce a limited additional electronic field either opposing to or adding 
to the external magnetic field. This causes shielded and de-shielded nuclei, respectively 255. Hence, 
a nucleus resonates at slightly different frequencies, depending on the surrounding electron 
densities. Chemical shifts are reported relative to a reference standard to establish that the values 
are independent of the applied field. Thus, a standard table of values could be used by all 
spectroscopists 256. 
Standard chemical shift values for nuclei bonded to different neighbours are tabulated and are used 
to identify the signal arising from different functional groups in a spectrum. For example, hydrogen 
atoms of an amino acid resonate at a specific frequency depending on which atom it is bonded to. 
As such, there is a specific pattern of signals from each amino acid, and this is used to identify 
each residue type in a given protein spectrum. The signals expected for the 20 standard amino 




H 2D  
correlation spectra are shown in Figure 2.1. 257. The chemical shift values correspond to amino 
acids in random coil structures. 











Figure 2. 1. Schematic diagram showing the spin systems of the 20 standard amino acid residues in a COSY/TOCSY 1H-
2D NMR experiment. Only peaks on the left-hand side of the diagonal are shown. In an actual spectrum, identical peaks 
reflected about the diagonal can be visible. 258 A characteristic pattern of signals results from each amino acid from which 
the amino acid can be recognised. All peaks may be shown in a TOCSY spectrum. Filled grey circles show diagonal peaks; 
filled black circles illustrate cross-peaks which are observable in a COSY spectrum, filled black squares show new cross-
peaks observable in a TOCSY spectrum 257. Random coil 1H chemical shift standards are included 257. 
 
The spin systems have complicated names, letters and numbers. The letters refer to the different 





coupled spins. The numbers signify the number of magnetically equivalent nuclei. For a better 
explanation, the reader is referred to the book “NMR of proteins and nucleic acids” by Wüthrich 
chapter five 259.  
In this thesis, only the specific patterns of the spin systems and the labelling of the atoms are of 
importance. Figure 2.2 exemplifies how the atoms in an amino acid are numbered. The first 
carbon in the side chain (attached to the carbonyl carbon) is called the α-carbon. The attached 
proton(s) is(are) the α-proton(s). The successive side-chain atoms are named by following the 
Greek alphabet. Thus, a proton is labelled α, β, γ, δ or ε depending on which carbon in the side 
chain it is attached. The proton attached to the backbone amide is labelled HN the protons on 
the aromatic side chains are labelled according to the standard numbering 
                        
Figure 2. 2. Schematic diagram showing the amino acid arginine with side-chain carbons labelled as is standard amino acid 
numbering system, taken from 260. 
Chemical shifts are among the most detailed data collected from an NMR-spectrum of a peptide. 
The values are sensitive to the local environment, which is dependent on the secondary structure 
of the peptide.   261–263.
15
N, Hα- and amid-protons experience a net up-field shift when in an α-
helical conformation and a net downfield shift when in a β-sheet conformation.
13
C-shifts display 
the reverse trend, with downfield shifts for α-helical conformations and up-field shifts for β-sheet 





conformations. From the above trends, it is possible to measure a specific part of a structure’s 
flexibility. If chemical shift values are close to random coil values, then the peptide is likely to 
be flexible, whereas, chemical shifts far from random coil value point at a somewhat rigid 
structure 264. 
2.1.4 Chemical shift index (CSI) 
The chemical shift index is a widely used graphical method in protein NMR. It is used to identify 
and display the type of secondary structures (beta strands, random coil and helices) in polypeptides 
utilising only the backbone chemical shift information. CSI was first designed for analysing 1Hα 
chemical shifts, and later the 13C backbone shifts. CSI makes use of the already known principle 
that is 1Hα, the chemical shift of amino acid residues in helices tend to move towards the right side 
of an NMR spectrum (shifted upfield) relative to their random coil values and moves left side of 
an NMR spectrum ( downfield) in β-strands. A similar movement of the 1Hα is also found in the 
13C chemical shift 262,265,266.      
2.1.5 Backbone angles (torsion angle) 
Backbone angles are angles found between two intersecting planes. By comparing chemical shifts 
which were derived from a new compound with those of an already known structure, phi (φ− ) 
and psi (ψ−) angles can be predicted 81,267. These angles can then be used as an additional 
parameter, alongside NOEs and J-couplings when calculating the structure, see Figure 2.3.  
 






Figure 2. 3. Amino acid torsion angles. φ Is the torsion angle around the N-Cα, while ψ is the torsion angle around Cα –C’ 
bond. (A) Plane of a backbone peptide with the side chains oriented above of the plane (filled wedge) or below the plane 
(striped wedge). The arrows designate the rotational bonds. (B) Projection of the peptide in part (A), observed along with 
the bond of rotation from the atom drawn as a small circle to the atom drawn as a big circle. The bold black line represents 
the bond between the atom drawn as a small circle and its neighbouring atom. The thin black line represents the bond 
between the atom drawn as a big circle and its neighbouring atom. The atoms are coloured as in (A). 
2.1.6 Scalar (spin-spin) couplings 
Interactions between nuclear spins that occur during electron bonding are known as scalar or 
spin-spin interactions. The interaction is measured by the scalar coupling constant 
n
Jab, where 
n represents the number of covalent bonds separating the two nuclei a and b 268. With scalar 
coupling (J-coupling), magnetisation is conveyed through bonds: All the spins predictably have 
an effect on each other, and this can aid in the determination and labelling of functional groups 
255. In a J-coupled correlation spectrum, all protons within an amino acid have the tendency to 
couple with each other. Correlation with protons on adjacent amino acids is so small that it is 
not visible. The basis for this is described under the TOCSY section. The essential couplings 
from a spectroscopist’s point of view are n=1-4 269. Couplings between nuclei cause splitting 





of the NMR-signal. Weakly and strongly coupled two-spin systems are referred to as AX- and 
AB-spin systems, respectively269. J-values for n=1-3 are reliant not only on internuclear 
distance but also molecular structure. As such, one can obtain possible parameters for structure 
calculations from scalar couplings270. Particularly 
3
J-couplings (vicinal couplings) are useful 
in this respect. The value is dependent on substituents, the distance between the two carbon 
atoms involved, H-C-C-H bond angle, along with torsional and dihedral angles, with the latter 
angle being of most interest 270. 
3
J-couplings vary in magnitude in a bond-angle dependent 
manner. The relationship between the coupling constant J and the dihedral angle φ (see Figure 
2.3.) is given by the Karplus equation  256. Thus, J-couplings can be used to measure dihedral 
angles and thus conformational arrangements around bonds. 
2.1.7 Linewidth and signal: noise ratio 
As the molecular mass increases, so does the rotational correlation time. This has a profound 
effect on the linewidth of the peaks; the longer the correlation time, the broader the lines 269. Thus, 
the peaks become less well defined, and they overlap. The decreased sensitivity can be understood 
by considering the small 
3
J scalar couplings that coherence transfer relies on upon as the 
linewidths broaden, they become similar or even more significant than the actual J-values we try 
to measure 269. Linewidth thus affects the resolution of a spectrum, but it also affects the signal-
to-noise ratio 269. Signal-to-noise ratio, or sensitivity, is proportional to the square root of the 
number of scans in the experiment 271,272. 
2.1.8 Two-dimensional (2D) NMR- approaches TOCSY, NOESY, COSY and 
HSQC. 
Two-dimensional NMR was first presented during the summer school lecture by Jean Jenner 





at Ampére in former Yugoslavia in 1971 273, and the principles he summarised still govern 
current techniques. 2D-experiment can be summarised into four stages.  They include; 
sample preparation, evolution, mixing and acquisition (see Figure 2.4 ) 269,274–276  
 
Figure 2. 4. The framework of a 2D experiment, each box represents a stage in the 2D NMR pulse sequence. The two-time 
domains t1 and t2 are acquired during the evolution period and the acquisition period, respectively taken from 260. 
The initial stage, which is the preparation phase, involves one or more pulse, perturbing the 
system from the original equilibrium state to a preparatory state. The evolution period (2nd stage) 
involves a sequential increase in t1 to achieve the F1 dimension in a broad spectrum. In the third 
stage, the mixing coherence is moved from one spin to another. This stage of the experiment 
describes the kind of correlation to be observed between the two dimensions (the information 
present in the spectrum) hence the vital information of a 2D spectrum.  The last stage involves 
the acquisition and recording of the FID, which give rise to the F2 (t2) dimension 277. At each 
stage, the evolutions of spins are recorded, and a possible image of events is gained. This means 
that one can trail the movement of the magnetisation from one nucleus to another either through 
space, bond or even both. 
  
In general, the correlation grows with mixing time, the longer the mixing time the more 
correlation.  On the other hand, because of nuclear relaxation, the signal decays with time (T1 





relaxation time).  Thus the two effects counter each other, and a compromise time is used.   241. 
2.1.9  Correlation spectroscopy (COSY) 
One of the first 2D techniques was COSY technique 274. Cross peaks result from protons divided 
by three or two bonds 269. A limitation of this technique is that the diagonal and cross-peaks in the 
spectrum are out of phase by 90° in both dimensions and as such, require substantial weighting to 
improve cross-peak line shapes 245. Secondly, correlations between spins more than three bonds 
apart cannot quickly be assigned. Also, the elements of a multiplet are in antiphase; this means 
that if the coupling is less than the peak linewidth, it performs self-cancellation to reduced peak 
intensities 245,278. 
2.1.10 Total correlation spectroscopy (TOCSY) 
TOCSY is also known as homonuclear Hartmann-Hahn (HOHAHA). TOCSY utilises 
magnetism, which can be transported via some couplings throughout the mixing time 245. When 
the Hartmann-Hahn prerequisite is satisfied, pulses are then applied 271,279,280. Under these 
conditions, there is an efficient transferred of magnetisation amongst coupled nuclei. Only intra-
residual couplings are observable in TOCSY. 269. 
 In a TOCSY experiment, it is possible to obtain data regarding spins that are coupled to one 
another as a spin system. With the effective use of long mixing time, it is possible to transfer 
magnetism via a spin system and the whole set of cross-peaks for spin-coupled systems can be 
seen 271. Regrettably, amino acids having short chains loose intensity during long mixing times. 
Thus, when recording spectra, it is best to use and record different mixing times and to compare 
the results 279. TOCSY is commonly used for detecting each amino acid residue in a protein 
concerning the type of residue, but not to a specific residue. For example, cysteine, histidine, 
phenylalanine, tryptophan and tyrosine residues all give rise to the same array of connected 





cross-peaks (see Figure 2.5). It is possible from a TOCSY spectrum to only identify a spin 
system as belonging to this group, but not which amino acid in particular. Alanine, however, has 
a different signal and a specific assignment can be made from TOCSY. Even so, if there is more 
than one alanine residue in the sequence, one can only state that a signal comes from an alanine 
but not which one245. 
2.1.11 Recognition of spin-systems (TOCSY) 
The initial step in the assignment procedure is to decide which peaks belong to the same spin-
system; that is to the same amino acid. A TOCSY-spectrum provides this kind of information. 
As mentioned in the description of TOCSY-spectra above, only the type of spin-system can be 
determined in this step 260. Figure 2.5. demonstrates how the peaks in a spin-system are 
connected in different regions of a TOCSY-spectrum. 






Figure 2. 5. Example of TOCSY correlation diagram. Chemical shift scale in ppm  taken from Haugen et al.,260.  
Figure 2.5 exemplified spin system identification in a TOCSY spectrum. HN refers to the proton 
connected to the backbone amide nitrogen, α to the proton connected to the Cα in the side chain 
and β to the Cβ. Similarly, protons connected to carbons in longer side chains are labelled 
according to the carbon it is associated with. Thus, the peaks are labelled according to the protons 
that contribute to a particular peak in the same order as the magnetisation travels(Haugen et al., 
2005) 
By tracing all the peaks aligned through a line vertically from an amide-shift on the left-hand 
side of the diagonal (the amide region), the potentially scalar coupled peaks are identified. To 





verify that the peaks are coupled and not the result of another spin system, the corresponding 
peaks originating from the α-proton and β-protons in the alkyl region are also traced. An array 
of peaks like the one in Figure 2.5 shows all possible connections in a TOCSY spectrum for an 
AMX spin-system. Names of the different atoms are also given in Figure 2.5 exemplified by the 
peaks in the fingerprint region. In short, a peak is named by stating the origin of the magnetisation 
(first) and the destination of the magnetisation (last). Thus, the peak identified as α/HN is a result 
of magnetisation travelling from the α-proton to the amide proton, whereas the HN/α peak results 
from magnetisation travelling in the opposite direction; from the amide-proton to the α-proton. 
2.1.12 NOESY (Nuclear Over Hauser Effect Spectroscopy) and Sequential 
assignment of the spin systems  
NOESY depend on the nuclear Over Hauser effect, which links nuclei that are correlated through 
space 271.  Having recognised the spin systems, the next step is to sequentially assign the spin 
systems by identifying the intraresidual NOE couplings (see Figure 2.6.) (Haugen & Sophie, 
2005). The sequential assignment resulting from the outstanding dipolar NOE-peaks and distance 
restraints are obtained from the remaining dipolar NOE-peaks 282.   
 
  






Figure 2. 6. Example of NOESY correlation diagram in ppm  taken from Haugen et al., 260. Blue and black peaks are 
intraresidue peaks already identified in the TOCSY spectrum. The red and green peaks are interresidue α-to- amide 
and amide-to-amide peaks, respectively. The horizontal arrows indicate how the cross-peaks are perused.  
In the fingerprint region, sequential couplings between side-chain protons are identified. 
Starting at the α-proton of residue i and moving horizontally, it is possible to find a strong 
peak along with the amide shift of residue i+1. This is the interresidual NOE peak between 
the α-proton of residue i and the amide proton of residue i+1. Following the same approach, 
starting at the α-proton of residue i+1 and moving horizontally, one should find a strong 
interresidual NOE peak along with the amide shift of residue i+2.  In the same approach, cross-
peaks from β-protons to amide protons and other side-chain protons supports the connection 
of the spin systems established by tracing cross-peaks between α-protons and amide protons 
(not illustrated in Figure 2.6.): Starting at the β/γ-proton of residue i and moving horizontally 
along the ω2-axis, one should find a peak along with the amide shift of residue i+1. This is 





the inter-residual NOE peak between the β/γ-proton of residue i and the amide proton of 
residue i+1. Inter-residual cross-peaks between the amide proton of a residue and side-chain 
protons other than the α-proton of a neighbouring residue are generally weaker than the cross 
peak between α-proton and amide proton on neighbouring residues. One could also 
alternatively search for sequential connections in the opposite direction: Moving vertically up 
or down from the α-proton of residue i, one should find a strong inter-residual NOE peak. By 
looking horizontally along the ω2-shift of this inter-residual peak, one should find the α- 
proton of residue i-1. This can be visualised by following the arrows from residue i+1 to i in 
Figure 2.6 in the opposite direction as to what is drawn. Usually, a string of three consecutive 
spin systems is enough to determine the location of these spin systems. However, sometimes 
more than three consecutive spin systems have to be identified to pick out a unique sequence. 
The aim is to locate a string of consecutive spin systems that can only be positioned one place 
in the sequence. If there is more than one possible position for the string of spin systems 
identified (irrespectively of the number of consecutive spin systems), neighbouring spin 
systems must be located. The number of residues in the molecule, type of spin systems 
represented in the sequence and their distribution along the sequence determines how many 
consecutive spin systems are needed to assign that particular sequence with confidence. 
2.1.13 Heteronuclear single quantum coherence spectroscopy (HSQC) 
HSQC is a pulse sequence, which allows magnetisation to transfer from a nucleus of a sensitive 
proton to another insensitive nucleus (13C- or 15N-) via direct 1J-couplings.  This is thus a 1J-
coupled correlation technique and can be used in the assignment of 13C- or 15N peaks based on 
their proton assignments.   For carbon, one can expect correlation peaks throughout the entire 
carbon-bonded side chain of amino acid. For nitrogen, mainly the amide backbone cross-peaks 
are of interest, but for some of those amino acids with amides in their side chains, additional 
peaks are expected. The 13C- and 15N chemical shifts are used for structural calculations. 





2.1.14 Solvent suppression  
Most NMR experiments involving peptides and proteins are performed in aqueous solution-
90%H20:10%D20 283,284. The significant challenges with this approach are the generation of a 
dominant spectral peak resulting from the high proton concentration of the solvent. This high-
intensity solvent peak could lead to a problem of dynamic range. The primary aim of solvent 
suppression is to decrease the size of the NMR signal entering the receiver coil. Solvent 
suppression has two primary known methods, namely:  
a. Pre-saturation.  
b. Solvent non-excitation methods.  
Solvent non-excitation methods are only suitable for solvent suppression if the chemical 
exchange between the solvent and sample protons, either do not occur or occur at a rate slower 
than their longitudinal relaxation rate 245.  The rate of exchange can, to a certain extent, be 
controlled by pH and temperature 284.  
2.1.15 Structure calculation, the CcpNmr analysis-program 
A significant difficulty with NMR is the reliability with which all information can be accurately 
assigned and labelled. Having identified all spin systems and labelled them according to the 
amino acid sequence, additional information yielding distance constraints such as NOE- cross-
peaks, volumes of these peaks, three-bond J-couplings and chemical shifts are used to calculate 
a plausible 3D-structure 285. The success of such a strategy for structure calculation depends on 
an as complete a list of chemical shift assignments as possible 252. An experienced 
spectroscopist can calculate structures manually for small molecules, but it is cumbersome and 
time-consuming. Preferably, one of several computerised model-simulating programmes is 
used. Here the CcpNmr Analysis program has embedded in it servers like CYANA (Combined 
assignment and dynamics Algorithm for NMR Applications), and ARIA (Ambiguous 





Restraints for Iterative Assignment) for automated NMR structure calculation 240,253,286,287. 
What ARIA and CYANA do is perform several refining cycles of conformational computations 
to reach a structural model with the least deviation from the experimental data (Herrmann et 
al., 2002; Linge et al., 2003). The calculated structure with minimum energy is the structure 
that has maximum compatibility with the experimental data. This iterative process utilises 
preliminary structures from earlier cycles to reduce the ambiguities of cross-peak assignments. 
Current selection criteria for cross-peaks and NOE assignments are added after each cycle, 
yielding better structures in the process. Cycle one is thus the most crucial as a previous 
structure is not available 240,253,286,287. The important conformational data-input are upper 
distance limits derived from nuclear Over Hauser effects (NOEs) 286. A difficulty with NMR 
is the unreliability with which all information can be accurately assigned and labelled. As 
mentioned above, distances constraints from NOEs are essential for structure calculation. Many 
of the NOE cross-peaks cannot be unambiguously assigned, i.e. there is more than one possible 
assignment for the peaks. CcpNmr overcomes this obstacle in several ways. Firstly, all 
ambiguous cross-peaks are treated as the superposition of the signals from each of its multiple 
possible assignments and weighing them inversely proportionally to their interatomic distance. 
If all the correct assignments are among the assignments that are selected, the distance 
constraint is never falsified, even though incorrect assignments are also included 252,286,289. 
Constraint combination takes the above a step further; assignment from different, often 
unrelated, cross-peaks are combined to generate distance restraints. 
Furthermore, the concept of network anchoring is a powerful tool for eliminating false 
conclusions. The basis of network anchoring is that each NOE assignment must be connected 
to all other assignments in a network without contradictions. This ensures that constraints from 
unstructured coil-regions are not falsely forced into a defined structure252,286,289. 





The actual calculation performed by ARIA or CYANA is carried out by defining a target 
function that measures the agreement between a structure and a given set of constraints 
240,253,286,290. A low target function value reflects a confirmation that satisfies the constraints 
more closely than another with the higher function value. Thus, the best agreement between 
constraints and a calculated 3D structure is defined as the set giving the lowest target function 
value. Simulations done with different chemical shift assignments left out show that at least 
90% of the shifts must be assigned for a satisfactory result. If some "essential" assignments 
that contribute actively to the structure are left out, a higher percentage of assignment might be 
necessary for a correct structure calculation240,252. 
2.1.16 Computational methods  
2.1.17 Molecular mechanics (MM) 
MM is one of the first computational tools used for modelling large molecules (i.e., nucleic 
acids and proteins). It ignores the quantum properties of electrons and takes into account a 
straightforward explanation of nuclei and electrons as point charges based on the Born-
Oppenheimer approximation 291. The point charges are connected by springs (bonds) and other 
possible functions that describe electrostatic interactions and van der Waals.  The potential 
energy functions of the system, bond angles, bond distances and other parameters are first 
determined empirically based on specific sets of atoms. The potential functions and the 
experimentally determined parameters used to define the potential energy function of a system 
is known as a forcefield. 
2.1.18 Force field 
Forcefields are parameters and a collection of functions that are utilised to define the potential 
energy of a system. The terms used in resolving the total energy of a system are divided into 
non-bonded interactions and bonded interactions. In a general force field equation, the non-





bonded interactions are further divided into van der Waals and electrostatic interactions. Also, 
the bonded interactions are subdivided into angle bending, bond stretching, improper dihedral 
angles and proper dihedral angles 
2.1.19 Bonded Interactions 
These interactions are based on fixed atoms, namely, bond angle, torsional angle interactions 
and bond stretching. Bond stretching is defined as a harmonic potential that considers the 
compression and stretching of bonds which make atoms behave as if they are connected by 
springs. The energy of the bond varies with the square of its displacement from the natural 
bond length. The stretching of the bond can be described by the addition of quartic terms to the 
harmonic potential and the Morse potential.  
 




2                                                            2.3 
Where the potential energy stored in oscillator is given by ʋ, k is the spring constant, the final 
bond length l and the natural bond length lo. The energy of each bond in the system is defined 
by a reference value and force constant, and the harmonic potential can also be described as 
angle bending denoted by θ.  
 





                                                       2.4 
Torsional or dihedral potentials describe the energy contributions of improper and proper 
dihedral angles. Though some MM force field does not make use torsional potentials, instead 
to achieve the desired energy profile, they make use of non-bonded interactions between 1-4 
atoms in a dihedral angle. Torsional potentials are often established using a cosine series 
expansion where potential energy stored in oscillator is given by ʋ, w is the angular frequency 
. 
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𝑣𝑛
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[1 + 𝑐𝑜𝑠(⋂𝑤 − 𝛾)]
ℕ
𝑛=0
                                    2.5 
Equation 2.6 below shows the improper torsion, and the improper torsion angle is maintained 
at 00 or 1800 
 
         𝜈(𝑤) = 𝑘(1 − 𝑐𝑜𝑠 2𝑤)                                                        2.6 
2.1.20 Non-bonded interactions 
 
Electrostatic interactions describe the forces experienced by atoms as a result of their charges. 
They are treated using the classical pair-wise additive Coulombic term. 
 
          𝜈(𝑟𝑖𝑗) =
𝑞𝑖𝑞𝑗
4𝜀0𝑟𝑖𝑗
                                                                      2.7 
Where the potential energy is given by ʋ, rij is the distance between i and j, qiqj are the atomic 
charge and εo is the permeability of free space. London forces are generally known as Van der 
Waals interactions. They mostly described as either repulsive or attractive forces between 
instantaneous dipoles. The van der Waals interactions are usually treated by Lennard Jones 
potential and are often shortened at a cut-off distance. To smooth truncated forces and thermal 
noise around the cut-off radius, different functions can also be applied. 
 










]                                                        2.8 
The general class 1 forcefield is described by equation 2.9. 
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            2.9 
 
2.1.21 Restraints and constraints  
During simulations, constraints are applied to help fix angles or bonds. Constraints are different 
from restraints. Constraints are used to position the restrained entities as close as possible to 
value.    Restraints are applied by improving an additional term to the potential energy function 
of a system, and a penalty is applied to the energy of the system when the bond or angle deviates 
from the reference value. Distance restraints are used to refine structures using NMR data. 
Targeted restraint is mostly generated from NOESY data 292. Targeted distance restraints can 
be applied using the following relationships (see equation 2.10) below a specified lower bound 


















         
𝑓𝑜𝑟      𝑟𝑖𝑗 < 𝑟0
     𝑓𝑜𝑟    𝑟0 ≤ 𝑟𝑖𝑗 < 𝑟1
        𝑓𝑜𝑟       𝑟1 ≤ 𝑟𝑖𝑗 < 𝑟2
𝑓𝑜𝑟         𝑟2 ≤ 𝑟𝑖𝑗
               2.10    
 
2.1.22 Minimization Energy (EM) 
EM is executed to remove steric clashes that may lead to instabilities of the system during 
molecular dynamics simulation. EM is achieved by searching for the global minimum energy 
potential of a macromolecule which is zero. Sometimes, the configurational space 
dimensionality of a macromolecule and the number of local minima the molecule have can be 
very high, making it impossible to sample the whole conformational space. To enable the 





determination of the global minimum within a short period, it is much easier to determine the 
nearest local minimum by systematically moving down the steepest local gradient of the 
potential energy function. Some EM methods usually applied include the L-BFGS and steepest 
descents. 
2.1.23 L-BFGS 
The L-BFGS is achieved by successively producing improved approximations of the Hessian 
matrix from a previous step, and a fixed number of corrections is used293.  
2.1.24 Steepest descents 
The Steepest descents EM is categorised under first-order minimisation algorithms. It does not 
consider any history built up in previous steps, and instead, it takes a step in the direction 
parallel to the force of the system. The motion is usually downhill, and the size of the step can 
be adjusted to achieve a quick result294.    
2.1.25 Temperature and pressure coupling 
In terms of energy potential, MD simulations can be executed under different conditions like 
NVT and NPT where the N = signifies the number of molecules in the system, V = volume, P 
= pressure, T = temperature. Usually, N and T are kept constant, and either P or V allowed to 
vary. For example, while studying the flexibility and stability of a GCPR molecule in a mimetic 
membrane all placed in a water box, the NPT ensemble is mostly preferred294,295. Likewise, in 
our systems, which are also highly flexible, for a proper understanding of how peptides activate 
a receptor leading to a conformational change, we performed MD simulations under NPT 
condition 296,297.    
2.1.26 Simulated annealing (SA) 
SA is a method used to search for the minimum energy of a molecular system. During SA, the 
temperature of the system is increased such that the system occupies high-energy states of its 





conformational space and can cross energy barriers217,298–300. The temperature is then dropped 
slowly to allow the system cool without becoming trapped in high energy conformations. At 
this stage, the lowest energy conformer could be attained. At absolute zero, it is expected that 
the system should occupy the lowest energy state that corresponds to the global minimum 
energy conformation217,298–300.  
2.1.27 Molecular dynamics simulations 
Molecular dynamics simulation technique encompasses the incorporation of Newtonian 
equations of motion for numerous molecules interacting over the control of a force field (F) t 
298,301 see equation 2.3 and 2.4.   
 𝑭 = 𝑴a           2.3 
Where F is the force field, M is mass, and a is the acceleration 






                                                                                                     2.4 
Where, mi = mass of an atom along one coordinate xi, Fxi = force on the atom in that direction. 
Integrating the equations of motion help define how the accelerations, velocities and positions 
of a molecule in a system can vary with time 298,301. 
2.1.28 Algorithms 
The potential energy function in molecular dynamics is made up of 3N atomic positions, which 
makes it extremely difficult to get an analytical solution to the equations of motion. To proffer 
a better solution that regard integration algorithms have been developed from the Taylor series 
expansion equation. The algorithms are the leap-frog algorithm, the Verlet algorithm, velocity 
Verlet algorithm and the Beeman's algorithm302–304. 





2.1.29 Varlet algorithm (VA) 
 
The VA 305 is the most commonly used algorithm for integration in MD simulations298. See the 
following equations.  
𝐫 (𝐭 +  𝛅𝐭) =  𝟐𝐫(𝐭) −  𝐫 (𝐭 −  𝛅𝐭) +  𝛅𝐭𝟐𝐚(𝐭)                                                             2.5 
𝐯(𝐭) =
[𝐫 (𝐭 + 𝛅𝐭)– 𝐫(𝐭)]
𝟐
𝛅𝐭                                                                                                    2.6 
𝒗 (𝒕 +. 𝜹𝒕) =
[𝒓 (𝒕 + 𝜹𝒕)– 𝒓(𝒕)]
𝜹𝒕
                                                                                              2.7                                                      
Where r = positions, a = accelerations, t = time and r (t - δ t) is the positions from the previous 
step while t + δt, r (t + δt) = is used to calculate the new positions at time t.  δt = is the time 
step.  
2.1.30 Leap-frog algorithms (LFA) 
The LFA 303, is a deviation of the VA with the following equation 2.8 and 2.9 298.  
𝒓(𝒕𝜹𝒕) = 𝒓(𝒕) + 𝝂 (𝒕 +
𝟏
𝟐




𝜹𝒕) = 𝝂 (𝒕 −
𝟏
𝟐
𝜹𝒕) + 𝒂(𝒕)𝜹𝒕                                                                   2.9 
Where r = positions, a = accelerations, (𝒕 +
𝟏
𝟐
𝜹𝒕) = time and t + δt = leap-frog velocity at a 
particular position of time 298,301. The LFA is cheaper and easy to apply when dealing with 
large molecules during MD. Choice of time step during the simulation  
The time step to be used when conducting MD simulations is crucial because if for any reason, 
a wrong time step is used it could lead to severe artefacts (i.e. thermostat artefacts, the origin 
of layer structure artefacts, collective motion artefacts and nonlinear resonance artefacts) 298,306. 





It is advisable, during simulation, to use as small a time step as possible.  However, shorter 
time steps mean more computational time.  In practice, a compromise is used.  298,307. 
Conducting MD simulation with Groningen machine for chemical simulation (GROMACS), a 
time step of 1 fs or 2 fs is normally used307,308. 
2.1.31 Periodic boundary conditions (PBC) 
PBC assist in the minimisation of the edge effects in a finite system 298,307,309–311. PBC is usually 
used for approximation of an infinite (extensive) system, by using a small part of a unit cell 
(Figure 2.7). Theoretically, any cell shape not limited to, hexagonal prism, cube, hexagonal 
prism, elongated dodecahedron, rhombic dodecahedron and truncated octahedron, can be used 
as long as it covers all space by translation operations of the inner box in a 3D format. 
Typically, a minimum image convention is used where a particle in the central box does not 
see more than one image of another particle within the box.   
                                                          
Figure 2. 7. Schematic diagram showing periodic boundary condition in two dimensions. Where x  is the length of the 
box in one direction, and dx is the distance direction of the vector from one object i  to another to object j. The horizontal 
x and the vertical y represent the two Cartesian coordinates 307,311. 





2.1.31.1 Elucidating the solution structure of Phote-HrTH 
2.1.31.2 Preparation of sample  
Phote-HrTH (pGlu-Leu-Thr-Phe-Ser-Pro-Asp-Trp-NH2) was bought from Peptic Co Ltd, 
China. Its purity was tested with HPLC–MS and establish to be > 98% pure. NMR samples 
were prepared by dissolving the dry peptide in a solution consisting of 150 mM sodium 
dodecyl-d25 sulfate (SDS), 20 mM phosphate pH 4.5, 0.05 mM TSP (trimethylsilyl propionate) 
and 10%v/v D2O to reach a final peptide concentration of 2 mM. Another sample was prepared 
by dissolving ~1 mg of Phote-HrTH in 0.5 ml of 30% deuteron-DMSO, which was 20 mM in 
phosphate buffer.    
2.1.32 NMR experiment  
All NMR spectra were obtained at 310 K on an 800 MHz Bruker Advance II spectrometer 
equipped with a 5mm TCI cryoprobe. 1H homonuclear TOCSY (mixing time τmix = 80 ms) and 
NOESY (τmix = 150 and 300 ms) were acquired with 512 points in the F1 dimension and 4k 
points in the F2 dimension.  Between 16 and 32 transients were accumulated with a 1.5 s 
recycle delay.   The data were multiplied with a squared sine bell function shifted by 90°.  The 
1H spectral window was set to 9600 Hz. 13C-1H HSQC experiments were performed with 256 
points in the F1 dimension and 4k points in the F2 dimensions.  64 Transients were acquired 
with a 2s recycle delay. The 13C spectral window was set to 33200 Hz. Non-uniform sampling 
15N-1H HSQC experiments were performed with 25% of 128 points in the F1 dimension and 
4k points in the F2 dimensions. 1024 Transients were acquired with a 1.5 s recycle delay. The 
15N spectral window was set to 3240 Hz. 
All data dimensions were zero-filled to twice the respective FID size. 1H chemical shifts were 
referenced to TSP at 0 ppm. Data were processed in Topspin (Bruker) then analysed using the 





CCPNmr Analysis program240,312–314.  Backbone and side chains were assigned using all 
experiments. 
2.1.33 Structure calculations 
The structure determination was achieved through the assignments of NOESY cross-peaks, 
after which NMR distance restraints where generated. The generated NOE distance restraints 
were supplemented with dihedral angle restraints predicted with DANGLE from Hα, HN, NH, 
Cα, Cβ chemical shifts
251. A standard CNS 1.1-based protocol was employed using the ARIA 
2.2 interface315. Ten lowest energy structures were refined in a water shell and evaluated with 
MolProbity316. 
The lowest energy structure from ARIA 2.2 was used as a starting structure for restrained 
molecular dynamics using GROMACS 2018.6 301,308,317.    
2.1.34 MD simulation  
2.1.35 Restrained molecular dynamics of Phote-HrTH 
The starting structure of Phote-HrTH was obtained using Ccp-Nmr software 240. Using the 
steepest descent algorithm, the structure was energy minimised for 50,000 steps. Using 
GROMACS version 2018.6, NMR distance restrained molecular dynamics simulations were 
conducted both in water and dodecyl phosphocholine (DPC) 301,308,317.  All molecular dynamics 
simulations were carried out using time-averaged NMR restraints with a disre-tau of 10 ps, a 
time step of 2 fs, and the OPLS-AA/L, all-atom force field.  The inter-nuclear distances 
determined from the NOE spectra were modified by adding 10 or 20% to set the first and 
second upper limits of a square well potential 318.  The potential was set to zero between the 
lower and upper bounds and increased quadratically (Force constant 1000 kJ mol−1nm−1) 
beyond that. The LINCS algorithm was applied to constrain all bonds. For van der Waals and 
electrostatic interactions, a cut-off of 1.0 nm was used.  





2.1.36 Simulation in water 
Using the single point charge (SPCE) water model, a box containing the peptide, and 7000 
water molecules with a cut-off of 1.0 nm was constructed. After equilibration, molecular 
dynamics was conducted for 10 ns at 300 K under NPT conditions. In total, 200 structures were 
collected at 50 ps intervals. Cluster analysis was then done using the linkage algorithm of 
GROMACS and a cut-off value of < 0.1 nm for superimposing backbone atoms. The minimum 
energy conformer from the most significant cluster gave the structure of Phote-HrTH. 
2.1.37 Simulation in water/DPC mixture 
The lowest energy structure from the most significant cluster from the water simulation was 
used as the starting conformer of Phote-HrTH in micelle solution.  The peptide was placed in 
the centre of a 7 nm cubic box filled with a 50 DPC molecule micelle and 10 000 water 
molecules. 319 The micelle was translated so that the centre of the micelle was at the bottom 
edge of the box. This meant that using periodic boundary conditions, half the micelle was at 
the bottom of the box and the other half was at the top. The peptide was then placed in the 
centre of the box. Energy minimisation was carried out, using the steepest descent method, for 
10,000 steps or the tolerance was < 10 kJ mol−1or to machine precision. Two stages of system 
equilibration were performed to solvate the peptide and to accomplish a steady starting state of 
temperature, pressure, and density. The first stage of equilibration involved performing MD 
for 100 ps under NVT conditions at 300K followed in the second stage by a further 1 ns MD 
under NPT conditions. The final MD simulation was for 10 ns, during which 200 structures 
were. Cluster analysis was performed in the same manner as before.  





2.1.38 Results and Discussion 
2.1.39 Spectral assignment  
Phote-HrTH is hydrophobic but readily soluble in SDS micelle solution; this signifies that the 
peptide interacts with the micelle. This interaction was confirmed by measuring the diffusion 
coefficient of the peptides, which was found to be approximately 8 × 10−11 m2s−1, which gives 
a micelle size of roughly 56 DPC molecules. Given the insensitivity of the diffusion coefficient 
to molecular mass, this is in good agreement with our assumed size of 50 DPC molecules per 
micelle but, more importantly, justifies our use of the NOESY pulse sequence for such a small 
peptide. An expanded assignment of the NH -Hα region of both the TOCSY and NOESY 
spectra is given in Figure 2.8. 
 
Figure 2. 8  Phote-HrTH spectral assignments of TOCSY (RED) and NOESY (green) overlay showing an expansion of 
the NH -Ha region with chemical shift (ppm).    





The chemical shifts and assignments of Phote-HrTH, in an SDS micelle solution, are given in 
Table 2.1.  These data were used to compute structure-induced chemical shift changes using 
the CSDb algorithm 320,321.  
Table 2.1. Chemical shift (ppm) assignments for Phote-HrTH 150 mM SDS micelles, pH 4.5, 2mM peptide, Temp = 310 
K referenced to TSP 
 
 
Residue N H HA. HB HG CA CB CG. Others 
1 Glu - - 4.39 2.36* 2.53
* 
59.6 28.2 32.2  




55.3 42.6 27.4 HD1 0.93, HD2 0.89, 
CD1 25.5, CD2 24.2 
3 Thr 115.1 7.98 4.30 4.14 1.09 61.7 70.1 21.4  
4 Phe 122.0 7.75 4.58 2.98*  - 40.3  HD 7.15, HE 7.21, HZ 
7.15, CD 131.9, CE 
131.3, CZ 129.7 
5 Ser 117.4 7.70 4.58 3.59, 
3.53 
 - 63.8   
6 Pro - - 4.15 1.68* 1.54, 
1.46 
55.9 31.6 27.0 HD1 3.10, HD2 3.42, 
CD 50.3 
7 Asp 120.4 8.09 4.52 2.69, 
2.46 
 54.4 41.1 -  
8 Trp 120.8 7.39 4.63 3.24*  - 30.1  NE 128.9, HD1 7.20, 
HE1 9.90, HE3 7.53, 
HZ2 7.40, HZ3 7.02, 
HH2 7.09, CD1 127.5, 
CE3 121.1, CZ2 114.4, 
CZ3 121.7, CH2 
124.2,  
 





2.1.40 Peptide flexibility 
The NMR chemical shift assignments are given in Table 2.1 and were used to probe the 
solution structure and flexibility of Phote-HrTH in SDS. Berjanskii and Tremblay et al. 265,322 
have demonstrated that by contrasting the measured chemical shifts to literature values for a 
random coil structure, some idea as to the structure and flexibility of the peptide can be obtained 
265,322.   Structure-induced chemical shift changes (observed shifts minus random coil reference 
values) were analysed using the CSDb algorithm available at   
andersenlab.chem.washington.edu/CSDb/about.php 320,321. Figure 2.9 shows a plot of random 
coil chemical shift deviations for Phote-HrTH.  Apart from Pro6, all the H deviations are small 
and downfield, while the HN shifts are both upfield and downfield.  Polypeptides with a helical 
structure have, HN and H chemical shifts which are, on average, −0.30 ppm less than their 
random coil values, while -sheet structures have shifts of ca. 0.4 ppm323. Thus, the results for 
Phote-HrTH indicate that it has some turn-like structure.  Similar results were found for Declu-
CC from the meloid beetle, Decapotoma lunata, Melme-CC from the Fruit beetle Pachnoda 
sinuata 324 and Dappu-RPCH from Daphnia pulex325. 
                
                               Figure 2. 9. Phote-HrTH random coil chemical shift deviation in SDS micelle solution. 
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Applying the Random Coil Index tool 322, the chemical shifts can also be used to estimate the 
model-free order parameter, S2, of Phote-HrTH (see Figure 2.10).  An order parameter of 1 
signifies the peptide is rigid, while an order parameter of 0 signifies the peptide has no structure.  
Figure 2.10 shows that Phote-HrTH is inflexible (rigid), with a maximum order parameter of 
0.97 around serine, whereas the C-terminal has less ordering (S2 = 0.96).   
 
                   Figure 2. 10. Phote-HrTH S2 order parameter calculated using RCI. 326 
Similarly, one can calculate the dynamic molecular root means square deviation (RMSD) and 
NMR RMSD.  The result obtained (Figure 2.11) shows that, as expected, Phote-HrTH is more 
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Figure 2. 11. MD and NMR root-mean-square deviations (RMSD)  
2.1.41 MD Analysis  
2.1.42 Simulation in water 
94 NMR derived NOE distance restraints, together with dihedral angle restraints predicted with 
DANGLE from Hα chemical shifts, were used to refine the structure of Phote-HrTH in water, 
using ARIA 2.2.  The results shown in Figure 2.12b is an overlay of the 10 lowest energy 
structures.   All the structures had the same basic shape but differed in the orientation of some 
of the turns, particularly at the N-terminus.  MolProbity analysis of the structures showed them 
to have no violations, no clashes and all torsion angles to be in the allowed or favourable 
Ramachandran space316.   
The lowest energy structure from the ARIA analysis was used as the starting structure for 
restrained molecular dynamics in water.   After a 10 ns simulation, cluster analysis gave one 
(Figure 2.12 a) dominant cluster, indicating that the conformation of the peptide is highly 
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Figure 2. 12. (a) Lowest energy conformation of Phote-HrTH calculated using NMR restraints in water. (b) overlay of 
10 lowest energy conformation of Phote-HrTH clusters. ARIA was used to generate these results.     
The three-dimensional structure of Phote-HrTH possesses a β-type I turn and is stabilised by 
H-bonding. The β-turn is due to Pro6 and is stabilised by a moderately strong, transient H-bond 
between Trp8(NH) and Thr3(CO) as well as many other H-bonds between the side chains and 
backbone. Further analysis was conducted to back up the β-type I turn postulate using the 
COUDES server 327 available at mobyle.rpbs.univ-paris-diderot.fr/cgi-
bin/portal.py#jobs::COUDES.M24372186968088. The prediction of the server was similar to 
our prediction in that a β-turn was found in the central residues of the motif, Ser-Pro-Asp-Trp. 
These observations agree with the S2 parameters and chemical shift deviations given before 
(Figure 2.9) and the random coil parameters (see Figure 2.10).  
2.1.42.1 Simulation in DPC.  
The root conformation from the water simulation was used as the starting structure for 
simulation in a DPC micelle solution.  The simulations were started with the peptide in the 





middle of the solvent box, but it quickly diffused to interact with the micelle.   
  
Figure 2. 13. Interaction of Phote-HrTH with DPC micelle solution, between 1ns – 2ns of MD. b) Interaction of Phote-
HrTH with DPC micelle solution, between 2.5 ns – 10ns of MD. c) Interaction of Phote-HrTH with DPC micelle solution 
after 10ns of MD. 
Depending on the starting orientation of the peptide relative to the micelle, the peptide would 
interact with the phospholipid and move away (see Figure 2.13) until a stable orientation was 
established.  To elaborate more on this, see Figure 2.14, where the peptide/DPC contact area 
is plotted as a function of time.  For Phote-HrTH, contact between the DPC and micelle is 
established during the first 10 ns.  After that, it is stable for 20 ns before the peptide moves 
along the surface of the micelle. It is interesting to note that the contact area between Phote-
HrTH is much higher than those reported for Declu-CC, Melme-CC and Dappu-RPCH but 
similar to that of Locmi-AKH-I 325.  The interaction between the peptides and the lipid surface, 
as shown by the contact area, is interesting as it has been postulated according to 'Membrane 
Compartments Theory", a flexible neuropeptide is postulated to first binds to its membrane. The 
membrane induces conformal changes before the peptide recognises and bind to its receptor 328,329. 
Hence, surface binding is an essential step in receptor activation. 







 Figure 2. 14.  Contact surface area (nm2) between Phote-HrTH and DPC micelle as a function of time. 
 
Cluster analysis of the trajectory gave a single large cluster for Phote-HrTH (Figure 2.15).   
The predominant conformation of Phote-HrTH does have a turn feature but a more open 
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Figure 2. 15. a) The lowest energy conformation of Phote-HrTH calculated using NMR restraints in DPC micelle. b) 
Overlay of 50 lowest energy structures of Phote-HrTH calculated using NMR restraints in DPC micelle.  
Figure 2.15 (a and b) illustrated a clear -turn around its proline residue. A tightly coiled 
conformer in the DPC solution was observed when compared to the starting structure (see 
Figure 2.12). 
Conclusion  
Phote-HrTH has been studied in both watter and micelle solution. The results have shown that 
Phote-HrTH has a natural  -turn and is not very flexible, having a model-free order parameter 
of 0.97 in the micelle-bound state. H-bonds between Trp8(NH) and Thr3(CO) as well as H-
bonds between the side chains and backbone stabilise this conformation. In general, the 
molecule has an opened conformation. 









To predict structure-based drug-ability of insect AKHRs, the newly available genome of the 
flesh fly AKHR was used to construct a three dimensional (3D) model of the receptor Sarcr-
AKHR 120,190,330.  Homology modelling techniques were employed using two target crystal 
structures, namely the beta2-adrenergic receptor (β2AR) and rhodopsin.   The β2AR 
structure has an open conformation meaning the receptor is inactive, while the rhodopsin 
structure possesses a closed, active, conformation.   To adequately explain the active and 
inactive conformation of the constructed models, these two target models were necessary. 
This is because literature has shown that active rhodopsin does not allow the diffusion of a 
ligand into the binding site 224,331.   
 
3.1.0 Introduction. 
The flesh fly (S. crassipalpis) is a carrion feeder and used in forensic entomology for estimating 
corpse death, as well as being used in labs as models for insect physiology and biochemistry. 
50–52. However, flesh flies are both beneficial and pest insects 6,7. The flesh flies are associated 
with some deadly diseases to both humans (they carry leprosy and transmit intestinal pseudo 




myiasis) and animals (causes myiasis and blood poisoning) 50–52.  Since the flesh flies have 
both beneficial and pest characteristics, care needs to be taking while managing them. The 
conventional method of managing them is by the use of chemical pesticides of which somehow, 
they have developed resistance37,38. These chemical pesticides do not just kill them but kill 
another beneficial insect, and they could also affect humans negatively. As such, there is a need 
for better and efficient insecticides (green insecticide) that will be selective in their activity, 
negatively affecting the targeted pest species without causing damage to valuable insect 
species.   One way of achieving the green insecticide is to target the GPCRs of pest insects29–
33,41,42. 
Neuropeptides and their G-protein-coupled receptors are considered suitable targets for new 
insect control agents, similar to the bases used in the enhancement of drugs for the treatment 
of human disease 29–33,41. 3D structures of GPCR/AKHR and ligand are crucial for molecular 
explanation and understanding of ligand binding and activations of receptors. However, to date, 
very few 3D structures of insect GPCR/ AKHR are available. Thus, the absence of adequate 
literature and elucidated 3D models hinders template target virtual screening332,333. Also, the 
lack of  3D models and inadequate ligand information has hinders ligand-based approaches to 
drug discovery  92,334.   Adequate information on 3D structures of adipokinetic hormones and 
their cognate receptors from different insect pests could help in the development of mimetic 
neuropeptide analogues that are selective in their activity, negatively affecting the targeted pest 
species without causing harm to beneficial insect species. 
Here we used the primary amino acid sequence from the flesh fly AKHR for the construction 
of 3D models of Sarcr-AKHR via homology modelling. To conduct homology modelling, there 
is a need for a template structure; these templates must have a sequence closely related to the 
protein being built. The amino acid sequence uniquely determines the structure of a protein. 




Knowing the sequence, it should, at least in theory, suffice to obtain the structure 209,330,335–338. 
Since we are interested in the activation of the receptor, models of both the active and inactive 
structures were constructed. The receptors were built based on the crystal structures of 
rhodopsin and beta2-adrenergic receptor (β2AR). Thus, the β2AR model is described as the 
open or inactive models, while the rhodopsin based model is termed the closed or active model. 
239 The closed conformation of the rhodopsin-based model is similar to the rhodopsin crystal 
structure where the close nature protects cis-retinal from hydrolysis.   
In this chapter, the constructed Sarcr-AKHR 3D model from the rhodopsin template will be 
referred to as the Rhodflf-model, while the Sarcr-AKHR 3D model constructed from the β2AR 
template will be referred to as the β2flf-model.  
3.2.0 Experimental Methods 
3.2.1 Constructing the α-helices 
3.2.2 Secondary structure prediction 
The primary sequence of Sarcr-AKHR was obtained from Genbank database accession number 
AOC38019.1.43 PSIPRED 4.0339–341and MEMSAT-SVM342,343 programmes, available on 
http://bioinf.cs.ucl.ac.uk/web_servers/, were used to predict the secondary structure and the 
transmembrane regions of the receptor. PSIPRED 4.0 and MEMSAT-SVM makes use of two 
feed-forward neural networks, which perform analysis on output obtained from PSI_BLAST 
341,344.  
3.2.3 Alignment of the Primary Sequence and Homology Model 
To adequately explain the inactive and active state of the flesh fly AKHR, two models were 
proposed, one to represent the active (closed state) and the other the inactive (open state) state.  




Because of the presence of the conserved amino acid residues generally found in most class A 
GPCRs, one could confidently say AKHRs also belong to the same class A GPCRs family. To 
select the best template structures that serve as our target templates, the PSI_BLAST 341,344  
search tool was used.  This gave the two crystal structures, β2AR (5D5A.1A) and rhodopsin 
(2X72.1A),  available in the Protein Data Bank 345,346, as the best templates. These selected 
templates were used as target templates for sequence alignment of Sarcr-AKHR, using 
Clustalw2 available at https://www.ebi.ac.uk/Tools/msa/clustalw2347,348.GMQE (Global 
Model Quality Estimation) was used for quality estimation. This combines properties from the 
target–template alignment and the template search method. Upon achieving an appropriate 
alignment, homology modelling was then conducted using the SWISS-MODEL server.  This 
is a web-based service strictly dedicated to protein structure homology modelling. SWISS-
MODEL server executes virtual protein structure modelling by satisfying spatial restraint349.  
3.2.4 Constructing the Model  
Both models were built based on the target-template alignment using ProMod3 installed in the 
SWISS-MODEL server. Coordinates that are conserved between the target and the template 
were copied from the template to the model. Insertions and deletions were remodelled using 
(SWISS-MODEL Template Library (SMTL) version 28/2/2019, PDB release 22/2/2019) the 
fragment library. Sidechains were then rebuilt. Finally, the geometry of the resulting model 
was regularised by using an opls force field. Loop modelling was done with ProMod3 alongside 
PROMOD-II as an alternative model all available on the SWISS-MODEL server. The models 
were viewed and analysed using the programs PYMOL350. 




3.3.0 Results and Discussion 
3.3.1 Results  
3.3.2 Analysis of primary sequence 
 
Figure 3.1: Primary amino acid sequence of Sarcr-AKHR submitted for secondary structure prediction to PSIPRED 
Primary structure analysis of the 429 amino acid residues (see Figure 3.1) indicated that not 
all the amino acid sequence residue could be used for the construction of the 3D model. To 
understand how the transmembrane topology and the interactive receptor features might look, 
a 2D Protter diagram was used (Figure 3.2)351. 
 





Figure 3. 2:  A 2D interactive receptor diagram showing the overall transmembrane topology of Sarcr-AKHR. The 
numbering 1-7 indicates the transmembrane helices. In dirty brown, is the core and water-lipid interface regions of the 
lipid membrane.  
 
The 2D interactive receptor diagram for Sarcr-AKHR has been carefully studied to understand 
and make sure the presence of the disordered part of the protein does not affect any of the 
conserved amino acid residues. The presence of these conserved, amino acid residues is vital 
when any 3D model is constructed.   
Having understood the primary structure analysis and the 2D interactive receptor diagram, 
three programs were employed to predict the secondary structure and transmembrane region of 
Sarcr-AKHR accurately. The three programs are PSIPRED 4.0352 (Figure 3.3 ), MEMSAT-
SVM 343,352 (Figure 3.4) and MEMSAT-SVM topology predictions (Figure 3.5)342,353. The 
result indicated that only 340 residues make up the seven transmembrane domain (7TMs).  
MEMSAT-SVM is a highly accurate predictor of transmembrane helix topology because it has 




the ability to discriminate between signal peptides and identify the cytosolic and extracellular 
loops. 
 
Figure 3.3: PSIPRED predicted secondary structure of Sarcr-AKHR H= helix (in yellow), S = strand (in pink) and C 
=coil (ash) 




The predicted result shows that the primary amino acid of Sarcr-AKHR when fed into the 
PSIPRED (Figure 3.3) and MEMSAT-SVM (Figure 3.4) programs, further established that the 
amino acid sequences are distributed into seven transmembrane (TMs) helical bundles. Also, 
they possess three loops connected to the helices from the extracellular region, making up the 
N-terminus and another three loops connected to the helices from the intracellular region 
making up the C-terminus. To further confirm this prediction, topology analysis was conducted 
see Figure 3.4.    
 
Figure 3.4: Schematic diagram of the MEMSAT3 and MEMSATSVM predictions for the query sequence of Sarcr-
AKHR. Traces indicate the RAW outputs for the prediction SVMs. Dashed lines indicate the prediction threshold. PL: 
Pore lining residue SP: Signal peptide residue RE: Re-entrant helix residue iL/oL & H/L: Helix prediction. 
 





Figure 3.5: Prediction of transmembrane helices and the topology analysis of Sarcr-AKHR. The helices are represented 
in yellow and labelled S1-S7, the membrane (black) and the loops (thin black line) starting from the N-terminus (the 
extracellular region) and terminating at the C-terminus (the intracellular region)   
The topology analysis predicted the helices as follows, H1(44-66), H2 (82-103), H3 (115- 144), 
H4 (160-177), H5 (205-231), H6 (265-286) and H7 (303-323) see Figure 3.5. The pore-lining 
was found to be at residues 82-103, 115-144, and 303 -323.  The extracellular region comprises 
the primary amino acid residue at 44, 103, 115, 177, 205, 206, and 303 while the cytoplasmic 
region comprises residues 66, 82, 144, 160, 231, 265 and 323.  
3.3.3 Homology modelling 
Two templates were selected for homology modelling, the crystal structure of beta 2 adrenergic 
receptor (5D5A.1A) and rhodopsin (2X72.1A). These two templates were selected because the 
rhodopsin crystal structure has a covalently bound ligand and, as such, represents the active 
state of the receptor.  The beta-2-adrenergic receptor (β2AR), on the other hand, does not have 
a bound ligand, and so represents the inactive state of the receptor. Clustalw2 was used to align 
the Sarcr-AKHR sequence to the templates as shown in Figure 3.6 





Figure 3.6: Clustalw2 sequence alignment of Sarcr-AKHR and the two selected target templates β2AR, (5D5A.1A / 
P07550), and rhodopsin (2X72.1A / P04695).  The sequence similarity is highlighted in a black and white colour while 
the transmembrane domain highlighted in yellow. 
The alignment (Table 3.1) showed a sequence identity ranging from 16% to 45% and sequence 
similarity between 52% and 88% for the different helices (helices 1-7).  Sequence alignments 
of the transmembrane residues of Sarcr-AKHR, with those of the target templates β2AR, 
(5D5A.1A) and rhodopsin (2X72.1A) (see Figure 3.7), displayed relatively low sequence 
percentage identity but possessed high sequence similarity (see Table 3.1). High sequence 
similarity and low sequence percentage identity are not new to class A GPCRs superfamily, 




because, with high percentage similarity, GPCRs / AKHRs do possess similar structural and 
functional features298.   
      
Figure 3.7: The statistical result from Psi-blast of Sarcr-AKHR illustrating the common ancestry. The best two 
templates with net score 96.782 and 93.886 were selected for the construction of the active and inactive model of Sarcr 
AKHR. 
Table 3.2: Comparison of sequences of AKHR, Rhodopsin, and β2AR helices. 
Helix      % Sequence identity with 
β2AR (β2flf)           rhodopsin (Rhodflf) 
      % Sequence similarity with 
β2AR(β2flf)            rhodopsin (Rhodflf) 
1 18                                  23 61                                   62 
2 25                                  16 58                                   52 
3 29                                  30 68                                   60 
4 28                                  40 76                                   80 
5 23                                  17 65                                   60 
6 34                                  23 83                                   74 
7 43                                  45 88                                   88 
 
The TM helix segments of both β2AR and rhodopsin show high sequence similarity; this could 
be the reason for their structural similarity354,355.  




The highly conserved amino acid residues that are common to  Class A GPCRs 190,223,356 are 
also present in the constructed models, see Figure 3.8.  
 
Figure 3.8: Schematic diagram representing an alignment of both models constructed from both rhodopsin and beta2 
androgenic receptor of Sarcr-AKHR. Red indicates residues in the seven transmembrane helices, blue shows the 
extracellular regions. In contrast, the intracellular regions are represented in purple, yellow denotes region cystine 
ionic lock, and green shows the highly conserved residues. 
Having established the similarities and alignments, the Swiss-Model server 330 was used to 
build two homology models of the 7 TM bundles of Sarcr-AKHR. These models were labelled 
β2flf-model (Figure 3.9 a) and Rhodflf-model (Figure 3.9 b) 




                     
(a)                                                     (b) 
Figure 3.9: The constructed seven transmembrane helices of the Sarcr adipokinetic hormone receptor. a) β2flf-model 
seven transmembrane helices of Sarcr -AKHR and b) Rhodflf-model seven transmembrane helices of Sarcr-AKHR. 
The overall structure of the constructed models (Figure 3.9) are alike, especially the 
anticlockwise arrangement of the transmembrane helices.  They both possess an eighth 
intracellular helix that is parallel to the cell membrane. Also, both structures have a tilted TM3, 























Figure 3.10: Ramachandran plots of a) β2flf-model and b) Rhodflf-model.  
The quality of the constructed models was assessed with evaluation programs, ERRAT357 and 
PROCHECK358. Ramachandran plots of the two models are shown in Figure 3.10. The result 
shows that most of the primary amino acid residue of the constructed models are either in 
allowed or favoured regions. For the β2flf-model, Val177 had a φ angle 100 outside the 




generously allowed region, while the Rhodflf-model had two residues, Thr112 andArg258, had 
ψ torsion angles 200 outside the allowed region.  These problems were corrected during the 
molecular dynamics of the models (see appendix for the Ramachandran plots) 358. The ERRAT 
program was used to check the quality of constructed models. A score of 95.73 and 89.73 for 
the β2flf-model and Rhodflf-models, respectively as the acceptable score range for a high-
quality model is > 50 357. As such, we conclude that these two models are of the high-quality 
model and are acceptable. 
3.4.0  Structural comparison of models  
The constructed models (β2flf-model and Rhodflf- model) can be compared to their template 
GPCR structures.  An overlay of the β2flf -model with its template (see Figure 3.11 a) gave 
an RMSD of 3.1Å for superimposition of Cα atoms of the whole molecule and 2.04Å for the 
helix bundles. Also, an overlay of the Rhodflf-based model with its template (see Figure 3.11 
b) gave an RMSD of 3.3Å for superimposition of Cα atoms of the whole molecule and 2.03Å 
for the helix bundles. Overall, both target templates have longer TM helices when compared 
to the two constructed models, with β2AR having 392 amino acid residue 331 as opposed to the 
constructed β2flf-based model which has 338 amino acids. Also, the rhodopsin template model 
has 442 amino acid residues  224 as against the constructed Rhodflf – based-AKHR model, 
which has 340 amino acid residues.   





Figure 3.11: An overlay of β2flf-based-AKHR (the constructed model, in yellow) and 5d5a (the template used for 
constructing the model, in purple). b) shows an overlay of Rhodflf-based-AKHR (the constructed model, in green and 
2x72 (the template used for constructing the model, in brown). 
Both constructed models have the CWxP(Y/F) (CWTPY) motif in TM6. For β2AR, the 
CWxP(Y/F) motif is CWLPF, while for rhodopsin, it is CWLPY. This is the only significant 
difference noticed as regards the conserved residue. This motif is significant to receptor 
activations and will be discussed later.  
3.4.1 Evaluation of the helix bundles 
In both models, the transmembrane helices have an anticlockwise helical arrangement, when 
viewed from the extracellular side.  This anticlockwise arrangement is found in most class A 
GPCRs 359.  Experimental data supported this anticlockwise arrangement, which is consistent 




with the arrangement found in neurokinin 1 (NK-1) and ĸ-opioid receptor 359.  The helical 
bundles are stabilised by interhelical interactions comprising the highly conserved residues. 223 
 
Figure 3.12: The superimposition of the β2flf-model structure and Rhodflf-model structure of Sarcr-AKHR. 
Superimposition of the two constructed 3D models gave a root mean square deviation (rmsd) 
of 3.18 Å for superimposition of Cα atoms of the whole molecule and 2.1 Å for the helix 
bundles.  TM6 and TM5 differ from each other with respect to length with both helices 
extending by 4-3 residues into the cytoplasm.  This observation is consistent with studies 
conducted on the accessibility of nitroxide labels fixed to ECL3 joining TM6 and TM5 360. 
Both structures possess a tilted TM3 conformation. This tilting of TM3 is also found other class 
A GPCRs model93,98,195,361,362. The orientation of the seven transmembrane helices is subtly 
different in the two models, which leads to differences in the intracellular and extracellular 




domains. Both the β2flf-based and Rhodflf-models have a disulphide bridge, commonly found 
in GPCRs, between Cys1163-25 and Cys192.  
The extracellular end of TM1 of β2flf-model bends away from the helical bundle (Figure 3.12) 
with an angle of deviation 38.9º with a distance of 4.35 Å between TM1 of β2flf-model and 
Rhodflf-model.   This gives a more open structure to the extracellular domain of the β2flf-
model as compared to the Rhodflf-model.  At the same time, the intracellular end of TM6 a 
distance of 6.8 Å (Figure 3.12) was recorded for both β2flf-model and Rhodflf-model. This 
gives a more closed structure to the intracellular domain of the β2flf-model. Thus, the β2flf-
model  is described as the open or inactive model, while the Rhodfrf-model is termed the closed 
or active model239. The closed conformation of the Rhodflf-model is similar to the rhodopsin 
crystal structure, where the closed nature protects cis-retinal from hydrolysis 96,98.   Since ligand 
binding takes place on the extracellular domain 363, the closed nature of the Rhodflf-model 
prevents the ingress of the ligand.  On the other hand, the open nature of the β2flf-model allows 
the ligand-free access to the receptor-binding pocket.  
3.4.1.0 Overview of transmembrane helical interaction and molecular 
switches 
A critical feature of most class A GPCRs is the existence of substantially preserved molecular 
switch motifs. The presence of these switches is essential for stabilising any GPCR either in 
the close (active) or open (inactive) state. To properly explain the switch the Ballesteros–
Weinstein numbering scheme will be used (where the most conserved residue from each helix 
is given high priority and is pined at 50 that is Helix 1Asn (1-50) Helix 2Asp (2-50) Helix 3Arg 
(3-50) Helix 4Trp (4-50) Helix 5Pro (5-50) Helix 6 Pro (6-50) and Helix 8 Pro (8-50). Hence, 
the numbering of any amino acid from its primary sequence shall be noted as follows if the 




counting is towards N terminal from the Most conserve residue of each Helix, one is expected 
to subtract from the fixed 50 and if the counting leads towards the C terminal addition is made. 
In summary, Thr3054-56 means Thr305 (primary-AA sequence number from the alignment 
table) 4-56 (Helix 4 and it is 6 places after the most conserved residue Trp)364,365.   In Sarcr-
AKHR, a 3-6 lock exists between Arg262 6-31 on TM6 and Tyr 1423-51 on TM3.  In the inactive 
state, Arg2626-31 points away from TM3, and so no interaction is possible (Figure 3.13 a).  
Upon activation, however, TM6 twists moving Arg2626-31 so that it now points toward Tyr1423-
51 (Figure 3.13 b).  This interaction locks the receptor in the active state.  Figure 3.13 b also 
shows that, in the active state, Arg2626-31 on TM3 interacts with Glu 246 of ECL2. This loop 
closes over the binding pocket after ligand binding. 
 





Figure 3.13: a) Molecular switch interactions (inactive) in the β2flf based between Tyr 142 in TM3 and Arg262 in TM6. 
b) molecular switch interactions (active) in the Rhodflf model between Tyr 142 in TM3 and Arg262 in TM6.  c) 
molecular switch interactions (active) in the Rhodflf model between Lys265 in TM 6 and Arg115 in TM3. d) molecular 
switch interactions (inactive) in the β2flf model between Lys265 in TM 6 and Arg115 in TM3. e) molecular switch, 
interactions (inactive) in the β2flf model between Asp89 in TM2 and Asn317 in TM7. f) molecular switch interactions 
(active) in the Rhodflf model between Asp89 in TM2 and Asn317 in TM7. 
In the Rhodflf-model, there is an ionic interaction between Lys2656-35 in TM6 and the 
positively charged side chain nitrogen atom of Arg1153-50 in TM3 (Figure 3.13 c).  This 
interaction does not exist in the β2flf-model (Figure 3.13 d).  These switches are found to be 
the same as those described for the AKH-receptor of A. gambiae, Rhodnius prolixus, and 
Tribolium castaneum 231,366. 




Class A GPCRs have a conserved aspartate on TM2 and an asparagine on TM7.  In the Rhodflf-
model structure, there is an intramolecular interaction between Asp89 and Asn317 (Figure 
3.13 f). In the β2flf-model  (Figure 3.13 e), the helices shifted such that these two residues are 
now 4.8Å apart and can no longer interact 239.  Experimental data backs the importance of these 
intramolecular interactions because of the vital role they play during receptor activation, basal 
activity and conformation flexibility reduction 239.  
 
 
Figure 3.14: Polar interactions a) Rhodflf-based AKHR, the molecules are far apart making it impossible for the polar 
interactions between TM1 Asn60 and TM7 Ser314 to occur. b) β2flf-based AKHR showing presence of polar 
interactions between TM1 Asn60 and TM7 Ser314 because of the proximity between the two residues. 
Talking about stability, in both β2flf-model AKHR and Rhodflf-model AKHR, there is polar 
interaction between TM1 Asn601-50 and TM7 Ser314 7-45 (Figure 3.14), which stabilises both 
structures. The β2flf-model AKHR TM6(Ser 2386-70 and Tyr325) H-bond TM5 Lys 2605-29 
(Figure 3.15 a), while in Rhodflf-model this interaction is absent (Figure 3.15 b) 





Figure 3.15: a) H-bond interaction between TM5 Lys260 and TM6 (Ser238 and Tyr325) for the open structure (β2flf-
model AKHR).  b) the absence of H-bond interaction between TM5 Lys260 and TM6(Ser238 and Tyr325)  for the 
Rhodflf-model AKHR. c) helical interaction between TM5 Met 209 and TM6 Met286. d) absence of helical interaction 
between TM5 Met 209 and TM6 Met286 
Another intramolecular interaction between Met 2095-39 in helix 5 and Met 286 6-56 in helix 6 
(see Figure 3.15 c & d) was also identified in the open structure but absent in the closed 
structure.   Dror et al., 2009 discovered that the inactive β2AR exists in equilibrium between 
conformations with the ionic lock ‘on and off’367. These intramolecular interactions are 
responsible for the reduction in conformational flexibility, basal activity and play a vital role 
in receptor activation239 
3.4.1.1 Evaluation of Kinks  
Experimental data backs the existence of kinks that initiate the helical twist (bend) at almost 
the same locations where Tyr, Thr or Met come before Pro195,368–370. The TM helices in both 
open and closed AKHR models have these proline-generated bends or kinks (Figure 3.16) 371. 
TM2 has a kink between Met 97 2-58 and Pro 982-52 (Figure 3.16 a), TM5 has a kink between 
Tyr216 5-47and Pro219 5-50 (Figure 3.16 b). For the β2flf-model, another turn was noticed in 




TM4 at Phe168 4-54 (Figure 3.16 d), although not found on the Rhodflf-model structure (Figure 
3.16 e). From the extracellular region, the kink in TM 6 instigates a twist near TM 5.  An 
overlay of the β2flf-model and Rhodflf-model in Figure 3.16 a, b and c shows the different 
effect of these kinks or bends on the two models.   
 
 
Figure 3.16: a) overlay of 3D models of the β2flf-model and Rhodflf-model structure, showing the presence of kinks in 
TM2. b) overlay of 3D models of the β2flf-model and Rhodflf-model structure showing the presence of kinks in TM5 
and c) overlay of 3D models of the β2flf-model and Rhodflf-model showing the presence of kink in TM4. d) The β2flf-
model, showing the presence of kink in TM4. e) The Rhodflf-model structure, showing the absence of kink in TM4. * 
β2flf = β2flf-model, Rhodflf =Rhodflf-model. 
3.4.1.2 Evaluation of the Loop Regions of the Models  
Besides the orientation of the transmembrane helices, there are other differences between the 
two models (Figure 3.12).  In the extracellular loop I (ECL I) β2flf-model has a β-strand 
between Ala104 and Gln108, and a small helical turn at the N-terminus, while in the Rhodflf-




model AKHR, there is a β-strand between Glu181 and Glu182, and a small helical turn between 
His183 and Cys192. ECL2 of β2flf-model has a helical turn between Ala175 and Tyr190.  This 
moves ECL2 away from the binding pocket.  At the same time, the N-terminus also moves to 
give any potential ligand access to the receptor-binding pocket.  However, ECL2 of the 
Rhodflf-model AKHR does not have the helical turn like β2flf-model AKHR. This keeps ECL2 
of the Rhodflf-model AKHR in an upright position above the helical bundle.  In this way, the 
N-terminus and ECL2 extend over the transmembrane helices, shielding all possible binding 
sites and preventing the ligand from gaining access to or leaving the binding pocket.  
ICL3 is commonly not characterised in the crystal structures of GPCR.  In both the β2flf-model 
and Rhodflf-model, ICL3 has a helical turn between Ile290 and Lys292.  Dror et al. identified 
this turn in β2AR367.  Moreover, the β2flf-model has a helical turn between Ser293-Ser294, 
while the Rhodfrf-model has a β-strand between Val295 and Asp296 and a helical turn between 
Asp297 and Ser300. 
Most Class A GPCRs have an eighth helix, which lies parallel to the intracellular membrane 
surface.  This helix is thought to be essential for receptor activation and binding of a G-protein 
239. Most GPCRs intracellular region are stabilised by palmitoylation of Cys, Ser, or Thr on the 
8th helix 372–374. Both the β2flf-model and Rhodflf-models have this 8th helix (the tail) see 
Figure 3.9, which has Cys311, which could be stabilised by palmitoylation. 
Since GPCRs are highly flexible, the different structural features, particularly in the extra and 
intracellular region of the two models, could represent features in different conformations 
during molecular dynamics and in the active and inactive state of the receptor. 
3.4.0 Conclusion 
We have successfully constructed two 3D models for the flesh fly AKH receptor, Sarcr-AKHR.  
One model is in an open conformation as the inactive state, while the other has a closed 




conformation as the active state of the AKHR. The elucidated structures possess the same 
features as most class A GPCRs.  
Some structural differences can be found around the highly conserved amino acid Asp, Arg 
and Tyr (DRY) residues.  Wherein the Rhodflf-model, posses an ionic interaction between TM3 
Arg1413-50 and the backbone C=O of  Lys2646-35 in TM6, this was not found in the open model. 
H-bond was identified between TM6(Ser 2386-70 and Tyr325) and TM5 Lys 2605-29  for the 
β2flf-model, but no salt bridge was found between TM5 and TM6 for the Rhodflf-model.  
A polar interaction was also identified between TM1 Asn601-50 and TM7 Ser3147-45 for the 
closed model but not found in the open model.  
In both models, the presence of kinks is found in TM2 (Met 972-5 and Pro 982-52), TM5 
(Tyr2165-47-Pro2195-50) and TM4 Phe1684-54   
The general conformation and structural features of the β2flf-model AKHR and Rhodflf-model 
AKHR models can be used to study the binding and activation of Sarcr-AKH receptor by Phote-
HrTH.










The genome of the fruit fly was used to predict and build the three-dimensional (3D) model 
of the fruit fly adipokinetic hormone receptor (AKHR). Computational homology modelling 
technique was employed to achieve two standard 3D models.  Beta2-adrenergic receptor 
(β2AR) and rhodopsin crystal structures were used as the target model. Essential for this 
regard, is to be able to explain the active and inactive conformation of a receptor. The β2AR 
structure has an open conformation meaning the receptor is inactive, while the rhodopsin 
structure possesses a closed (active) conformation. 
It is understood that that active rhodopsin does not allow the diffusion of a ligand into the 
binding receptor binding pocket, but the β2AR dose.  
The constructed flesh fly AKHR (chapter 3). When compared to the fruit fly AKHR is very 
similar but different.    
 
4.1.0 Introduction.  
Over the years, some pest insects like the fruit fly have gained resistance to the widely-used 
insecticides 37,38, and the more disturbing, massive decline in beneficial insects like the honey 
bee has been recorded of late 39,40. Hence, the need for active biological pesticides that are 
selective in their activity, negatively affecting the aimed pest species without causing damage 




to valuable insect species. The best idea for developing a biological insecticide that will be 
selective in its action is to target the GPCRs of pest insects29–33,41,42. For this to be successful 
and applicable, research into ligand-GPCR interactions is needed for pest and beneficial insects 
to find those that are specific to pest insects for further drug development. Thus, AKH and their 
AKHR/GPCR are considered suitable targets for new insect control agents. However, in order 
to target the GPCR binding site, the 3D structure of both ligand and receptor needs to be known. 
Unfortunately only very few 3D structures of most AKHRs are available as data on the 
constructed 3D molecules and the binding sites will allow the design of novel, species-specific, 
non-peptidic mimetics, which can block the binding site and hinder the activities of the insect. 
The published primary sequence of Drome-AKHR was extracted from the Genbank database 
(accession number AAN10047.1) and used to predict the 3D structure of the fruit fly receptor. 
The experimental procedure for the construction of the fruit fly AKHR is similar to those in 
chapter 3, so only results will be presented in this chapter.   
4.2.0 Results and Discussion 
4.2.1 Results  
4.2.2 Analysis of primary sequence 
 
Figure 4. 1: Primary amino acid sequence submitted for secondary structure prediction of Drome-AKHR to PSIPRED. 




The Drome-AKHR possess 443 primary amino acid residues (see Figure 4.1). The PSIPRED 
primary structure analysis indicated that not all the amino acid sequence residue could be used 
for the construction of the 3D model. A 2D Protter diagram (see Figure 4.2) was used to further 




Figure 4. 2: A 2D interactive receptor diagram showing the overall transmembrane topology of Drome-AKHR. The 
numbering 1-7 indicates the transmembrane helices. In dirty brown, is the core and water-lipid interface regions of the 
lipid membrane.  




The primary importance of the 2D interactive receptor diagram of Drome-AKHR is to enable a 
proper analysis of Drome-AKHR, and it also helps to avoid the use of any the disordered part 
of Drome-AKHR during receptor construction. The 2D interactive receptor diagram also helps 
to ensure the presence of conserved amino acid residues. As the presence of conserved amino 
acid residues, patterns, and motifs generally found in all Class A GPCRs is vital when any 3D 
model is constructed.  These conserved residues play a vital role via helical interactions to 
stabilise the helices. Also, they are essential for receptor activation and ligand binding204,375,376. 
Having understood the 2D interactive receptor diagram and the primary structure analysis, 
three programs, PSIPRED 4.0 (Figure 4.3)327,341,377,378, MEMSAT (Figure 4.4)342,343,353, 
MEMSAT-SVM topology predictions (Figure 4.5)341,353  were employed to predict the 
secondary structure and transmembrane region of Drome-AKHR accurately. The result 
indicated that only 329 residues make up the seven transmembrane domains (7TMs).   
 





Figure 4. 3: PSIPRED predicted secondary structure of Drome-AKHR. H= helix (in yellow), S = strand (in pink) and 
C =coil (ash) Pred: Predicted secondary structure (H=helix, E=strand, C=coil), AA: Target sequence. 




The predicted results from PSIPRED 4.0 (Figure 4.3)327,341,377,378 and MEMSAT (Figure 
4.4)342,343,353 further established that the amino acid sequences are distributed into seven 
transmembrane (TMs) helical bundle. Also, they possess three loops connected to the helices 
from the extracellular region, making up the N-terminus and another three loops connected to 
the helices from the intracellular region making up the C-terminus. To further confirm this 
prediction, topology analysis was conducted using the MEMSAT-SVM topology predictions 
program(Figure 4.5)341,353. 
 
Figure 4.4: Schematic diagram of the MEMSAT-SVM predictions for the query sequence of Drome-AKHR. Traces 
indicate the RAW outputs for the prediction SVMs. Dashed lines indicate the prediction threshold. PL: Pore lining 
residue SP: Signal peptide residue RE: Re-entrant helix residue iL/oL & H/L: Helix prediction. 
 





Figure 4.5: Prediction of transmembrane helices and the topology analysis of Drome-AKHR. The helices are 
represented in yellow and labelled S1-S7, the membrane (black) and the loops (thin black line) starting from the N-
terminus (the extracellular region) and terminating at the C-terminus (the intracellular region)   
The topology analysis predicted the helices as follows, H1(40-63), H2 (79-103), H3 (111-139), 
H4 (155-172), H5 (202-227), H6 (263-285) and H7 (301-321) see Figure 4.5. The pore-lining 
was found to be at residues 79-103, 111-139 and 301 -321.  The extracellular region comprises 
the primary amino acid residue at 40, 103, 111, 172, 202, 285 and 301 while the cytoplasmic 
region comprises residues 63, 79, 139, 155, 227, 263 and 321.  
4.2.3 Homology modelling 
The same approach used in chapter 3 was applied to build two models (active and inactive). 
Also, the same template crystal structure of beta 2 adrenergic receptor (5D5A.1A) and the 
crystal structure of rhodopsin (2X72.1A) used in chapter 3 were used for the construction of 
the models. Clustalw2 was used to align the Drome-AKHR sequence to the templates, as shown 
in Figure 4.6. The constructed models are identified as β2frf-model (based on β2AR AKHR) 
and rhodfrf (based on rhodopsin AKHR). 








Figure 4.6: Clustalw2 sequence alignment illustrating Drome-AKHR and the two selected target templates β2AR, 
(5D5A.1A / P07550), and rhodopsin (2X72.1A / P04695).  The sequence similarity is highlighted in a black and white 
colour while the transmembrane domain highlighted in yellow. 
The alignment (Table 4.1) showed a sequence identity ranging from 17% to 45% and sequence 
similarity between 51% and 89% for the different helices. The two target templates, β2AR, 
(5D5A.1A) and rhodopsin (2X72.1A), displayed a relatively low sequence percentage identity 
but possessed high sequence similarity (see Table 4.1). Low sequence percentage identity and 




high sequence similarity are not new to class A GPCRs superfamily, because, with high 
percentage similarity, GPCRs / AKHRs do possess similar structural and functional features298.   
 
Figure 4.7: The statistical result from Psi-blast of the Drome-AKHR illustrating the common ancestry. The best two 
templates with net score 96.782 ( β2AR, 5d5a) and 93.886 (rhodopsin 2x72)  were selected for the construction of the 
active and inactive model of Drome- AKHR. 
Having established the similarities and alignments (Figure 4.6 and Figure 4.7); homology 
modelling was then conducted using Swiss-Model 330.  The alignments were used to build two 











Table 4. 1. Comparison of sequences of AKHR, Rhodopsin and β2AR helices. 
Helix      % Sequence identity with 
β2AR (β2frf)         rhodopsin (Rhodfrf) 
      % Sequence similarity with 
β2AR(β2frf)           rhodopsin (Rhodfrf) 
1 16                                  20 60                                   61 
2 25                                  16 58                                   52 
3 29                                  30 68                                   60 
4 28                                  40 76                                   80 
5 23                                  17 65                                   60 
6 34                                  23 83                                   74 
7 43                                  45 88                                   88 
 
High sequence similarity was recorded for the TM helix segments of both β2AR and rhodopsin 
and could be the reason for their prominent structural similarity354,355.  
The presence of conserved amino acid residues, patterns, and motifs commonly found in all 
Class A GPCRs 190,223,356, are also present in the constructed models see Figure 4.8  
 
Figure 4. 8: Schematic diagram representing an alignment of both models constructed from both rhodopsin and beta2 
androgenic receptor of Drome-AKHR. Red indicates residues in the seven transmembrane helices, blue shows the 
extracellular regions, while the intracellular regions are represented in purple, yellow denotes region cystine ionic lock, 
and green shows the highly conserved residues. 





 Figure 4. 9: The constructed seven transmembrane helices of the adipokinetic hormone receptor. a) β2frf- model seven 
transmembrane helices of AKHR and b) Rhodfrf-model seven transmembrane helices of AKHR. 
Overall, the constructed models (Figure 4.9) are alike, especially the anticlockwise 
arrangement of the transmembrane helices, and they both possess the eighth intracellular helix 
that is parallel to the cell membrane. Also, both structures have a tilted TM3, and the shortest 




















Figure 4. 10: Ramachandran plots of a) β2frf- model and b) Rhodfrf-model.  




ERRAT357 and PROCHECK358 evaluation programs were used to check the quality of the 
constructed models. Also, Ramachandran plots of the two models see Figure 4.10. The result 
of both models shows that the phi and psi, which represent the backbone torsion angle, are 
acceptable and most of the primary amino acid residue of the constructed models are either in 
allowed or favoured regions. Also, the β2frf-model, Arg66, Arg256 and Thr108 had a φ angle 
100 outside the generously allowed region, while the Rhodfrf-model had two residues Arg66 
and Leu123, had ψ torsion angles 200 outside the allowed region. These problems were 
corrected during the molecular dynamics of the models. The ERRAT program score of  97.73 
and 93.63 was calculated for the  β2frf-model and Rhodfrf-models, as the acceptable score 
range for a high-quality model is > 50 357. As such, we conclude that these two models are of 
a high-quality model and are acceptable. 
4.2.3.1 Structural comparison of models  
The constructed models of both β2frf-model and Rhodfrf-model can be compared to the two-
class A GPCR structures, that were used as a template to build them.  An overlay of the β2frf- 
model with its templates (see Figure 4.11 a) gave an RMSD of 3.3Å for superimposition of 
Cα atoms of the whole molecule and 2.07Å for the helix bundles. Also, an overlay of the 
Rhodfrf-model with its templates (see Figure 4.11 b) gave an RMSD of 3.5Å for 
superimposition of Cα atoms of the whole molecule and 2.05Å for the helix bundles.   Overall, 
the target templates have longer TM helices when compared to the two constructed models, 
with β2AR having 392 amino acid residue331 as opposed to the constructed β2frf- model which 
has 330 amino acids. Also, the rhodopsin template model has 442 amino acid residue224 as 
against the constructed Rhodfrf – based- model, which has 327 amino acid residues.   





Figure 4.11: An overlay of β2frf- model-AKHR (the constructed model, in red) and 5d5a (the template used for 
constructing the model, in yellow) with RMSD 3.6Å. b) shows an overlay of Rhodfrf (the constructed model, in red) 
and 2x72 (the template used for constructing the model, in green) with RMSD 3.6Å.  
Both constructed models have the CWxP(Y/F) (CWTPY) motif in TM6; when compared with 
the templates, a slight difference in the amino acid residues was noticed. For β2AR, the 
CWxP(Y/F) motif is CWLPF while for rhodopsin, it is CWLPY. This is the only significant 
difference noticed as regards the conserved residue. This motif is significant to receptor 
activations and will be discussed later. 
4.2.3.2 Evaluation of the helix bundles 
In both models, the transmembrane helices have an anticlockwise helical arrangement, when 
viewed from the extracellular side.  This anticlockwise arrangement is found in most class A 
GPCRs 359.  Literature supported this anticlockwise arrangement and have linked the cause to 
distance restraints from Zinc (II) binding cavity in neurokinin 1 (NK-1) and ĸ-opioid receptor 




359.  The helical bundles are stabilised by interhelical interactions comprising the highly 
conserved residues 223 
                                            
 
Figure 4. 12: The superimposition of β2frf-model and Rhodfrf-model of Drome-AKHR. 
Superimposition of the two constructed 3D models gave a root means square deviation (rmsd) 
of 3.6 Å, for superimposition of Cα atoms of the whole molecule and 2.12 Å for the helix 
bundles. TM6 and TM5 differ from each other with respect to length with both helices 
extending by 4-3 residues into the cytoplasm.  This observation is consistent with studies 
conducted on the accessibility of nitroxide labels fixed to ECL3 joining TM6 and TM5 360. 
Both structures possess a tilted TM3 conformation. This tilting of TM3 is also found other class 
A GPCRs model93,98,195,361,362. The orientation of the seven transmembrane helices is subtly 
different in the two models, which leads to differences in the intracellular and extracellular 




domains. Also, both β2frf- model-AKHR and Rhodfrf-models have a disulphide bridge 
between Cys112 and Cys188. This disulphide bridge is commonly found in GPCRs.  
In the β2frf- model, the extracellular end of TM1 bends away from the helical bundle (Figure 
4.12) with a distance of 5.42 Å from TM1 of Rhodfrf-model.   This gives a more open structure 
to the extracellular domain of the β2frf-model as compared to the Rhodfrf model.  At the same 
time, a distance of 8.7 Å at the intracellular end of TM6 between both model (Figure 4.12) 
was recorded. This gives a more closed structure to the intracellular domain of the β2frf- model. 
Thus, the β2frf- model is described as the open or inactive model, while the Rhodfrf-model is 
termed the closed or active model239. The closed conformation of the Rhodfrf-model is similar 
to the rhodopsin crystal structure where the close nature protects cis-retinal from hydrolysis 
96,98.   Since ligand binding takes place on the extracellular domain 363, the closed nature of the 
Rhodfrf-model prevents the ingress of the ligand.  On the other hand, the open nature of the 
β2frf- model allows ligand-free access to the receptor-binding pocket.  
4.2.3.3 Overview of transmembrane helical interaction and molecular 
switches  
A crucial feature of most class A GPCRs is the presence of primarily preserved molecular 
switch motifs. The existence of these switches is vital for stabilising any GPCR either in the 
close (active) or open (inactive) state.   In Drome-AKHR a transmembrane 3-6 lock occurs 
between Arg260 on TM6 and Tyr1383-51 on TM3.  In the inactive state, Arg2606-29 points away 
from TM3, and so no interaction is possible (Figure 4.13 a).  Upon activation, however, TM6 
twists moving Arg2606-29 so that it now points toward Tyr1383-51 (Figure 4.13 b).  This 
interaction locks the receptor in the active state.  Figure 4.13 b also indicates that, in the active 
state, Arg2606-29 on TM3 interacts with Glu 244 of ECL2. This loop closes over the binding 
pocket after ligand binding. 





Figure 4. 13: a) molecular switch interactions (inactive) in the β2frf-model between Tyr 138 in TM6 and Arg260 in 
TM3. b) molecular switch interactions (active) in the Rhodfrf-model between Tyr 138 in TM6 and Arg260 in TM3.  c) 
molecular switch interactions (active) in the Rhodfrf-model between Lys263 in TM 6 and Arg113 in TM3. d) molecular 
switch interactions (inactive) in the β2frf-model between Lys263 in TM6 and Arg113 in TM3. e) molecular switch, 
interactions (inactive) in the β2frf-model between Asp85 in TM2 and Asn311 in TM7. f) molecular switch interactions 
(active) in the Rhodfrf-model between Asp85 in TM2 and Asn311 in TM7. 
In the Rhodfrf-model, there is an ionic interaction between Lys2636-35 in TM 6 and the 
positively charged side chain nitrogen atom of Arg1133-50 in TM 3 (Figure 4.13 c).  This 
interaction does not exist in the β2frf- model (Figure 4.13 d).  These switches are found to be 




the same as those described for the AKH- receptor of A. gambiae, Rhodnius prolixus and 
Tribolium castaneum 231,366. 
Class A GPCRs have a conserved aspartate on TM2 and an asparagine on TM7.  In the Rhodfrf 
model, there is an intramolecular interaction between Asp85 and Asn311  (Figure 4.13 f). In 
the β2frf-model (Figure 4.13 e), the helices are shifted such that these two residues are now 
4.8Å apart and can no longer interact 239.  Experimental data backs the importance of these 
intramolecular interactions because of the vital role they play during receptor activation, basal 
activity and conformation flexibility reduction 239.  
 
The stability of the AKHRs is sometimes achieved by the presence of anionic / cationic-π 
interaction 379–381. β2frf-model forms a π-cationic interaction between TM5 Tyr 2315-66 and TM 
6 (Asp2516-22 and Lys 2596-29) (see Figure 4.14 a), this interaction was not found with Rhodfrf-
model instead an H-bond interaction was identified between TM 5 (Ser 2345-69) and TM 6 (Lys 
2596-29) (see Figure 4.14 b).  
 





Figure 4.14: (a) β2frf-model have a π-cationic interaction between TM5 Tyr 2315-66 and TM 6 (Asp2516-22 and Lys 2596-
29) (b) Rhodfrf-model H-bond interactions between TM 5 (Ser 2345-69 ) and TM 6 (Lys 2596-29). (c) the Rhodfrf-model 
have a molecular interaction between Tyr 212 5-46 in helix 5 and Thr 277 6-49 in helix 6 (d) the β2frf model have molecular 
interactions in between Gln 2045-39 in helix 5 and Ser 2836-55 in helix 6. 
Intramolecular interaction was identified in Rhodfrf-model between Gln 2045-39 in helix 5 and 
Ser 2836-55 in helix 6 (see Figure 4.14 c).  This interaction was not found in β2frf-model see 
Figure 4.14 d. Also, another interaction, which was found in the Rhodfrf-model is an 
interaction between Tyr2125-46 in helix 5 and one of the conserved residues Thr277 6-49 in helix 
6, see Figure 4.14 c.  Thus, in the β2frf -model, due to helical shifts, the Tyr212 5-46 in helix 5 
and Thr277 6-49 in helix 6 residues are 4.1Å apart, thereby decreasing any chances of 
interaction.   
Class A GPCRs have a conserved aspartate on TM2 and an asparagine on TM7 239. In the β2frf- 
model (Figure 4.15 a), the side chains between TM7 Asn3117-49 and TM2 Asp852-50 are 
orientated away from each other.  This decreases the possibilities of interactions between them. 




In the Rhodfrf-model (Figure 4.15 b), the side chains of TM 7 Asn3117-49and TM 2 Asp 852-




Figure 4.15: a) Absence of molecular interactions between TM1 Asp85 and TM7 Asn311 (β2frf -model). b) presence of 
molecular interactions between TM1 Asp85 and TM7 Asn311 (Rhodfrf-model). 
In the Rhodfrf structures, Asp 85 2-50 in helix 2 forms an ionic interaction with Ser126 3-39 in 
helix 3, though this interaction is absent in the β2frf- model (Figure 4.16 a & b). Also, in both 
open and closed structures, there is polar interaction between Asn 56 1-50 (helix 1) and Ser312 
7-46 (helix 7) (Figure 4.16 d), which stabilises the structure. Dror et al., 2009 discovered the 
‘on and off’367 ionic lock in different conformations of an inactive β2AR while in equilibrium.  




    
Figure 4. 16: (a) Rhodfrf model showing a salt-bridge inter interaction between Asp 85 in helix 2 and Ser 126 helix 3 . 
(b) The β2frf- model is showing the same interaction as in (a).  (c) absence of polar interaction between TM 1 and TM 
7. (d) presence of polar interaction between TM 1 and TM 7.  
These interactions (Figure 4.16) involving helices 7,2 and 1 are structurally essential for all 
Class A GPCRs molecule stabilisation 382.  
4.2.3.4 Evaluation of Kinks  
The existence of kinks that initiate the helical twist (bend) at almost the same locations where 
Tyr, Thr or Met come before Pro is also backed by experimental data195,368–370. The TM helices 
in both open and closed AKHR models have these proline-generated bends or kinks (Figure 
4.17). TM2 has a kink between Met 932-58 and Pro 942-59 (Figure 4.17 a). TM5 has a kink 
between Tyr2125-47 and Pro2155-50 (Figure 4.17 b). A turn was noted on TM4 between Gly162 
4-52 and Val644-54 for the β2frf-model (Figure 4.17 d).  This was not found in the Rhodfrf 
structure (Figure 4.17 e). From the extracellular region, the kink in TM 6 instigates a twist 




near TM 5.  An overlay of the β2frf- model Rhodfrf-models in Figure 4.17 a, d and g show the 
different effect of these kinks or bends have on the two models.  
 
Figure 4. 17: Overlay of 3D models of the β2frf-model and Rhodfrf-model structure, showing the presence of kinks in 
TM2. b) overlay of 3D models of the β2frf-model and Rhodfrf-model structure showing the presence of kinks in TM5 
and c) overlay of 3D models of the β2frf-model and Rhodfrf-model structure showing the presence of kink in TM4. d) 
The β2frf-model showing the presence of kink in TM4. e) The Rhodfrf-model showing the absence of kink in TM4. * 
β2flf = β2frf-model, Rhodfrf =Rhodfrf-model. 
4.2.3.5 Evaluation of the loop regions of the constructed models 
Apart from the orientation of the transmembrane helices, there are other dissimilarities between 
the two models (Figure 4.12).  In the extracellular loop I (ECL I), the open structure has no β-
strand, while in the Rhodfrf-model there is a β-strand between Ala100 and Gln104, a γ-turn 
between Trp105 and Leu106 and a small helical turn between Ser107 and Thr108.  In the β2frf- 
model, there is a helical turn between Ala171 and Tyr185.  This moves ECL2 away from the 
binding pocket.  At the same time, the N-terminus also moves to give any potential ligand 




access to the receptor-binding pocket. In the Rhodfrf-model, there is a β-strand between Glu177 
and Gln184, and a small helical turn from His179 to Cys188. This keeps ECL2 in an upright 
position above the helical bundle.  In this way the N-terminus and ECL2 extend over the 
transmembrane helices, shielding all possible binding sites and preventing the ligand from 
gaining access to or leaving the binding pocket.   
 
ICL3 is usually not characterised in the crystal structures of GPCR.  In both the β2frf-model 
and Rhodfrf-model, ICL3 has a helical turn between Ser234 and Ser249.  Dror et al. identified 
this turn in β2AR367.  In both the open and closed models, ECL3 has a β-strand involving Ile293 
and Pro298. Moreover, the β2frf-model has a helical turn between Leu299 - Leu300, while the 
Rhodfrf-model has a β-strand between Leu288 and Lys290 and a helical turn between His291 
and Gly294. 
The eighth helix is familiar with most Class A GPCRs and lies parallel to the intracellular 
membrane surface.  This helix is thought to be essential for receptor activation and binding of 
a G-protein 239. Most GPCRs intracellular region are stabilised by palmitoylation of Cys, Ser 
or Thr on the 8th helix 372–374. Both the β2frf-model and Rhodfrf-model have this 8th helix, 
which has Cys313, which could be stabilised by palmitoylation.   
Since ligands prefer to binding at the extracellular part of a receptor 363, the closed nature of 
the Rhodfrf-model stops the ingress of the ligand that way proper binding of a ligand to the 
extracellular part is impossible.  On the other hand, the open nature of the β2frf-model allows 
ligands free access to the receptor-binding pocket. 
Also, since GPCRs are highly flexible, the different structural features, particularly in the extra 
and intracellular region of the two models, could represent features in different conformations 
during molecular dynamics and in the active and inactive state of the receptor. 
 





We have successfully constructed 3D AKHR models for the fruit fly, Drosophila 
melanogaster, AKH-receptor and we present the open conformation as the inactive state and 
the closed conformation as the active state of the AKHR. The elucidated structures possess the 
same features as most class A GPCRs.  
Structural differences can be found around the highly conserved amino acid DRY residues, 
where the Rhodfrf-model posses an ionic interaction linking the positively charged side chain 
nitrogen atom of Arg1133-50 in TM 3 and the backbone C=O of Lys2636-35 in TM 6.  This was 
not found in the open model. 
A π-cationic interaction between TM5 Tyr 2315-66 and TM 6 (Asp2516-22 and Lys 2596-29) was 
identified in β2frf-model but absent in Rhodfrf-model instead an H-bond interaction was 
identified between TM 5 (Ser 2345-69) and TM 6 (Lys 2596-29).  
In the closed model, a polar interaction was identified between Asn 56 1-50 on TM1 and Ser312 
7-46 on TM7, but not found in the open model.  In the closed structure, an intramolecular 
interaction exists between TM5 (Gln2045-39) and TM6 (Ser 2836-55). Also, in the closed 
structure, another intramolecular interaction was identified between TM5 (Tyr2125-46) and one 
of the conserved residues, Thr 277 6-49 on TM6.  
In both models, kinks were also identified in TM2 (Met 932-58-Pro 942-59), TM5 (Tyr2125-47 -
Pro2155-50) and TM4 (Gly162 4-52, - Val644-54). 
The general conformation and structural features of the β2frf-model and Rhodfrf-models can 
be used to study the binding and activation of the Drome-AKH receptor by Phote-HrTH.





Constructing a 3D Model of the AKH-receptor of the Oriental Fruit Fly, 
Bacdo-AKHR. 
Summary  
The newly available oriental fruit fly (Bactrocera dorsalis) AKHR was utilised in the 
construction of a three dimensional (3D) model of the receptor 120,190,330, doing so will enable 
the prediction and development of new insect control agent that are selective in their actions.   
Using homology modelling, two target crystal structures were found, namely the beta2-
adrenergic receptor (β2AR) and Rhodopsin.    The β2AR structure has an open conformation 
meaning the receptor is inactive, while the rhodopsin structure possesses a closed (active) 
conformation.   The construction of the open and closed conformation was proposed to 
enable adequate explanation of the active and inactive model.   The constructed AKHR from 
rhodopsin template does not allow the diffusion of the ligand into the receptor binding site, 
meaning the AKHR is active while the AKHR constructed from the β2AR template allows the 
diffusion of the ligand into the receptor-binding site. This study is consistent with other 
experimental studies conducted on both Rhodopsin and β2AR 224,331. Both constructed 
models for Bacdo-AKHR are identified as β2off and Rhodoff. 
Both models when compared with those constructed for the flesh fly AKHR (chapter 3) and 
the fruit fly (Chapter 4) are very much alike (they possess almost the same molecular 
interaction) and can be compared to other class A GPCRs.   
5.1.0 Introduction. 
The oriental fruit fly Bactrocera dorsalis is a highly invasive insect pest  and is a significant 
threat to food security.  The oriental fruit fly not only feeds on ripe fruit but also on ripening 
fruit. This action can cause severe loss to farmers. Controlling the invasion of this pest insect 
has not been comfortable as they continue to gain resistance to the widely-used insecticides 
37,38,44. The widely used insecticides pose severe challenges as when used, both beneficial and 




pest insects are killed 39,40. This has prompted the search for “green insecticides”, biological 
effective pesticides that are selective in their activity, negatively affecting the targeted pest 
species without causing damage to beneficial insect species. Since neuropeptides and their G-
protein-coupled receptors are considered suitable targets for new insect control agents, similar 
to the bases used in the enhancement of drugs for the treatment of human disease 29–33,41. Using 
the same method of targeting the GPCR/ AKHR, a new insect control agent that is selective in 
there could be produced.  This cannot be achieved without the presence of the insect 
GPCR/AKHR 3D structure. The presence of 3D structures will help molecular explanation and 
understanding of ligand binding and receptor activations of the insect. The absence of adequate 
literature and elucidated 3D models hinders template target virtual screening332,333. Also, the 
lack of  3D models and inadequate ligand information has hindered ligand-based approaches 
to drug discovery  92,334.   Here to provide a possible solution by providing an adequate 
molecular explanation of the pest insect, the recently published primary sequence of the 
oriental fruit fly AKH-receptor (Bacdo-AKHR) was extracted from the GenBank database 
(accession number AQX83416) and used to predict the 3D structure of the oriental fruit fly 
AKH receptor. The experimental procedure for the construction of the oriental fruit fly AKHR 
is similar to that in chapter 3, so only results will be presented in this chapter.    




5.2.0 Results and Discussion  
5.2.1 Analysis of primary sequence 
 
Figure 5.1: Primary amino acid sequence submitted for secondary structure prediction of Bacdo-AKHR to PSIPRED 
Primary structure analysis of the 424 amino acid residues (see Figure 5.1) indicated that not 
all the amino acid sequence residue could be used for the construction of the 3D model. To 
understand how the transmembrane topology and the interactive receptor features might look, 
a 2D Protter diagram was employed to further analyse the transmembrane topology and the 
interactive receptor features see Figure 5.2 351.  
 





Figure 5.2: A 2D interactive receptor diagram showing the overall transmembrane topology of Bacdo-AKHR 
Having confirmed the presence of the conserved residues motif in the Bacdo-AKHR, three 
secondary structure prediction programs were employed to help accurately predict the 
secondary structure and transmembrane region of Bacdo-AKHR. The programs are PSIPRED 
4.0 (Figure 5.3), MEMSAT-SVM (Figure 5.4) and MEMSAT-SVM topology predictions 
(Figure 5.5)342,353. The result from the programs indicated that only 325 residues make up 
seven transmembrane (7TMs).  





Figure 5.3: PSIPRED predicted secondary structure of Bacdo-AKHR H= helix (in yellow), S = strand (in pink) and C 
=coil (ash) Pred: Predicted secondary structure (H=helix, E=strand, C=coil), AA: Target sequence. 
The predicted result indicated that the primary amino acid of Bacdo-AKHR when feed into the 
PSIPRED (Figure 5.3) and MEMSAT-SVM (Figure 5.4) programs. This further established 
that the amino acid sequences are distributed into seven transmembrane (TMs) helical bundles. 
Also, they possess three loops connected to the helices from the extracellular region, making 
up the N-terminus and another three loops connected to the helices from the intracellular region 




making up the C-terminus. To further confirm this prediction, topology analysis was conducted 
see Figure 5.4. 
 
Figure 5.4: Schematic diagram of the MEMSAT-SVM predictions for the query sequence of Bacdo-AKHR. Traces 
indicate the RAW outputs for the prediction SVMs. Dashed lines indicate the prediction threshold. PL: Pore lining 
residue SP: Signal peptide residue RE: Re-entrant helix residue iL/oL & H/L: Helix prediction. 
 
Figure 5.5: Prediction of transmembrane helices and the topology analysis of Bacdo-AKHR. The helices are 
represented in yellow and labelled S1-S7, the membrane (black) and the loops (thin black line) starting from the N-
terminus (the extracellular region) and terminating at the C-terminus (the intracellular region)   




The topology analysis predicted the helices as follows, H1(48-71), H2 (89-111), H3 (123-153), 
H4 (167-184), H5 (213-239), H6 (268-289) and H7 (305-325) see Figure 5.5 The pore-lining 
was found to be at residues 89-111, 123-153 and 305 -325.  The extracellular region comprises 
the primary amino acid residue at 44, 111, 123, 184, 213, 268, and 305 while the cytoplasmic 
region comprises residues 71, 89, 153, 167, 239, 268 and 325. 
5.2.2 Homology modelling 
Two templates were selected (same as those in chapter 3) for homology modelling, the crystal 
structure of beta 2 adrenergic receptor (5D5A.1A) and Rhodopsin (2X72.1A). These two 
templates were selected because the rhodopsin crystal structure has a covalently bound ligand 
and, as such, represents the active state of the receptor.  The beta-2-adrenergic receptor (β2AR), 
on the other hand, does not have a bound ligand, and so represents the inactive state of the 
receptor. Clustalw2 was used to align the Bacdo-AKHR sequence to the templates as shown in 
Figure 5.6 





Figure 5.6: Clustalw2 sequence alignment illustrating Bacdo-AKHR and the two selected target templates β2AR, 
(5D5A.1A / P07550), and Rhodopsin (2X72.1A / P04695). The sequence similarity is highlighted in a black and white 
colour while the transmembrane domain highlighted in yellow. 
The alignment (Table 5.1) showed a sequence identity ranging from 16% to 45% and sequence 
similarity between 52% and 88% for the different helices.  Sequence alignments of the 
transmembrane residues of Bacdo-AKHR, with those of the target templates, β2AR, 
(5D5A.1A) and Rhodopsin (2X72.1A) (see Figure 5.7), Appendix A and B), displayed 
relatively low sequence percentage identity but possessed high sequence similarity (see Table 
5.1). High sequence similarity and low in sequence percentage identity are not new to class A 




GPCRs superfamily, because, with high percentage similarity, GPCRs / AKHRs do possess 
similar structural and functional features298.   
 
 
Figure 5.7: The statistical result from Psi-blast of the Bacdo-AKHR illustrating the common ancestry. The best two 
templates with net score 96.782 ( β2AR, 5d5a) and 93.886 (rhodopsin 2x72) were selected for the construction of the 
active and inactive model of Bacdo-AKHR. 
Table 5.1: Comparison of sequences of AKHR, Rhodopsin, and β2AR helices. 
Helix      % Sequence identity with 
β2AR (β2off)       rhodopsin (Rhodoff) 
      % Sequence similarity with 
β2AR(β2off)           rhodopsin (Rhodoff) 
1 17                                  22 65                                   63 
2 25                                  16 58                                   52 
3 29                                  30 68                                   60 
4 28                                  40 76                                   80 
5 23                                  17 65                                   60 
6 34                                  23 83                                   74 
7 44                                  45 88                                   88 
 
The TM helix segments of both β2AR and Rhodopsin show high sequence similarity; these 
could be the reason for their prominent structural similarity354,355. The highly conserved amino 




acid residues that are common to  Class A GPCRs 190,223,356, are also present in the constructed 
models see Figure 5.8. 
 
Figure 5.8: Schematic diagram representing an alignment of both models constructed from both Rhodopsin and beta2 
adrenergic receptor of Bacdo-AKHR. Red indicates residues in the seven transmembrane helices, blue shows the 
extracellular regions, while the intracellular regions are represented in purple, yellow denotes region cystine ionic lock, 
and green shows the highly conserved residues. 
Having established the similarities and alignments; homology modelling was then conducted 
with the two recognised template ( β2AR 5d5a and rhodopsin 2x72) using the Swiss-Model 
server330. The models built are labelled β2off-model and Rhodoff-model (see Figure 5.9). 




                       
 
Figure 5.9: The constructed seven transmembrane helices of the Bacdo adipokinetic hormone receptor. a) β2off-model 
seven transmembrane helices of AKHR and b) Rhodoff-model seven transmembrane helices of AKHR. 
The overall structure of the constructed models (Figure 5.9) is alike, especially the 
anticlockwise arrangement of the transmembrane helices, and they both possess the eighth 
intracellular helix that is parallel to the cell membrane. Also, both structures have a tilted TM3, 
and the shortest transmembrane in both models is TM4. 






Figure 5.10: Ramachandran plots of a) β2off-model and b) Rhodoff-model. 




The quality of the constructed models was assessed with evaluation programs, ERRAT357 and 
PROCHECK358.  Ramachandran plots of the two models are shown in (Figure 5.10). The result 
shows that most of the primary amino acid residue of the constructed models are either in 
allowed or favoured regions; also, phi and psi, which represent the backbone torsion angle, are 
acceptable. For the β2off-model, Thr120 had a φ angle of 140 outside the generously allowed 
region. In contrast, the ψ torsion angles 210 outside the allowed region. The ERRAT program 
was used to check the quality of constructed models (Appendix C and D). A score of 92.37 and 
89.93 was calculated for the β2off-model and Rhodoff-model models, respectively, as the 
acceptable score range for a high-quality model is > 50 357. As such, we conclude that these 
two models are of a high-quality model and are acceptable. 
 
5.2.2.1 Structural comparison of models  
The constructed models of both β2off-model and Rhodoff-model can be compared to the two-
class A GPCR structures, that were used as a template to build them.  An overlay of the β2off 
-model with its template given in Figure 5.11a gave an RMSD of 3.3Å for superimposition of 
Cα atoms of the whole molecule and 2.01Å for the helix bundles. Also, an overlay of the 
Rhodoff-model with its template (see Figure 5.11 b) gave an RMSD of 3.1Å for 
superimposition of Cα atoms of the whole molecule and 2.03Å for the helix bundles. Overall, 
the target templates have longer TM helices when compared to the two constructed AKHR 
models, with β2AR having 392 amino acid residue 331 as opposed to the constructed β2off-
model which has 325 amino acids. Also, the rhodopsin template model has 442 amino acid 
residues  224 as against the constructed Rhodoff –model, which has 330 amino acid residues.   





Figure 5.11. An overlay of β2off-model (the constructed model, in yellow) and 5d5a (the template used for constructing 
the model, in purple). b) shows an overlay of Rhodoff-model (the constructed model, in blue and 2x72 (the template 
used for constructing the model, in purple).  
Both constructed models have the CWxP(Y/F) (CWTPY) motif in TM6; when compared with 
the templates, a slight difference in the amino acid residues was noticed. For β2AR, the 
CWxP(Y/F) motif is CWLPF while for Rhodopsin, it is CWLPY. This is the only significant 
difference noticed as regards the conserved residue. This motif is significant to receptor 
activations and will be discussed later. 
5.2.2.2  Evaluation of the helix bundles 
In both models, the transmembrane helices have an anticlockwise helical arrangement, when 
viewed from the extracellular side.  This anticlockwise arrangement is found in most class A 
GPCRs 359.  Experimental data supported this anticlockwise arrangement of neurokinin 1 (NK-
1) and ĸ-opioid receptor 359.  The helical bundles are stabilised by interhelical interactions 
comprising the highly conserved residues 223 




   
 
Figure 5.12: The superimposition of the β2off-model structure and Rhodoff-model structure of Bacdo-AKHR. 
Superimposition of the two constructed 3D models gave a root mean square deviation (rmsd) 
of 3.36 Å for superimposition of Cα atoms of the whole molecule and 2.4 Å for the helix 
bundles. TM6 and TM5 differ from each other with respect to length with both helices 
extending by 4-3 residues into the cytoplasm.  This observation is consistent with studies 
conducted on the accessibility of nitroxide labels fixed to ECL3 joining TM6 and TM5 360. 
Both structures possess a tilted TM3 conformation. This tilting of TM3 is also found other class 
A GPCRs model93,98,195,361,362 The orientation of the seven transmembrane helices is subtly 
different in the two models, which leads to differences in the intracellular and extracellular 
domains. Also, both β2off-model and Rhodoff-model has a disulphide bridge, between 
Cys1243-25 and Cys200, commonly found in GPCRs. 
 In β2off-model, the extracellular end of TM1 bends away with an angle of deviation 39.4º 
from the helical bundle (Figure 5.12).  This deflection is not present in the Rhodoff-model.   




Due to the bend of TM1 of β2off-model, a distance of 4.25Å was recorded between the end of 
TM1 helices of the superimposed structure. This gives a more open structure to the extracellular 
domain of the β2off-model when compared to the Rhodoff-model.  At the same time, the 
intracellular end of TM6, a distance of 4.7 Å was recorded (Figure 5.12) relative to its position 
in the Rhodoff-model towards the helical bundle. This gives a more closed structure to the 
intracellular domain of the β2off-model. Thus, the β2off-model is described as the open or 
inactive model, while the Rhodoff-model is termed the closed or active model 239. The closed 
conformation of the Rhodoff-model is similar to the rhodopsin crystal structure, where the 
close nature protects cis-retinal from hydrolysis 96,98.   Since ligand binding takes place on the 
extracellular domain 363, the closed nature of the Rhodoff-model prevents the ingress of the 
ligand.  On the other hand, the open nature of the β2off-model allows ligand-free access to the 
receptor-binding pocket.  
5.2.2.3 Overview of transmembrane helical interaction and 
molecular switches 
A critical feature of most class A GPCRs is the existence of substantially preserved molecular 
switch motifs. The presence of these switches is essential for stabilising any GPCR either in 
the close (active) or open (inactive) state.   In Bacdo-AKHR, a 3-6 lock exists between Tyr1503-
51 on TM3 and Arg 2646-29 on TM6.  In the inactive model, Arg 2646-29 points away from TM3, 
such that no interaction is possible (Figure 5.13 a).  Upon activation, however, TM6 twists 
moving Arg 2646-29 so that it now points toward Tyr1503-51 (Figure 5.13 b).  This interaction 
locks the receptor in the active state.  Figure 5.13 b also shows that, in the active state, Arg 
2646-29 on TM3 interacts with Glu 248 of ECL2. This loop closes over the binding pocket after 
ligand binding. 





Figure 5.13: a) Open molecular switch in the β2off (inactive) model between Tyr 150 in TM3 and Arg264 in TM6. b) 
Closed molecular switch in the Rhodoff model (active) between Tyr 150 in TM3 and Arg264 in TM6.  c) molecular 
switch interactions (inactive) in the β2off model between Lys267 in TM 6 and Arg149 in TM3. d) molecular switch 
interactions (active) in the Rhodoff model between Lys267 in TM 6 and Arg149 in TM3. e) molecular switch, 
interactions (inactive) in the β2off model between Asp97 in TM2 and Asn319 in TM7. f) molecular switch interactions 
(active) in the Rhodoff based between Asp97 in TM2 and Asn319 in TM7. 
In the Rhodoff-model, there is an ionic interaction between Lys2676-35 in TM6 and the 
positively charged side chain nitrogen atom of Arg1493-50 in TM3 (Figure 5.13 d).  This 
interaction does not exist in the β2off-model AKHR (Figure 5.13 c).  These switches are found 
to be the same as those described for the AKH-R receptor of A. gambiae, Rhodnius prolixus, 
and Tribolium castaneum 231,366. Class A GPCRs have a conserved aspartate on TM2 and an 
asparagine on TM7.  In the Rhodoff-model structure, there is an intramolecular interaction 
between Asp97 and Asn319  (Figure 5.13 f). In the β2off-model(Figure 5.13 e), the helices 
shifted such that these two residues are now 3.4Å apart and can no longer interact 239.  




Experimental data backs the importance of these intramolecular interactions because of the 
vital role they play during receptor activation, basal activity and conformation flexibility 
reduction 239.  
  
In the Rhodoff-model (Figure 5.14a), Asp 97 2-50 has a strong ionic interaction of 2.58 Å with 
Ser138 3-39.   However, in the β2off-model this interaction is absent as the side chains of Asp 
97 2-50 and Ser138 3-39 are orientated away from each other leading to an internuclear distance 
of 5.11 Å.   Also, in the closed, Rhodoff-model, there is polar interaction between Asn60 1-50 
and Ser316 7-45 (Figure 5.14 b), while in the open, β2off-model the interaction is between 
Ser316 7-45 and Asn 64 1-54.  
 
Figure 5.14: a) Rhodoff model (blue) with a salt-bridge interaction between Asp 97 and Ser138.  In the β2off model 
(blue) this interaction is absent.  (b) Rhodoff model (blue) a polar interaction is identified between Asn60 and Ser136, 
while in the β2off model (green) the polar interaction is identified between Asn64 and Ser136. 
In the β2off-model there is a π-cationic interaction between Tyr2395-70 and Lys2636-29 (Figure 
5.15 a).   In the Rhodoff-model the π-cationic interaction is between Lys2626-28 and Tyr2435-74 
(Figure 5.15 b) 





Figure 5. 15: a) π-cationic interactions between TM6 Lys 263 and  TM5Tyr 239. b) π-cationic interactions between 
TM6 Lys 262 and TM5 Tyr 243. c) H-bond interactions betweenTM6 Lys262 and TM5 Ser246. d) absence of H-bond 
interactions between TM6 Lys262 and TM5 Ser246. 
An intramolecular interaction was also identified in the open structure, between TM6 Lys 262 
and TM5 Ser246 (Figure 5.16 c). This interaction was not found in the closed structure (see 
Figure 5.15 d). Dror et al., 2009,  discovered that the inactive β2AR exists in equilibrium 
between conformations with the ionic lock ‘on and off’367. This could be the case with the 
β2off-model AKHR structure, which does not have the ionic lock between helices 3 and 2 but 
between helices 5 and 6. These intramolecular interactions are responsible for the reduction in 
conformational flexibility, basal activity and play a vital role in receptor activation 239 
5.2.2.4 Evaluation of kinks  
Experimental data backs the existence of kinks that initiate the helical twist (bend) at almost 
the same locations where Tyr, Thr or Met come before Pro 195,368–370. The TM helices in both 
open and closed AKHR models have these proline-generated bends or kinks (Figure 5.16). 
TM2 a kink between Met 105 2-58 and Pro106 2-59 (Figure 5.16 a), TM5 has a kink between 
Tyr224 5-47 and Pro227 5-50 (Figure 5.16 b). Another turn was noticed in TM4 in Val 176 4-54 




for the β2off-model (Figure 5.16 c) although not found on the Rhodoff-model structure 
(Figure 5.16 d). from the extracellular region, the kink in TM 6 instigates a twist near TM 5. 
An overlay of the β2off-model and Rhodoff-model Figure 5.16 shows the different effect of 
these kinks or bends on the two models.  
 
Figure 5.16: a) Overlay of 3D models of the β2off-model and Rhodoff-model, showing the presence of kinks in TM2. b) 
overlay of 3D models of the β2off-model and Rhodoff-model showing the presence of kinks in TM5. c) β2off-model 
showing the presence of kink in TM4. d) Rhodoff-model, showing the absence of kink in TM4. * β2off = β2off-model, 
Rhodoff =Rhodoff-model.   
5.2.2.5 Analysis of the loop regions 
Besides the orientation of the transmembrane helices, there are other differences between the 
two models (Figure 5.12).  In the extracellular loop I (ECL I), the β2off-model has no β-strand, 
while the Rhodoff-model has a β-strand between Ala112 and Gln116 and a small helical turn 
at the N-terminus. In the ECL2 of the Rhodoff-model there is a β-strand between Ser119 and 
Phe112, and a γ -turn between Trp117 and Arg118.  This keeps ECL2 in an upright position 
above the helical bundle.  In this way, the N-terminus and ECL2 extend over the 
transmembrane helices, shielding all possible binding sites and preventing the ligand from 
gaining access to or leaving the binding pocket.  In the ECL2 of the β2off-model, there is a β-
strand involving Glu182 and 190 and a small helical turn between His192 and Cys200.  This 




moves the ECL2 away from the binding pocket.  At the same time, the N-terminus also moves 
to give any potential ligand access to the receptor.  This opens access to any potential binding 
pocket. 
ICL3 is commonly not characterised in the crystal structures of GPCR.  In both the β2off-
model and Rhodoff-model, ICL3 has a helical turn between Ile292 and Lys294.  Dror et al. 
identified this turn in β2AR 367.  Moreover, the β2off-model has a helical turn between Ser247 
and Ser 253, while the Rhodoff-model has a β-strand between Val300 and Asn301 and a helical 
turn between Pro302 and Leu304. This findings are consistent with those identified and 
reported by Dror et al. 367 
 
Most Class A GPCRs have an eighth helix, which lies parallel to the intracellular membrane 
surface.  This helix is thought to be essential for receptor activation and binding of a G-protein 
239. Most GPCRs intracellular region are stabilised by palmitoylation of Cys, Ser, or Thr on the 
8th helix 372–374. Both the β2off-model and Rhodoff-models have this 8th helix, which has 
Cys313, which could be stabilised by palmitoylation. 
Since GPCRs are highly flexible, the different structural features, particularly in the extra and 
intracellular region of the two models, could represent features in different conformations 
during molecular dynamics and in the active and inactive state of the receptor. 
5.3.0 A general overview of the constructed models  
The constructed AKHRs from chapters 3, 4 and 5 all have similar properties. Alignment of 
their primary amino acid sequence along with their templates, shows a high similarity, 
particularly with their transmembrane helices, see Figure 5.17. 





Figure 5.17:  An alignment of the three constructed models and their template structure is showing helical similarities 
* 1rhodflf= rhodopsin based model of the flesh fly, 1β2flf = beta 2AR based model of the flesh fly, 2rhodfrf = rhodopsin 
based model of the fruit fly, 2β2frf= beta2 AR-based model of the fruit fly, 3rhodoff =  rhodopsin based model of the 
oriental fruit fly, β2ofrf = β2AR based model of the oriental fruit fly, 5d5a = template β2AR and 2x27 = template 
rhodopsin model.  
Further structural alignment of the constructed β2AR models (Figure 5.18 a) alongside the β2AR 
template (Figure 5.18 b) shows a perfect similarity. Also, the structural alignment of all three 
constructed Rhodopsin models (Figure 5.18 c) shows a good similarity when aligned with their 
template structure (Figure 5.19 d).  





Figure 5. 18: a) An overlay of all three constructed model from β2AR. b) an overlay of all three constructed model from 
β2AR and the template β2AR. c) an overlay of all three constructed model from the Rhodopsin model. d) an overlay of 
all three constructed model from the Rhodopsin model and the Rhodopsin template model. 
The alignment and similarities of these models could mean a close similarity in the point of 
activation during molecular docking calculations.  Understanding the similarities and 
differences of the models could give proper insight into other AKHRs that their 3D models are 
yet to be elucidated.        





We have successfully constructed 3D AKHR models for the oriental fruit fly AKH-receptor, 
Bacdo-AKHR and we present the open conformation as the inactive state and the closed 
conformation as the active state of the AKHR. The elucidated structures possess the same 
features as most class A GPCRs.  
The structural differences can be found around the highly conserved amino acid residue Asp, 
Arg and Tyr (DRY) motif. Where the Rhodoff-model posses an ionic interaction between TM3 
Arg1493-50 and the backbone C=O of TM6 Lys2676-35 but, this was not found in the open 
model. 
π-cationic interaction was noticed in the closed model between TM2 Asp 97 2-50 and TM3 
Ser1383-38. Also, the closed model has ionic interaction between TM6 Lys2626-28 and TM5 
Tyr2435-74. While the open model has two, the ionic interaction is between TM5 Ser 2465-70 
and TM6 Lys 2626-29 and the other between TM5 Tyr2395-70 and TM6 Lys2636-29 
The closed model has a polar interaction between TM1 Asn60 1-50 and TM7 Ser314 7-45, but no 
polar interaction between TM1 Asn60 1-50 and TM7 Ser314 7-45 was found in the open model.   
In both models, kinks were also identified in TM2 (Met 105 2-58 and Pro106 2-59), TM5 (Tyr224 
5-47and Pro227 5-50) and TM4 Val 176 4-54.  
The general conformation and structural features of the β2off-model and Rhodoff-model could 
be used to study the binding and activation of the Bacdo-AKH receptor by Phote-HrTH.                                                            
The constructed AKHRs from chapters 3, 4 and 5 all have similar properties. Alignment of 
their primary amino acid sequence along with their templates, shows a high similarity, 
particularly with their transmembrane helices. The identified similarities of these models could 
mean a close similarity in the point of activation during molecular docking calculations.  





  6 
Binding Pocket Identification of AKHRs, Molecular Docking Calculations, 
and MD Simulations of AKHRs in a Membrane 
Summary 
Using blind docking protocols, similar binding sites were identified at the extracellular half 
of the fruit fly AKHR, the oriental fruit fly and the flesh fly. Phote-HrTH (pGlu-Leu-Thr-Phe-
Ser-Pro-Asp-Trp-NH2) was used as the ligand during molecular docking. As predicted, the 
binding cavity was at the extracellular side of the receptor. It was easy for the ligand to 
access the binding cavity of the inactive β-2AR models. However, the Rhodopsin-based 
model generated no poses.  
To determine the mode and actual changes during receptor-ligand binding for all three 
receptors, molecular dynamics simulation was executed, after the molecular docking 
calculation. Separately, the docked ligand-receptor complex for each fly species was placed 
into a membrane mimetic (POPC).  
During the molecular dynamic simulations, the ligand was observed to sink deep into the 
receptor. After 1.5 ns of MD simulation, conformal changes were observed in each of the 
AKHR models. The helices of the receptors moved toward each other on the extracellular 
side. At the same time, they moved away from each other on the intracellular sides in a 
scissor-like action. 
These changes were much pronounced in TM3, TM5, and TM6, respectively.  
For all three AKHR-models, the AKHR-ligand complexes are stabilised by a strong network 
of H-bonds, -stacking / π-cationic interaction and salt bridges. In each of the three models, 
the conserved residue motif CWTPYY in TM6 was identified to interact with the ligand 
during simulation binding; this could be vital for receptor activation. 





6.1.0 Introduction  
Molecular docking is a vital tool in computer-aided drug design (CADD) and structural 
biology. The primary aim of molecular docking is to predict the binding mode or binding site 
in a receptor molecule187,202,383–385. In drug design and discovery, molecular docking is 
executed as a means to cut down time, and to predict the best conformation of specific 
molecules, thereby reducing the number of molecules to be analysed during experimental 
procedures 302,386–389. 
 The first stage involves three processes. The first stage involves the cavity/ site identification, 
generation of pose around the binding pocket and the selection of best pose/ conformation at 
the binding site to mention but a few196,390. The other stages are examining391,392 and scoring 
of the poses383,393,394. In situations where a homology modelled molecule binding cavity/ site 
is not known, it first has to be identified using other programs191,395,396.   Hence, programs like 
Glide protocol from the Schrodinger package 397,398, AutoDock 399–403 program or the molecular 
environment  (MOE)404 program could be employed for both molecular docking and binding 
cavity/ site identification. 
Molecular docking uses the three-dimensional structure of the target protein.384,402 During free 
association of receptor-ligand complex, identification of the receptor cavity (active pocket) is 
dynamic due to conformational changes (poses) of both ligand and receptor, which is the only 
way to exploit total free energy by both ligand and receptor187,206. Molecular docking 
algorithms are designed such that a large number of poses can be generated within a short time. 
Example of molecular docking programs with such features include DOCK390, FTDOCK 
128,405, FlexX and QSDOCK 405,406.   DOCK, FTDOCK 128,405, FlexX, and QSDOCK  programs 
can only be used when both receptor and ligand are rigid 390. There are other programs designed 
for cases where both ligand and receptor are flexible or in a case where one is flexible, and the 
other is rigid, these programs include AutoDock 399,407,408, DARWIN409 and GOLD 405,410.  





A growing number of docking protocols have incorporated protein flexibility 196,383. 
Determination of protein flexibility using energy minimisation during post-docking refinement 
helps to optimise dihedral angles. Studies have shown that receptor-ligand binding stimulates 
numerous conformational changes in the receptor which comprises side-chain rearrangement 
and pivot movement of the C-domain in some cases 196,410–412. The assessment of relative 
binding affinity follows post-docking calculation of binding energy, and this is using Molecular 
Mechanics terms such as Generalised Born Surface Area (MM-GBSA) 413–418. 
In this thesis, Prime MM-GBSA413,417 was applied, using an implicit solvent model with a 
protein-ligand complex. The following equation (2.13) defines the binding affinity of the 
protein-ligand complex: 
           
      𝜟𝑮𝒃𝒊𝒏𝒅 =  𝑮(𝐏𝐋) − 𝑮(𝐏) − 𝑮(𝐋)                                                                            2.13 
 
Where the binding free energy is represented by ΔGbind, protein-ligand complex is represented 
by G(PL), protein G(P) and ligand G(L). Relative binding affinities are calculated and are 
recognised to relate to the free energy of binding. The more negative the binding affinity is, the 
stronger the binding of the ligand to the receptor protein. The MM-GBSA free energy of 
binding is calculated according to equation 2.14414,416,419–421. 
 
     𝚫𝐆 𝐛𝐢𝐧𝐝 =  𝚫𝐆𝐬𝐨𝐥𝐯 + 𝚫𝐆𝐜𝐨𝐧𝐟 + 𝚫𝐆𝐢𝐧𝐭 + 𝚫𝐆𝐫𝐨𝐭 + 𝚫𝐆𝐭/𝐫 + 𝚫𝐆 𝐯𝐢𝐛                   2.14 
 
 Where ΔGsolv represents the impact of the solvent due to solvent effects, the simulated 
conformational changes in the receptor/ligand is represented by ΔGconf. ΔGint represents the 
calculated free energy from the protein-ligand interactions. ΔGrot represents the free energy 
lost by freezing internal rotations of the protein and ligand complex. ΔG t/r denotes the loss in 





rotational and translational free energy of the ligand and receptor as they interact to give the 
bound complex, and the vibrational mode free energy is denoted by ΔG vib.  
AKHRs/ GPCRs are highly flexible; as a result, they display multiple and dynamic structural 
properties 296. GPCR models have been generated using MD simulation in vacuum for drug-
related designs, but this does not represent the actual environment of the protein. To represent 
the actual biological environments of these GPCRs,  one could depend on recent literature on 
several membrane-embedded human GPCR models 297,422–424. Phospholipid bilayers represent 
the fundamental structures of most biomembranes 425. Periodic lipid bilayers involving, for 
example,1-palmitoyl-2-oleoyl-sn-glycerol-3-phosphocholine (POPC), dipalmitoylphospha-
tidylcholine molecules (DPPC), dodecyl phosphocholine (DPC) and solvated with water, have 
been simulated and equilibrated 422. POPC, DPC and DPPC are universally used in the MD 
simulation of GPCRs 426. To that effect, MD simulations of both free and bound AKHR inserted 
in a preequilibrated POPC membrane model were performed. 
In this study, the homology models of the AKH receptors of three fly species are presented in 
Chapter 3, 4 and 5, and the 3D conformation of the ligand is discussed before that.  
6.2.0 Experimental Methods:  
6.2.1 Molecular docking Calculations 
6.2.2 Identification of the binding cavities for the receptors  
To identify the binding cavities and the best binding pocket, Blind Docking (BD) 396,400,427 was 
performed using AutoDock4.2428 and MOE version 2014.0901,429 and confirmed using 
SiteMap.430 these tools are highly recommended for both binding pockets 
identification191,396,400,430–435 molecular docking187,202,383–385.   





The ligand used for this study is Phote-HrTH (pGlu-Leu-Thr-Phe-Ser-Pro-Asp-Trp-NH2). 
Phote-HrTH have been reported to regulate the supply of fuel metabolites for oxidation in the 
flight muscles of insects (fruit fly, flesh fly and the oriental fruit fly) 43–45,436. The solution 
structure of Phote-HrTH was discussed in Chapter two. Also, the receptors used are of the fruit 
fly, flesh fly and the oriental fruit fly. The elucidation of the 3D models of the three fly AKHRs 
are reported in chapters three, four and five. 
The ligand was prepared by setting the number of active torsions and degrees of freedom. 
Docking parameters for the ligand and macromolecules were set, as described by Hetényi et 
al. 191,396,437,438. Only the β2AR-based receptor models were used in the determination of the 
binding sites of each constructed receptor model. After that, the accessibility of the binding 
cavities from the extracellular domain was conducted as reported in the binding cavity of class 
A GPCRs46,78,188,438. Using the Auto Grid 4 program, grid maps from the extracellular region 
were generated 396,408,437. In the form of 67 x 72 x 67 x, y and z position with a grid spacing of 
0.387nm, having generated the grid map, a grid box in the same x y z position was created with 
the following parameters 36.12 x 70.11 x 36.11. All other parameters were set to default. To 
search for the binding cavity, the ligand was allowed to undergo 100 trials of the blind dock. 
After which cluster analysis was conducted for the protein-ligand molecule based on a cut-off 
value of <0.2   nm for protein-ligand backbone atom and the best conformer with the least 
energy collected with the lowest estimated free energy of binding 427 
Upon identifying the binding site, molecular docking calculations of the ligand-receptor were 









6.2.3 Glide Receptor Preparation 
Glide receptor preparation program (prep wizard version 2019-3, Schrödinger, LLC, New 
York, NY, 2019) 439, from Schrödinger package, for each of the AKHR model, prep wizard 
was executed for the preparation of the receptors. For pre-docking refinement, the AKHRs 
were energy minimised. The OPLS_2005 force field was used for the further refinement and 
energy minimisation to a 0.3Å RMSD of non-hydrogen atoms 438,439. To execute the Glide 
docking program, receptor grids were generated for each of AKHRs identified binding sites. 
After which docking calculations were executed.  During grid generation, no restraint was 
applied, and allowance was made for the peptide-docking grid. Docking calculations were 
executed using Glide S-peptide docking available in the Schrödinger Suite version 2019-
3398,412. The protocols used are, the force field-based scoring methods of Glide and the 
empirical scoring for docking results 396,398 The best binding poses were selected and rescored 
and filtered based on MM-GBSA free energy binding calculations using Prime 413,416,418. 
6.2.4 Preparation of Ligand 
The modelled structure, presented in Chapter 3, was used. The charge of the ligand was Glide 
Docking calculations. 
Docking was performed using the β2AR-based homology models constructed in chapters 3, 4 
and 5. Glide version 6.3, Schrödinger, LLC, New York, NY, 2019 docking protocol 398 was 
used for the execution of all the docking calculations 440. Grid-based SP-Peptide docking was 
performed using the determined peptide (see chapter 2) and the constructed β2AR-based 
models in chapter 3, 4 and 5. For each scenario, the top 50% docking conformations obtained 
from the docking calculations were refined, using post-docking MM-GBSA to calculate the 
protein-ligand binding affinity. The 30 poses generated per receptor were visually inspected. 





The best poses were selected and optimised, and the free energy of binding calculated using 
MM-GBSA (Prime version 2019, Schrödinger, LLC, New York, NY, 2019) and the total 
binding free energy calculated (∆𝑮𝒃𝒊𝒏𝒅). 
                           ∆𝑮𝒃𝒊𝒏𝒅 = ∆𝑮𝑷𝒉𝒐𝒕𝒆/𝑫𝒓𝒐𝒎𝒆 − (∆𝑮𝑷𝒉𝒐𝒕𝒆 + ∆𝑮𝑫𝒓𝒐𝒎𝒆)                              
                                              𝑮 =  𝑮𝑺𝑮𝑩 + 𝑬𝑴𝑴 + 𝑮𝑺𝑨                                                                 
 𝑮𝑺𝑮𝑩 is the surface-generalised born model polar solvation energy, 𝑬𝑴𝑴 is the potential 
energy and 𝑮𝑺𝑨  represents the non-polar solvation energy.                                                                
6.3.0  MD Simulation in a Mimetic Membrane 
For further refinement after the molecular docking calculations where conducted, the three 
docked models (β2flf, βfrf and βoff) each was inserted together with bond Phote-HrTH into a 
palmitoyl-oleoyl-phosphatidylcholine (POPC) membrane, (see Figure 6.1).  MD simulation 
was achieved via GROMACS software package tools 307.  The simulation was executed in three 
phases, namely minimisation, equilibration and MD simulation.   






  Figure 6. 1. Example of AKHR in a POPC membrane with its ligand docked at the extracellular part. 
 
    
The MD simulation was performed for 10 ns under NPT condition to allow the lipid to arrange 
itself around the complex and the water to soak the construct. Cluster evaluation was then 
performed using the linkage algorithm of GROMACS and a cut-off value of < 0.1 nm for 
superimposing backbone atoms, and the best lowest structure saved. Further MD simulation 
was conducted for 100 ns under NPT condition, applying the same procedure.  
6.4.0 Results and Discussion 
6.4.1 Identifying the binding pocket of the AKHRs 
The three different protocols (AutoDock4.2, MOE version 2014.0901 and Sitemap) identified 
similar binding sites. Four binding sites were identified for each AKHR. The possible binding 
site from the constructed models is given in Figure 6.2 






Figure 6. 2. 3D possible binding sites identified using blind docking program.   a) the binding site for the β2AR based 
model b) binding site for the Rhodopsin based model β2AR model. * The white balls represent the binding site, and the 
red balls represent hydrophilic contact area. 
The possible binding site could be seen in Figure 6.2 a and b (tiny white balls). The potential 
water sites are omitted. Where a hydrophilic contact is probable, the little tiny clusters marked 
points are coloured red. To further explain the tiny clusters on each receptor, see Table 6.1 for 
the Rhodopsin models and Table 6.2 for the β2AR models. For clarity, since the results for all 
the AKHRs are similar, only that of the fruit fly will be displayed. For the rest of the fly 
AKHRs, see appendix (C & D). 
 
 





Table 6. 1. Ranking of potential binding pockets in Rhodfrf receptor found using MOE * Size- Number of contributing 
spheres # PLB- predicted ligand-binding site # Hyd- Number of hydrophilic points # Side - side-chain contact atoms 
Residues - Residues at the local surface 
Site Size PLB Hyd Side Residues 
1 122 2.41 48 85 ARG77 ILE78 ASP79 MET81 LEU82 ILE137 ASP140 
ARG141 ILE145 TYR227 ILE230 VAL255 ARG258 
ALA259 ARG262 THR263 LYS265 MET266 THR267 
ILE270 VAL320 TYR321 GLY322 PHE324 ASN325 
ILE326 ARG327 ARG329 
2 54 1.74 28 55 ARG123 VAL124 TYR128 SER131 VAL193 THR194 
HIS196 TYR207 ASN208 ASN211 MET212 MET215 
TYR216 TRP278 TYR281 TYR282 CYS285 
3 60 1.41 24 41 GLY59 THR62 VAL63 LEU66 LEU67 ARG70 GLY74 
ASP79 LEU82 MET83 PRO318 ILE319 TYR321 
GLY322 ALA323 ASN325 ARG327 GLY328 ARG329 
ASN331 HIS332 
4 33 0.84 28 41 PRO184 LYS185 TYR189 GLN191 VAL193 THR194 
PHE195 HIS196 SER197 TYR281 ILE284 ARG303 
LYS304 LEU306 PHE307 
 
A thorough evaluation of the site map results of the Rhodfrf, reveals that the receptor is closed 
(active) and will not allow the ingress of ligand, while the β2AR models are open and inactive 
as such, they should allow free access of the ligand see Table 6.2 for data representation. These 















Table 6. 2. Ranking of potential binding pockets in β2frf receptor found using MOE * Size- Number of contributing 
spheres # PLB- predicted ligand-binding site # Hyd- Number of hydrophilic points # Side - side-chain contact atoms 
Residues - Residues at the local surface 
Site Size PLB Hyd Side Residues 
1 295 4.15 93 180 MET95 GLU96 TRP99 VAL103 GLN104 
TRP105 ASP109 CYS112 ARG113 SER116 
PHE117 ARG119 VAL120 LEU123 GLN170 
LEU173 HIS175 LEU176 GLU177 ALA181 
VAL182 THR183 TYR185 CYS188 VAL189 
PHE191 SER193 PHE194 ARG195 SER196 
ASP197 PHE198 ASP199 GLU200 LYS201 
TYR203 GLN204 MET208 MET211 TRP276 
TYR279 TYR280 ILE282 SER283 TYR286 
TRP287 LYS290 HIS291 LYS295 ILE296 
ASN297 PRO298 LEU299 ARG301 LYS302 
PHE305 
2 195 1.73 53 101 LEU63 THR64 ARG67 LEU68 ARG69 GLY70 
PRO71 LEU72 ARG73 ILE74 ASP75 ILE76 
MET79 ARG137 ALA140 ILE141 PRO144 
ARG147 ARG153 ILE230 ALA257 LYS258 
ARG260 THR261 LEU262 LYS263 MET264 
TYR319 LEU321 TYR322 ASN323 ILE324 
ARG325 GLY326 ARG327 
3 54 0.31 15 22 PRO71 LEU72 ARG73 MET77 CYS132 
LEU135 ASP136 PHE139 LYS143 PRO144 
LEU145 LYS146 ARG147 SER148 ARG151 
GLY152 MET155 
4 22 -0.01 18 19 ILE220 TYR223 GLY224 TYR227 LEU254 
LYS263 ILE266 VAL269 ILE270 ILE273 
 
A thorough evaluation of the site map results of the β2AR-model, reveals that the site ranked 
1 (see Table 6.2) has 295 residues as against the Rhodopsin-model which has 122 residues; 
this indicates that the ligand will fit more into the β2AR-model. Also, both models have four 
selected binding sites, labelled site 1 to 4. For Rhodopsin-model the best site ranked 1 is from 
the extracellular region, and the ECL2 covers the binding site, the reason for that could be 
because Rhodopsin-model is already activated. In contrast, β2AR-model has the extracellular 





region as the best binding site and ranked 1, and the ECL2 does not cover the binding site. The 
best explanation for this is the receptor is inactive. The ranked extracellular region as 1 is 
expected because the location of the binding cavity and the participation of the entire 
extracellular domain conform with experimental data239,441.  The same situation of ligand 
binding to the extracellular domain was reported for the human gonadotropin-releasing 
hormone receptor 442.  
Having obtained the position of the preferred binding sites for the AKHRs, more focused 
docking was carried out to determine the binding mode of the AKHRs.  
6.4.2 Accessibility of the AKHRs binding pocket, and determination of 
binding mode during docking calculations. 
AKHs are biologically active peptides that are produced in modified neurons and are released 
into the circulatory system of the insect to trigger action through a ligand-receptor 14,87. To 
trigger this said action at the fat body(where insects store energy reserves in the form of 
glycogen and triglycerides), the extracellular portion of the GPCR needs to be accessible; for 
the ligand to diffuse through the binding cavity24,87. Here in our observation, when the ligand 
(Phote-HrTH), was introduced from the extracellular side into the binding cavity, of both 
β2AR-models and Rhodopsin- models for the three-fly species only the β2AR-model binding 
cavity of all three modes were accessible (Figure 6.3). Meaning it was easy for the ligand to 
occupy the putative binding sites. In contrast, the Rhodopsin model produced no pose though 
this was expected, as the Rhodopsin AKH-receptors were already active and will not allow 
ligand penetration.   
 






Figure 6. 3. The binding of Phote-HrTH to all three β2AR-based AKHRs. *  a) flf = The flesh fly AKHR b) frf = The 
fruit fly AKHR c) off = oriental fruit fly AKHR. The colours represent H1-H6.  
In contrast, in Rhodopsin models, even when the ligand was forced into the identified binding 
site from the extracellular region, the ECL2 had already covered the binding site leaving a tiny 
space. Unfortunately, the available space between the loops and the helices was too small for 
the ligand to access the binding cavity. Also, for the Rhodopsin models, when the Glide S-
peptide docking command was initiated, no poses were generated, indicating the absence of 
cavities. While in the β2AR-based AKHRs, because of their open conformation, it was easy 
for proper diffusion of the peptide in and out of the binding site access. Since the Rhodopsin 
AKHR models are closed and would not allow further probing, by allowing the peptide to sink 
in, one could postulate that the β2AR-models could represent the conformation of the 
receptor/inactive AKHR. At the same time, the Rhodopsin-model is used as a control. Hence, 
provide information on the active AKHR state of each receptor. 
6.4.2.1 Molecular docking calculations for the β2flf-AKHR 
 Crucial interactions between Phote-HrTH peptide and β2flf AKHR were observed after the S-
peptide docking. The docking scores were -13.20 kJmol-1, and the ΔGbind (MMGBSA) was -





75 kJmol-1. The most critical interaction is a salt bridge experienced between the Asp7 of Phote-
HrTH and Arg303 of the receptor. To provide a significant amount of binding enthalpy and 
stability to the system, a - stacking interaction was experienced between Trp8 of Phote-
HrTH and His 203 of the ECL2. This interaction with ECL2 help closes the loop over the 
binding site. These observations were similar to the studies on cation-pi interaction reported by 
Dougherty 379,443. The ligand interaction maps are presented in Figure 6.4. The -cationic 
interaction falls at 4.64Å, which is within the confines of < 6 Å proposed by Gallivan and 
Dougherty 380.  
 
 Figure 6.4: Ligand interaction diagram of Phote-HrTH bound to the β2flf model of Sarcr-AKHR. Residues are 
represented as coloured spheres, labelled with the residue name and residue number, and coloured according to their 
properties, green for hydrophobic, blue for positive charge and red for a negative charge. The ligand is displayed as a 
2D structure. Interactions between the residues and the ligand are drawn as lines, coloured by interaction type, purple 
for H-bonding and green for pi-pi stacking. The binding pocket is indicated by a line drawn around the ligand, in the 





same colour as the nearest residue. Solvent exposure is indicated on the ligand atoms, and by the break in the line 
drawn around the pocket. 
 
6.4.2.2 Molecular docking calculations for the β2frf-AKHR 
A β2frf putative binding site with Phote-HrTH is similar to those reported for Anopheles 
gambiae by Jackson et al., 324. The docking scores were -14.33 kJ mol-1, and the ΔGbind 
(MMGBSA) was -79 kJ mol-1. The most critical interaction is a salt bridge between Asp7 of 
Phote-HrTH and Arg301. There is H-bonding between Phote-HrTH Ser5 and Val103 of ECL1 
and Trp99 of TM2. The NH of Phote-HrTH Ser5 and C=O Asp7 H-bond to Ser196 on ECL2. 
Also, Phote-HrTH Trp8 NH interacts with Asp197 of ECL2. These interactions with ECL2 are 
interesting as this loop closes over the binding site after the ligand binds. The terminal amide 
of ligand H-bonds to Ile296 of ECL3. To provide proper stability and a significant amount of 
binding enthalpy to the system, -stacking interactions were experienced between Trp8 and 
Phe4 of  Phote-HrTH and Phe198 of ECL2. Hence, the - stacking interaction of 3.94 Å was 
noticed, which falls within the confines of < 6 Å as proposed by Gallivan and Dougherty 380  
The ligand interaction is presented in Figure 6.5. 





Figure 6. 5: Ligand interaction diagram of Phote-HrTH bound to the β2frf model of Drome-AKHR. Residues are 
represented as coloured spheres, labelled with the residue name and residue number, and coloured according to their 
properties, green for hydrophobic, blue for positive charge and red for a negative charge. The ligand is displayed as a 
2D structure. Interactions between the residues and the ligand are drawn as lines, coloured by interaction type, purple 
for H-bonding and green for pi-pi stacking. The binding pocket is indicated by a line drawn around the ligand, in the 
same colour as the nearest residue. Solvent exposure is indicated on the ligand atoms, and by the break in the line 
drawn around the pocket. 
6.4.2.3 Molecular docking calculations for the β2off-AKHR 
β2off putative binding site with Phote-HrTH is similar to those reported for Anopheles gambiae 
by Jackson et al., 324, frf-model and flf-model. The docking scores were -14.03 kJmol-1, and the 





ΔGbind (MMGBSA) was -82 kJmol-1.  Lys 306 was also discovered to act as an anchor in the 
binding pocket, forming a π-cation and hydrogen bond interaction with Phe4 of Phote-HrTH. 
A π-cation interaction of 4.96 Å was observed, which falls within the confines of < 6 Å as 
proposed by Gallivan and Dougherty. Also, a salt bridge was identified between Arg 306 and 
Asp 7 Phote-HrTH (see Figure 6.6). These interactions are similar to those shown for β2frf 
and β2flf.  
 
 
Figure 6. 6: Ligand interaction diagram of Phote-HrTH bound to the β2off model of Bacdo-AKHR. Residues are 
represented as coloured spheres, labelled with the residue name and residue number, and coloured according to their 
properties, green for hydrophobic, blue for positive charge and red for a negative charge. The ligand is displayed as a 
2D structure. Interactions between the residues and the ligand are drawn as lines, coloured by interaction type, purple 
for H-bonding and green for pi-pi stacking. The binding pocket is indicated by a line drawn around the ligand, in the 
same colour as the nearest residue. Solvent exposure is indicated on the ligand atoms, and by the break in the line 
drawn around the pocket. 





The ligand interaction diagram is comparable to one another since they all have hydrogen 
interactions, salt bridge, ionic interactions and - stacking interactions, though β2frf has two 
- stacking interactions originating from same molecule Phe4 and Trp8 of Phote-HrTH and 
Phe198 of the receptor, while β2flf has a - stacking interactions between Trp8 of Phote-
HrTH and His203 and β2off possess a π-cationic interaction between Lys 306 and Phe4. The 
- stacking and π-cationic interactions experienced by these AKHRs and the ligand signifies 
discrepancies in the strength at which the molecules bind. 
6.5.0 Molecular Dynamics simulation of the AKHRs-Phote-HrTH (ligand) 
complex 
Having performed docking calculations for the AKHRs, to further refine and optimise the 
β2AR-based AKHRs-ligand complexes of the lowest ΔGb, MD simulations were performed 
427. For each system, the docked Phote-HrTH and β2flf or β2frf or β2off based AKHR was 
inserted in a mimetic POPC membrane and MD simulations executed for 100 ns in a water box 
see Figure 6.1. Since the receptors are open (inactive), and literature available pinpoint Phote-
HrTH to be responsible for the activation of these receptors 43–45. To understand the molecular 
explanation of how these activations occur by a single neuropeptide, we conducted these 
simulations in order to establish the real-life situation of binding conformations and hydrogen 
bond occupancy as well as evaluate whether the peptide will further sink into the receptors 
beyond its current position anchor during free MD simulations (see Figure 6.7).  
 






Figure 6. 7: Refined structure of Phote-HrTH /Phote AKHR after MD simulation. *  a) off = oriental fruit fly AKHR. 
b) frf = The fruit fly AKHR. c) flf = The flesh fly AKHR. 
Observations from the MD simulations were amazing, as the refined structures of the Phote-
HrTH folded and sank deep into their AKHR, thereby fitting correctly into the binding pocket 
see Figure 6.7. Hence, causing a severe conformational change to the receptors.   
6.5.1 Conformational Changes AKHRs during activation 
For the specific receptors, after 1.5 ns, a drastic conformational change in the entire receptor 
molecule was seen. The helices of the individual receptors move towards each other on the 
extracellular side, at the same time, the move away from each other at the intracellular sides 
367,444. The best explanation for this is the molecule converted from an open (inactive) to a 
closed (active) conformation see Figure 6.8.    
 






Figure 6.8: (a) Overlay of the β2frf receptor model of Drome-AKHR at the start (purple) and end (green) of a 100 ns 
MD simulation in a POPC membrane: a side view and top view. (b) Overlay of the β2flf receptor model of Sarcr-AKHR 
at the start (cyan) and end (green) of a 100 ns MD simulation in a POPC membrane: a side view and top view. Overlay 
of the β2off receptor model of Bacdo-AKHR at the start (blue and red) and end (green) of a 100 ns MD simulation in a 
POPC membrane: a side view and top view. * frf = fruit fly-AKHR, flf = flesh fly AKHR, off = oriental fruit fly. 
 
An overlay of unbound and bound of the individual AKHRs helices is given in Figure 6.8. In 
each AKHR, both structures, most residues maintained α- helicity and the helix bundles are 
very stable. An inward movement of the individual AKHRs around their extracellular domain, 
of the receptor molecule, results in a closed conformation, like their Rhodopsin-based model. 
The Root Mean Square Deviation (RMSD) 445 of the amino acid backbone atoms between the 
starting structure and structure after 1.5 ns was calculated to be 2.37 Å for the β2frf receptor 
model, 2.17 Å for the β2flf receptor model and 2.46 Å for the β2off receptor model. Also, all 
three intracellular loops were pushed outwards, and the ECL2 loop closes over the binding 





pocket with the ligand inside the binding site. These movements are shown in Figure 6.8. The 
best explanation for this is that the molecules converted from an open (inactive) to a closed 
(active) conformation. The same observation was recorded when epinephrine (agonist) was 
introduced to its receptor89. However, the rapid realisation of the active conformation is 
consistent with the activation of fluorescently labelled β2AR in a detergent by noradrenaline, 
which happens within approximately 40ms231,446–448.  
In the extracellular region of all three AKHR model, three helices H1, H3, and H6 had a 
significant tilt towards the centre of the helix bundle. This tilting leads to the breaking of the 
Asp, Arg and Tyr (DRY) ionic lock due to the movement of TM6 and TM3 from the 
intracellular regions of these AKHRs. For a proper understanding of these movements, the 
reader is referred to chapter 3, 4 and 5. After each MD simulation, each AKHR model is 
compared to its starting structure, and the distance between helices H1, H3, and H6 recorded. 
All three models behave the same (see Table 6.3). Their helices were drawn towards the centre 
of the individual helix bundle by an approximate 4 Å each from their initial positions, 
moreover, after 70ns approximately of MD simulation, all models were seen to have stabilised 
with no further movement. These individual distances when compared with their Rhodopsin-
based models, the distances were found to be approximately the same. Also, the starting 
structure of all three models when compared to the template β2AR model were found to be 













Table 6. 3: Change in conformational distance with time during MD simulation. * frf = fruit fly-AKHR, flf = flesh fly 
AKHR, off = oriental fruit fly. H1, H2 and H3 = helix 1-3 


















1.5 3Å 1Å 2Å 2Å 1Å 1Å 1Å 2Å 3Å 
10 4Å 2Å 3Å 4Å 2Å 2Å 2Å 3Å 4Å 
30 5Å 3Å 4Å 6Å 3Å 3Å 6Å 5Å 5Å 
50 6Å 4Å 5Å 6Å 4Å 3Å 12Å 7Å 6Å 
70 8Å 6Å 6Å 6Å 5Å 3Å 12Å 7Å 7Å 
90 9Å 6Å 7Å 6Å 5Å 3Å 12Å 7Å 7Å 
100 9Å 6Å 7Å 6Å 5Å 3Å 12Å 7Å 7Å 
 
Finally, the conformational changes of all three AKHR models, when  Phote-HrTH is 
introduced, has established Phote-HrTH peptide to be the agonist of these three AKHRs. Also, 
the braking of the DRY ionic lock due to the movement of TM6 and TM3 from the intracellular 
regions of these AKHRs and the easy diffusion of Phote-HrTH into these receptors is a clear 
indication that Phote-HrTH activated the receptor. Hence, this information could be utilised as 
a piece of firm supporting information relating to the binding of ligands to  AKHR/GCPRs449.  
Hence, these observations support the idea that the results obtained in Chapters 3, 4 and 5, that 
upon receptor activation, the open β2AR-based AKHR model represents the inactive state. In 




The binding sites of the three AKHRs were effectively identified with the aid of molecular 
docking calculations using the same neurohormone (Phote-HrTH) that is known to activate 





each of them. The identified binding sites of these AKHRs were not different from most already 
identified GPCRs, where their helix bundles, the extracellular loop domains, and the N-
terminus define their active sites. The docking score of the models are β2flf-model has -13.20 
kJ/ mol, β2frf-model is - 14.33 kJ/mol and β2off-model is - 14.03 kJ/mol. The binding scores 
(ΔGbind) calculated using MMGBSA, are -75 kJ/mol for β2flf-model, -79 kJ/mol for β2frf-
model and – 82 kJ/ mol for β2off-model.  
 
Only the β2AR models were used for the docking calculations because the Rhodopsin models 
did not give any pose as such, they served as a control for our model. The best-docked models 
were placed into a membrane box to mimic the actual environment of the receptor-ligand and 
further refine the docked structure; molecular dynamics simulations were conducted.  
During MD simulations, simultaneously from both the extracellular and intracellular regions 
of the AKHRs, rapid opening and closing respectively of these regions were noticed. These 
opening and closing of receptors have been described as activation in GCPRs since AKHRs 
are also GCPRs. After 100 ns simulation, the ligand folded and sank into the individual 
receptors and their binding energy was calculated and found to be -95 kJ/ mol for β2flf, -102 
kJ/ mol β2frf and – 107 kJ/ mol. In each model, it was noticed that the agonist Phote-HrTH 
was stabilised by polar and -stacking / π-cationic contacts with residues in Helices 2, 5, 6 and 
the second extracellular loop. Also, Tyr in the conserved residue CWTPY in H6 was noted to 
interact continuously with the agonist in each model.  
Since these AKH-receptors when activated are involved in the production of energy during 
insect flight, data on the constructed 3D molecules and the binding sites will allow the design 
of novel, species-specific, non-peptidic mimetics which can block the binding site and hence 
prevent insect flight (dispersal of pest insects).





          7 
Structure-activity studies of Phote-HrTH on the fruit fly (Drosophila 
melanogaster) AKHR (Drome-AKHR) 
Summary 
For the first time, an in-silico structure-activity relationship study (SAR) of an AKHR was 
conducted using the computational technique. The technique involves a series of mutation of 
the primary amino acid sequence of Phote-HrTH. At the already identified and docked 
Phote-HrTH/Drome-AKHR, the Phote-HrTH was mutated such that the N-terminal was 
substituted with alanine, and the amino acid residues at the C-terminal replaced with 
glycine. The mutation was done with the aim of identifying the amino acid residue position 
that is vital for receptor activation. Also, the SAR was conducted to validate the molecular 
docking process of Drome-AKHR/Phote-HrTH. 
The aromatic Phe ring in position 4 and that of the indole ring Trp8, which have been 
reported in the previous chapter as providing stability to the ligand during ligand-receptor 
binding is crucial for receptor activation. Leu in position 2, Thr in position 3, Ser in position 
5 and Pro in position 6 are also crucial in receptor binding but not necessary activation. 
Asp in position 7 does not seem to participate in either binding or activation of the receptor, 
as when exchanged with Gly the ligand gained an additional negative charge and the 
receptor was activated.   Knowledge from these studies could help identify the most critical 
molecule necessary for ligand-receptor activation. 
 
7.1.0 Introduction  
Since the earlier discovery of an AKH in Locusta migratoria, there have been over 60 AKHs 
discovered in insects.62 Although these AKHs differ in terms of primary sequence and length 
(octa-, nona- or decapeptides), they all have a blocked pyroglutamate at the N-terminus, a Phe 





or Tyr at position four, Trp at position eight, and a blocked carboxy amidation at the C-
terminus.63 These specific residues appear to be essential for AKH peptide activity.  
AKHs work by binding to their cognate GPCR as demonstrated via in vitro receptor assays and 
in vivo biological assays of a variety of insects450,451.  For receptor activation to take place, the  
AKH must have a turn secondary structure, Phote-HrTH also demonstrates the turn structure 
in solution  436,452,453.  
Previously, numerous structure-activity relationship (SAR) studies have been conducted via 
experimental procedures (in vitro and in vivo assays) to identify critical primary amino acids 
present in AKH peptides. Some of the insects that were studied include cockroaches, Blaberus 
discoidalis and Periplaneta americana, the moth, Manduca sexta, and the migratory locusts, 
Locusta migratoria as well as the desert locust, Schistocerca gregaria. Generally, the outcome 
from these studies showed that the amino acids at positions 2, 3, 4, 5 and 8 are vital for receptor 
activation. Also, position 4 (usually Phe) and 8 (Trp) are the most critical.  Amino acids at 
positions 6 and 7 are either non-reactive or play a minor role in receptor activation454–459.  
Although D. melanogaster AKHR was characterised in 200245 and the SAR study conducted 
in 2012 76, no molecular modelling (in silico) studies have been done on any AKHR/GPCR.   
In this thesis, we report the first SAR in silico study on D. melanogaster AKH peptide using 
computational techniques. The study involves a sequential mutation of the Phote-HrTH amino 
acids corresponding to the experimental mutation study on Drome-AKHR.76    The mutated 
peptides were then docked to the Drome-AKHR developed in this thesis.  The objectives of this 
study were two-fold.  Firstly, if the computational results mirror the experimental results, this 
would lend confidence to the receptor model developed in Chapter four.  Secondly, the 
agreement would afford the first opportunity to explain the conserved nature of the amino acids 
at a molecular level.  





7.2.0  Experimental Methods 
7.2.1 The ligand, protein preparation, and molecular docking.  
The elucidated structure of the ligand Phote-HrTH was presented in Chapter Two, the 3D 
structure of the receptor in chapter four, and the molecular docking results in chapter six.  The 
alanine/ glycine (in vitro) replacement experiment was first reported in 2012 by Caers et al, , 
where the Drome-AKHR was expressed in a cell line and the chemically synthesised peptide 
ligands were applied to the receptor and receptor activation was monitored. 76 The same series 
of Phote-HrTH mutations were made computationally as shown in Table 7.1   
Table 7.1. The Phote-HrTH sequence mutations 
Peptide sequence / modification                                                    Name 
pGlu-Leu-Thr-Phe-Ser-Pro-Asp-Trp-NH2                                 Phote-HrTH  
[N-Ac-Ala]-Leu-Thr-Phe-Ser-Pro-Asp-Trp-NH2                     [N-Ac-Ala1] Phote-HrTH  
pGlu-Ala-Thr-Phe-Ser-Pro-Asp-Trp-NH2                                 [Ala2] Phote-HrTH  
pGlu-Leu-Ala-Phe-Ser-Pro-Asp-Trp-NH2                                 [Ala3] Phote-HrTH  
pGlu-Leu-Thr-Ala-Ser-Pro-Asp-Trp-NH2                                 [Ala4] Phote-HrTH  
pGlu-Leu-Thr-Phe-Gly-Pro-Asp-Trp-NH2                                [Gly5] Phote-HrTH  
pGlu-Leu-Thr-Phe-Ser-Gly-Asp-Trp-NH2                                [Gly6] Phote-HrTH  
pGlu-Leu-Thr-Phe-Ser-Pro-Gly-Trp-NH2                                 [Gly7] Phote-HrTH  
pGlu-Leu-Thr-Phe-Ser-Pro-Asp-Gly-NH2                                [Gly8] Phote-HrTH  
pGlu-Leu-Thr-Phe-Ser-Pro-Asp-Gly-OH                                [Trp-OH] Phote-HrTH  
 
7.2.2 Alanine and glycine scanning  
The amino acid mutation was achieved using the residue scanning module of Glide (version 
2019, Schrödinger, LLC, New York, NY, 2019).  This module provides the option to specify 
the residue of interest to be mutated. The stability and affinity of the mutated peptide was then 
calculated. Backbone minimisation and side-chain prediction were set to 0. The calculated 





binding affinity predicted for the system was achieved with the following equation 
(thermodynamic cycle) 















→     𝑹𝑨 ∗  𝑳𝑩  
                ∆𝑮𝑪𝒂𝒍𝒄





→     𝑹𝑨 ∗  𝑳′𝑩 
Where ∆∆G represents free energy while E is the calculated energy of the ligand before or after 
refinement, L’ represents the mutated ligand, while L is for the unmutated ligand. NT 
represents the unmutated, and R is the receptor. Using these equations, the free energy 
difference, ΔΔG, was calculated by computing the free energy variations (vertical arrows). The 
vertical arrows symbolise variations that are simpler to simulate experimentally while the 
horizontal arrows symbolise recognisable procedures. 
With Maestro, we were able to achieve the mutation of Phote-HrTH residues by positioning 
the chi-angles to those of the residue that was being substituted. In situations, where there is 
no chi- angles, the first residue is expanded to an extensive value (say above 180°). Hence, in 





circumstances of refinement, where the residue radius happens to be higher than zero (> 0), 
that region or the residue is defined based on the size of arginine and minimised 460.   
7.3.0 Results  
7.3.1 Ligand modification and structure-activity relationship (SAR) 
The Phote-HrTH, solution structure was elucidated and identified to possess a turn structure 
(see chapter two) and the 3D structure of the fruit fly AKHR has also been determined (see 
chapter four). Molecular docking calculations on the fruit fly AKHR were conducted using 
Phote-HrTH as the ligand, (see chapter six). Phote-HrTH in the docked position of the 
constructed fruit fly AKHR-model was modified such that position 1-4 primary amino acid 
was interchanged with alanine while glycine was used to replace positions 5-8, as seen in Table 
7.1.  The reason for choosing Ala or Gly is because of the availability of the experimental data 
of the fruit fly (Drome-AKHR)76.  
There are various experimental data available on the structure-activity of both AKHs/RPCHs 
to their cognate receptors454,457–459,461,462. However, no molecular data or computational 
comparison of any kind has been conducted, despite its importance. With the Drome-AKHR 
experimental data76, we were able to conduct SAR studies at the molecular binding site to 
ascertain if there is any correlation between the experimental and molecular data (see Figure 
7.2).  






Figure 7. 1: a) Phote-HrTH docked to the extracellular part of Drome-AKHR alongside the mutated [Ala/Gly]Phote-
HrTH. b) Phote-HrTH and the mutated [Ala/ Gly]Phote-HrTH showing the difference in conformation of both ligand. 
7.3.2 Structure-activity of Phote-HrTH on its receptor binding site  
The binding cavity of Drome-AKHR containing Phote-HrTH was identified in Chapter four. 
For this reason, it was possible to conduct a mutational study on the already docked ligand at 
the binding site. The Ala/Gly scanning for the N-terminus amino acids residues (Leu2, Thr3, 
Phe4) except for Thr3 shows a relatively low binding affinity.  Also, the C-terminus residues 
(Ser5, Pro6 and Trp8) had much lower (more positive value) binding affinity when compared 
to the binding affinity of Leu2 and Phe4 of the C-terminal (see Figure 7.2 B). The Ala/Gly 
scanning for Asp7 of Phote-HrTH reveals that both [Gly7] Phote-HrTH and Asp7 of Phote-
HrTH have almost the same binding affinity (see Figure 7.2 B).    





      
Figure 7. 2: A)  Experimental Structure-activity relationship results from the Phote-HrTH 76. B) Molecular data on the 
Relative binding activity of alanine/ glycine (KJ /mol) exchange against the Phote-HrTH peptide on the Drome-AKHR 
binding site. B) is also showing ([Gly8] Phote-HrTH) and ([Ala4] Phote-HrTH) as the most critical position with the 
lowest binding affinity (KJ /mol) when exchanged with Ala/ Gly.  
 
([Ala4] Phote-HrTH) and ([Gly8] Phote-HrTH) had the highest (positive value)binding affinity 
(see Figure 7.2 B)  when scanned with Ala/Gly. The higher positive value in binding affinity 
calls for attention. Since we are dealing with probability and inherent uncertainty, Monte Carlo 
simulation method was used for further optimisation of [Ala4] Phote-HrTH and [Gly8] Phote-
HrTH molecule with the aim of understanding which residue, when exchanged, will have the 
most critical effect relative to Phote-HrTH at the receptor-binding site. The result shows that 
[Gly8] Phote-HrTH has a higher (positive value) binding affinity when compared to [Ala4] 
Phote-HrTH (see Figure 7.3). 
 





                 
Figure 7.3 SAR scan of Phote-HrTH  position 4 and position 8 via Monte Carlo simulation for the most critical ligand 
residue position  
7.4.0 Discussion  
Neuropeptides undergo conformational changes to obtain an “active conformation” during 
ligand-receptor binding78. The tendency to evaluate the activity of neuropeptides 
experimentally only based on their primary sequence and the charge of specific amino acids is 
known as structure-activity relationship. To understand the structure-activity relationship of a 
ligand, it is essential to consider the conformational changes that occur with the peptide 
analogue. Also, for conformational changes to take place during ligand binding, there must be 
a binding interaction between the ligand and the receptor.  The strength of these interactions is 
known as binding affinity.  For a ligand to properly bind to a receptor, the binding affinity must 
be high (in negative value). This implies that a positive relative binding affinity result 
designates a low binding while a negative relative binding affinity result represents a high 
binding. That is to say, the more negative the binding affinity data, the stronger the binding of 
the ligand to the receptor and the higher the activity response. Here we study the molecular 
structural relationship depending only on the strength of the relative binding affinity between 
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Leu2, when compared to Ala2, has a higher binding affinity. Though, Leu2 does not show 
much interaction with its cognate receptor, the same as [Ala2]Phote-HrTH when scanned with 
Ala /Gly. Leu2 has the same hydrophobic properties as Ala, and the belief is that both 
molecules could play a similar role463. However, the reverse is the case when compared using 
the hydropathy index. The index helps to define the relative hydrophilicity or hydrophobicity 
of a molecule; the more positive the value, the more hydrophobic the residue is. Leu2 is 3.8 
while is Ala 1.8 on the hydropathy index464. Also, Leu2 is more buried into the β-turn of the 
ligand in the receptor core when compared to Ala2 and distortion of this turn could lead to a 
breakdown instability of the ligand, hence lack of receptor response (see Figure 7.1). The 
presence of low stability caused by the Ala2 side chain could be the reason for the low binding 
affinity and the lack of response reported for the experimental SAR studies76.  
 
The binding affinity of Thr3, when compared to Ala3, was much higher. Thr3 interacts with 
the receptor by H-bonding to Gln187 of the receptor, but Ala3 does not have a proton to donate 
and instead was buried inside the receptor  (see Figure 7.1). The absence of proton donor can 
have an adverse effect on the ligand stability in position 3 and hence, cause a reduction in the 
binding affinity. Almost the same response was reported in a biological experimental set-up 
when Ala3 was interchanged for Thr3 a nearly complete lack of response was recorded 76.     
 
[Phe4]Phote-HrTH of the native ligan is buried more into the receptor when compared to 
[Ala4]Phote-HrTH (see Figure 7.1) and forms a pi-cationic interaction with Phe198. This pi-
cationic interaction is crucial for ligand stability; no wonder the binding affinity is much higher 
when compared to another N-terminal molecule. Phe4, when replaced by Ala4, a sharp drop in 
the binding affinity was noticed. The best explanation for this is the lack of pi-interaction that 





is supposed to create stability for the ligand. The absence of stability reduces the binding 
affinity.   This claim is consistent with other response reported in a biological experimental set-
up, where Phe4 was replaced by Ala4 lead to a complete lack of response by the 
receptor.454,455,457,458  
      
Ser5 when compared to [Gly5]Phote-HrTH there was a slight decrease in the binding affinity 
of the ligand. The decrease in the binding affinity could be because [Gly5] Phote-HrTH is 
hydrophobic and is buried inside the protein (see Figure 7.1). The presence of β-strand at 
position5 is because of the Ser5 a polar molecule, and its absence could expose the backbone 
of the ligand molecule at position 5. The exposure of the backbone reduces the chance of 
attaining a turn structure and could lead to a drop in the binding affinity. This observation is 
consistent with the experimental data expressing the need for a turn structure at position 5; 
otherwise, the strand stability necessary for activation will be interrupted 76,458.  
 
Pro6, when bonded to the receptor, provides rigidity to the peptide chain by imposing torsion 
angles on the segment of the structure of the ligand, thereby increasing the binding affinity.  
Pro6 when compared to Gly6, there was a sharp drop in the binding affinity (see Figure 7.2 
B). Also, Pro6 and Gly6, are directly opposite of each other. And Gly6 when viewed from the 
docked site the molecule was found at the surface of the receptor, unlike Pro6 which was buried 
within the receptor molecule (see Figure 7.1). The presence of Gly6 rendered the backbone 
flexible hence a reduction in stability and Gly6 behaves more hydrophilic when compared to 
Pro6. The flexibility of the Gly6 could be the primary reason for the drop in the binding affinity 
of the ligand. This finding is consistent with other experimental studies where Pro6 when 
replaced with Gly6 lead to a reduction in the activity of the receptor.454   
 





Asp7 forms a salt bridge with Arg301, H-bond with Arg301 and H-bond Ser196 of receptor 
molecule, and the presence of these interactions helps to stabilise the receptor. Asp7 when 
compared to [Gly7] Phote-HrTH, Asp7 is understood to possess a nett negative charged 
sidechain, while Gly7 has no charge and no side chain. Gly7 has almost the same binding 
affinity when compared to Asp7.  Gly7 due to its inert and flexible nature cannot form a salt 
bridge that is necessary for the stability of the ligand so a drop in binding would have been 
expected, but this was not the case as the inert Gly7 bonded almost the same as the charged 
Asp7 molecule. This observation is consistent with experimental data on SAR studies when 
Gly was exchanged with Asp7 showing no change in activation (see Figure 7.2 A) 76.  The 
possible explanation for the inadequate response of the system for the molecule in position 
Asp7 when interchanged Gly7,  Asp is a negatively charged molecule, its presence causes the 
ligand to have a nett negative charge. 
Trp8 forms a pi-cationic interaction with Phe198 and donates a proton to Asp197 of the 
receptor molecule. These interactions provide stability to the ligand. Trp8 when compared to 
Gly8, a serious drop in the binding affinity of the ligand was noticed. The Gly8 residue is buried 
inside the receptor molecule while Trp8 could be located at the surface of the receptor (see 
Figure 7.1).  Trp8 analogue, due to its amphipathic orientation forms a β-strand; the presence 
of turn structure have been reported to be critical for receptor activation. 452,453,458,465. So, the 
possible reason for the pronounced drop in binding affinity could be due to the flexible nature 
of the Gly8 molecule which distorts the stability and the amphipathic orientation of the ligand 
leading to virtually no response between the ligand-receptor molecule.  The same observations 
were also confirmed in other SAR studies when Trp8 was replaced with Gly8 leading to a 
complete lack of response 454,455,457,458. 





The Phote-HrTH analogues (Leu in position 2, Thr in position 3 and Ser in position 5 ) when 
scanned with the Ala/Gly, shows a reduced binding affinity when compared to Phote-HrTH. 
The reduction in binding could be as a result of the presence of turn structure between the N-
terminus molecules of Phote-HrTH. The cause of the turn structure at the N-terminus residues 
is supported by the presence of alternating polar water-soluble group (pGlu1, Thr3 and Ser5) 
and the water-insoluble molecule (Leu2 and Phe4) causes an amphipathic orientation. Studies 
have proven the presence of amphipathic orientation as the primary cause of turn structure in a 
molecule 452,453,458,465. So, the best explanation as to why there is a reduced binding affinity is 
that for proper binding to occur, there is a need for a turn structure. Phote-HrTH possess this 
turn structure. During Ala/Gly scanning, there is an alteration of the backbone amide protons 
by the side chains of Ala. The disruption of the side chains disrupts the amphiphilicity pattern 
necessary for providing stability to the ligand. So, the lower the stability, the lower the binding 
affinity.  
The binding affinity of and [Gly8]Phote-HrTH is much higher when compared to the binding 
affinity of. [Ala4]Phote-HrTH. The best explanation for the higher binding affinity at 
[Ala4]Phote-HrTH and [Gly8]Phote-HrTH is that Ala molecule has a simple methyl side chain 
while the Gly molecule does not have a side chain. As such, it is expected for Phe4 when 
replaced with Ala, disrupts the backbone, thereby lowering the stability of the ligand and hence 
a low binding affinity.   These specific residues at position four and eight appear to be essential 
for peptide activity 63 no wonder their activity response were much pronounced. An interchange 
of these amino acid residues in the said position with Ala in position 4 or Gly in position 8 
results in the total shut down of Drome-AKHR 76 just like in other insects 454,455,458.  





The investigation of the modified amino acid sequences and knowledge on which position is 
vital for receptor activations will go a long way in the design of agonist or antagonist or even 
species-specific pesticides 466–468.       
7.5.0 Conclusion  
The structure-activity studies of Phote-HrTH neuropeptide have been conducted using 
molecular binding data of the Drome-AKHR. This is the first time a molecular structure-
activity study has been conducted on an AKH/RPCH family. In general, the result provides 
molecular binding data regarding Phote-HrTH/Drome-AKHR activation. The results 
correspond to the experimental data already available. This study further validates the 
constructed 3D model in previous chapters.  
Since GPCRs are a frequent drug target for the treatment of human disease and given the 
physiological role of AKHs in energy metabolism in insects, AKHs and their GPCRs are 
considered suitable targets for new insect control agents. The binding of a neuropeptide to its 
receptor is vital for hormonal activity to take place.  However, in order to target the GPCR, 
having an elucidated 3D structure and the identified ligand binding site, the position of the 
amino acid residue that is known to be most important for receptor activation could help in 
providing better information that could be used in the development of mimetic neuropeptide 
analogues that are selective in their activity, negatively affecting the aimed pest species without 
causing damage to valuable insect species.  





 Conclusions and Recommendations 
 
Neuropeptides and their cognate G-protein-coupled receptors (GPCRs) engage in a significant 
role, particularly in the regulation of most crucial metabolic, reproductive, developmental, and 
behavioural processes in the life cycle of insects. G protein-coupled receptors (GPCRs) are the 
largest family of cell surface receptors. They are crucial human drug targets because bioactive 
peptides and proteins signal in the animal body via GPCRs, and if one interferes with this 
ligand-receptor binding, one could potentially influence or disrupt critical physiological 
processes in the animal body29–33,41.   
The AKHR is one such GPCR in insects that has the AKH as a ligand to regulate metabolism 
and energy availability for intense locomotion, like flying. AKH is functionally like the 
vertebrate hormone glucagon that causes a rise in the circulating glucose concentrations15. In 
insects, the sugar in the haemolymph is trehalose, and this is converted from stored glycogen 
in the fat body 15,18. Another fuel for insect metabolism is in the form of the lipid diacylglycerol 
(DAG). DAG is obtained from the stored triacylglycerols (TAG) in the fat body of the 
insect19,20. The mobilisation of both fuel types for energy (cellular respiration) in animal cells 
is under the hormonal regulation of AKH14–17. 
Insects are the most abundant and most diverse group of animals on this planet. It is not 
surprising, therefore, that insects account for many pests as seen from a human perspective: 




they compete for the same food (agricultural and stored food pests)1, and they act as vectors of 
numerous, severe pathogens to both man and domesticated animals (medical pests and 
transmitters of disease) 469,470. However, not all insects are pests; some are very beneficial, 
while some are both beneficial and pest 6,7. Some beneficial insects serve as a source of 
pharmacologically active substances such as antimicrobial, antiviral and antitumor compounds. 
Some are decomposers of organic material 8,9,471. Others are pollinators of flowers resulting in 
fruit and seed production.  
Despite the difference in “ecological services” offered by different insect species, the current 
method of combatting insects is killing via commercially available non-specific toxic 
chemicals 472. Over the years, some of the harmful insects have gained resistance to the widely 
used insecticides 34–36. Moreover, more disturbing, a massive decline in insect biodiversity has 
been recorded of late; this includes the essential beneficial insects37,38. This has spurred on the 
search for “green insecticides” (species-specific pesticide that is selective in its action, 
negatively affecting the pest insect and causing no harm to the beneficial insect), to curb the 
massive, indiscriminate killing of insects, especially the beneficial ones. One idea for 
developing a green insecticide is to target the AKHRs of pest insects. For this to be successful 
and applicable, research into structure-based ligand-AKHR interactions is needed for pest and 
beneficial insects to find those that are specific to pest insects for further drug development. 
Essential for this is the availability of 3D AKHR models.  Even though the relationship between 
physiological process and 3D structures are vital, minimal 3D structures of insect AKHRs are 
available.  No 3D model of an AKHR of the flesh fly, the fruit fly, or the oriental fruit fly 
(Bactrocera dorsalis, Drosophila melanogaster, and Sarcophaga crassipalpis) is known. This 
means that no molecular data ranging from a 3D molecule of their AKHR and the binding sites 
of these insects are available. The absence of the 3D structures of these insect AKHRs serves 
as an obstacle to structure-based drug design. 




In this context, this project was developed to focus on Phote-HrTH identified to have the same 
effect on the AKHR of three different fly species (Drosophila melanogaster (vinegar/fruit fly), 
Bactrocera dorsalis (oriental fruit fly) and Sarcophaga crassipalpis (flesh fly)), in which 
Phote-HrTH occurs naturally. Understanding the AKH/ AKHR interactions will provide us 
with enough molecular data in which we can investigate how an endogenous ligand (Phote-
HrTH) may interact with its endogenous AKH receptor in beneficial, and pest fly species. The 
resulting models will shed light on whether the same amino acids are involved with ligand 
binding and whether the same conformation is maintained in all species. Hence, insight can 
ultimately be gained into whether a species-specific effect can be predicted between the three 
fly species and possibly others who also produce Phote-HrTH as a potential lead for peptide 
mimetics. Computational techniques were employed here to study AKH-AKHR interactions. 
Via nuclear magnetic resonance (NMR) restrained molecular dynamic (MD) the solution 
structure of the ligand (Phote-HrTH) was elucidated (see Chapter 2). Homology modelling 
techniques were used to construct two 3D models for each of the fly species, using β2AR and 
rhodopsin crystal structures as templates (see Chapter 3, 4 and 5 for more detail). The two 
receptor models built for each species differ in a few critical features, the most important of 
which is that the β2AR-based models have an open conformation, while the rhodopsin-based 
models have a closed structure46. Since ligand binding takes place on the extracellular domain 
363, the closed nature of all the rhodopsin-like AKHR-models prevents the ingress of the ligand. 
This behaviour of the rhodopsin model is similar to the behaviour reported for the rhodopsin 
template crystal structure 96,98. Also, the rhodopsin-models produced no pose when ligand 
docking was attempted, so only the β2AR models were used for molecular docking calculation. 
To enable us to imitate the ligand- receptor’s precise nature, molecular docking calculation 
using Phote-HrTH as the ligand for each of the β2AR-models were conducted. The docking 




calculation was followed by long MD simulations in a model membrane to determine stability 
and conformational changes during agonist binding (see Chapter 6 for more details).  
In order to validate the model built of the fruit fly AKH-receptor (Drome-AKHR), in-silico 
structure-activity studies were conducted and compared with previously published biological 
activity data. 
8.1  Questions addressed by this study  
The constructed 3D structures of all three fly species are based on the two-target template, 
namely β2AR (5D5A.1A) and rhodopsin (2X72.1A). The overall structure constructed AKHR 
models (Figure 8.1) are alike, especially the anticlockwise arrangement of the transmembrane 
(TM) helices, and they both possess the eighth intracellular helix that is parallel to the cell 
membrane. Also, all three structures have a tilted TM3, and the shortest transmembrane helix 
is TM4.  In all the models, TM6 and TM5 differ with respect to length with both helices 
extending by approximately 4-7 residues into the cytoplasm.  This observation is consistent 
with the studies conducted on the accessibility of nitroxide labels fixed to ECL3 joining TM6 
and TM5 360. The AKHR models possess a disulphide bridge, commonly found in GPCRs.  





Figure 8.1: Constructed 3D model of the fly AKHR from the β2AR and rhodopsin templates. (a) β2AR Flesh fly model, 
(b) β2AR Fruit fly model and (c) β2AR Oriental fruit fly model.  (d) Overlay of all three constructed 3D models from 
the β2AR template structure. (e) Rhodopsin flesh fly model, (f) Rhodopsin fruit fly model and (g) Rhodopsin oriental 
fruit fly model.  (h) Overlay of all three rhodopsin models.   
The two receptor models constructed for each species differ in a few critical features, the most 
important of which is that the β2AR-based models have an open conformation (inactive) (see 
Figure 8.1 a-d).  In contrast, the rhodopsin-based models have a closed structure (active) 
(Figure 8.1e-h). The closed conformation of all the constructed rhodopsin-like AKHRs is 
similar to the template rhodopsin crystal structure 96,98.   Since ligand binding takes place on 
the extracellular domain 363, the closed nature of all the rhodopsin-like AKHR-models prevents 
the ingress of the ligand. 
On the other hand, the open nature of all the β2AR-based AKHR-models allows the ligand-
free access to the receptor-binding pocket. As is typical with most class A GPCRs, all the 
constructed AKHR models have flexible joints, known as kinks. The presence of kinks enables 




the molecule to initiate a helical twist during receptor activation 371. These kinks are usually 
identified with Tyr, Thr or Met proceeding a proline 368,370.   A critical feature of most class A 
GPCRs is the existence of substantially preserved molecular switch motifs. The presence of 
these switches is essential for stabilising any GPCR either in the close (active) or open 
(inactive) state.   In all the constructed models, these switch motifs were identified. The famous 
3-6 lock was identified between Tyr on TM3 and Arg on TM6. In the inactive state, Arg points 
away from TM3, and so no interaction is possible. Upon activation, however, TM6 twists 
moving Arg so that it now points toward Tyr.  This interaction locks the receptor in the active 
state.   Also, a molecular switch interaction between Lys in TM6 and the positively charged 
side chain nitrogen atom of Arg in TM3 was identified in all the rhodopsin based AKHR 
models.  These switches are found to be the same as those described for the AKHR of A. 
gambiae, Rhodnius prolixus, and Tribolium castaneum 231,366. 
The helices in all the constructed β2AR-based molecules (Figure 8.1 a-d) are longer when 
compared with that of the rhodopsin-based AKHR models (Figure 8.1 e-h). β2AR-based 
AKHR models all possess β-strands in ECL1.  In all constructed β2AR-based AKHR models, 
a helix is identified in their N-terminus but is absent in all the rhodopsin AKHR models. 
Because of these differences, the rhodopsin models were proposed to serve as controls for the 
active models of GPCRs. This paragraph answers question one from Chapter 1 which asked 
about the difference and similarities of the constructed models.   
During the MD simulations in a membrane (to mimic the actual receptors environment), all 
three receptors were seen to behave in the same manner.   The opening on the extracellular side 
of all three AKHR/ligand complexes of the β2AR-based models gradually closed.  
Concurrently the intracellular side was observed to open up. The opening and closing of each 
receptor were evident from TM3 moving away from TM6. The inward movement of the 
extracellular domain of the receptor results in a closed conformation, similar to the rhodopsin-




based model. This movement or conformational structural change of these transmembrane 
helices is essential for receptor activation 29. The RMSD of the amino acid backbone atoms 
between the starting structure and structure after 100 ns was calculated to be 2.37Å for Drome-
AKHR, 2.47Å for Sarcr-AKHR and 2.31Å for Bacdo-AKHR. Also, for each of the three 
AKHR models, all three intracellular loops were pushed outwards. These movements are 
shown in Figure 8.2. The best explanation for this is that the molecule converted from an open 
(inactive) to a closed (active) conformation. The same observation was recorded when 
epinephrine (agonist) was introduced to its receptor. 89 The rapid realisation of the active 
conformation is consistent with the activation of fluorescently labelled β2AR in a detergent by 
noradrenaline which happens within approximately 40 ms. 447,448. This paragraph answers the 
question concerning conformational changes of the constructed GPCRs / AKHR during MD 
simulations. 






Figure 8.2: Overlay of  β2AR models of Drome-AKHR (frf), Sarcr-AKHR (flf) and Bacdo-AKHR(off) at the start and 
end (blue lines) of a  100 ns MD simulation in a POPC membrane  * flf -model = flesh fly, frf-model = fruit fly and off-
model = oriental fruit fly. 
The binding cavities of the constructed models are the same as their template structures. 
Rhodopsin models, even when the ligand was forced into the identified binding site from the 
extracellular region, the ECL2 had already covered the binding site leaving a tiny space. 
Unfortunately, the available space between the loops and the helices is too small for the ligand 
to access the binding cavity. Also, for the Rhodopsin models, when the Glide S-peptide docking 
command was initiated, no poses were generated, indicating the absence of cavities. While in 
the β2AR-based AKHRs, because of their open conformation, it was easy for proper diffusion 
of the peptide in and out of the binding site access. Since the Rhodopsin AKHR models are 
closed and would not allow further probing, by allowing the peptide to sink in, one could 




postulate that the β2AR-models could represent the conformation of the receptor/inactive 
AKHR. At the same time, the Rhodopsin-model is used as a control.  In each of the β2AR-
based models, the extracellular loops (ECL) and transmembrane (TM) helices were involved 
in hormonal binding. Also, the identified binding cavity of these models is situated between 
ECL1, ECL2, the N-terminus and TM2-7. These finding of the binding site are consistent with 
those reported for Anopheles gambiae by Jackson et al.,324.   
 
The ligand binding to the individual constructed receptor (β2frf, β2off and β2flf-model) is 
comparable to each other since they all have hydrogen interactions, salt bridge, ionic 
interactions and - stacking interactions. Though, β2frf-model has two - stacking 
interactions originating from same molecule Phe4 and Trp8 of Phote-HrTH and Phe198 of the 
receptor, while β2flf-model has a - stacking interactions between Trp8 of Phote-HrTH and 
His203 and β2off-model possess a π-cationic interaction between Lys 306 and Phe4. The - 
stacking and π-cationic interactions are the only differences recorded, the presence of -
interaction provides a significant amount of binding enthalpy and stability to the system. The 
-interaction with the ECL2 help closes the loop over the binding site; in other words, the 
receptor got activated.  These observations were similar to those reported by Dougherty 379,443.  
The question relating the location of the constructed receptors binding site and ligand binding 
of both active and inactive receptor is answered in this paragraph.  
 
The docking score of the models are β2flf-model -13.20 kJ/ mol, β2frf-model is - 14.33 kJ/mol 
and β2off-model is - 14.03 kJ/mol. The binding scores (ΔGbind) calculated using MMGBSA, 
are -75 kJ/mol for β2flf-model, -79 kJ/mol for β2frf-model and – 82 kJ/ mol for β2off-model.  
 




During MD simulations of the beta2-adrenergic-based models, simultaneously from both the 
extracellular and intracellular regions of the AKHRs, rapid opening and closing respectively 
of these regions was noticed. These opening and closing of receptors have been described as 
activation in GCPRs since AKHRs are also GCPRs141,224,329. 
In order to validate our model of Drome-AKHR computational, mutation studies (structure-
activity studies) were carried out.  Experimental structural activity studies, conducted on 
Drome-AKHR, explains that most AKHs have  Phe or Tyr at position four and Trp at position 
eight 63,450. Hence, these specific residues appear to be essential for peptide activity 63.   
Exchange of this amino acid residue with Ala at position 4 or Gly at position 8  results in total 
shut down of Drome-AKHR 76.  The same phenomenon is observed in other insect species 
454,455,458. These same observations were also confirmed in the molecular binding studies, see 
Chapter seven. The computational mutation studies were able to mimic the experimental 
activity data successfully.  The aromatic Phe ring in position 4 and that of the indole ring Trp 
8, which have been reported in the previous chapter as providing stability to the ligand during 
ligand-receptor binding is very much crucial for receptor binding and activation. Leu in 
position 2, Thr in position 3, Ser in position 5 and Pro in position 6 are also important in 
receptor binding but not necessary activation. Asp in position 7 does not seem to participate in 
either binding or activation of the receptor, as when exchanged with Gly the ligand gained an 
additional negative charge and the receptor was activated.   Knowledge from these studies 
could hit the final nail in the coffin regarding fly species threatening food security and 
Agriculture. The correlation between the experimental data and molecular data on structure-
activity is given in this section.  
The constructed models have proven to be high standard as the data obtained is consistent with 
structures elucidated by the experimental method 125,201,331,361,444,473–478.  




Finally, the aim of this project has been achieved. The project was able to demonstrate Phote-
HrTH ligand activating receptors from three different insects, namely, the flesh fly Sarcophaga 
crassipalpis, the vinegar fly (also called fruit fly) Drosophila melanogaster and the oriental 
fruit fly Bactrocera dorsalis. Molecular data provided from this study could be exploited 
towards the design of biological active pesticides that are selective in their activity, negatively 
affecting the aimed pest species without causing damage to valuable insect species. 
8.2 Future Work 
 
An essential aspect of this research is the development of mimetic neuropeptide analogues that 
are selective in their activity, negatively affecting the targeted pest species without harm to 
beneficial insect species like the honeybee. Phote-HrTH could be modified, making sure it 
retains full efficacy on any of the constructed flies AKHR from this study.  The modified Phote-
HrTH should also be tested on the honeybee AKH-receptor (Apime-AKHR) to check 
selectivity. 
 
Secondly, the tsetse fly, Glossina morsitans morsitans, has two AKHs code-named Glomo-
AKH I (pGlu-Leu-Thr-Phe-Ser-Pro-Gly-Trp-NH2) and Glomo-AKH II ( Phote-HrTH: pGlu-
Leu-Thr-Phe-Ser-Pro-Asp-Trp-NH2). The binding of Glomo-AKH II/ Phote-HrTH to the 
extracellular binding site of a G protein-coupled receptor causes the tsetse fly receptor 
activation same as the Glomo-AKH I 43–45,70.    Since Phote-HrTH / Glomo-AKH II is also 
found to bind and activate Glomo-AKHR, Drome-AKHR, Sarcr-AKHR and Bacdo-AKHR, 
3D Model of Glomo-AKHR and the peptide Glomo-AKH II should be elucidated.  Molecular 
docking studies should be conducted on both Glomo-AKHR, Drome-AKHR, Sarcr-AKHR and 
Bacdo-AKHR using Glomo-AKH I as the ligand to see if the ligand will activate or show 
selectivity on the AKHRs. 
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Target templates for the AKHRs 
 
 






Target templates from which the AKHRs where built 
 
 






Ranking of potential binding pockets in β2AR and the rhodopsin models found using MOE * Size- 
Number of contributing spheres # PLB- predicted ligand-binding site # Hyd- Number of hydrophilic 
points # Side - sidechain contact atoms Residues - Residues at the local surface 
Rhodflf (rhodopsin model from the flesh fly) 
Site Size PLB Hyd Side Residues 
1 185 2.91 54 102 ARG73 ILE74 ASP75 MET77 LEU78 ILE133 ASP136 
ARG137 ALA140 ILE141 LEU145 LYS146 ARG147 
TYR223 ILE226 ILE230 LYS233 GLU244 ARG245 
ALA257 ARG260 THR261 LYS263 MET264 THR265 
ILE268 TYR322 ASN323 ILE324 ARG325 ARG327 
2 70 1.99 38 57 ARG119 VAL120 LEU123 TYR124 VAL189 ILE190 
ASN192 TYR203 GLN204 SER207 MET208 MET211 
TYR212 TRP276 TYR279 TYR280 SER283 ARG301 
3 50 1.29 25 45 HIS38 SER41 VAL103 GLN104 TRP105 THR108 
ASP109 CYS112 GLU178 HIS179 ALA181 VAL182 
THR183 GLY184 TYR185 PHE186 PRO298 LEU299 
LYS302 
4 42 0.55 15 28 ASN192 SER193 PHE194 ARG195 SER196 ASP199 
GLU200 LYS201 GLN204 SER283 TYR286 TRP287 
LYS290 ALA293 
 





Beta2flf (Beta 2AR model from the flesh fly) 
Site Size PLB Hyd Side Residues 
1 295 4.15 93 180 MET95 GLU96 TRP99 VAL103 GLN104 TRP105 
ASP109 CYS112 ARG113 SER116 PHE117 ARG119 
VAL120 LEU123 GLN170 LEU173 HIS175 LEU176 
GLU177 ALA181 VAL182 THR183 TYR185 
CYS188 VAL189 PHE191 SER193 PHE194 ARG195 
SER196 ASP197 PHE198 ASP199 GLU200 LYS201 
TYR203 GLN204 MET208 MET211 TRP276 
TYR279 TYR280 ILE282 SER283 TYR286 TRP287 
LYS290 HIS291 LYS295 ILE296 ASN297 PRO298 
LEU299 ARG301 LYS302 PHE305 
2 195 1.73 53 101 LEU63 THR64 ARG67 LEU68 ARG69 GLY70 
PRO71 LEU72 ARG73 ILE74 ASP75 ILE76 MET79 
ARG137 ALA140 ILE141 PRO144 ARG147 ARG153 
ILE230 ALA257 LYS258 ARG260 THR261 LEU262 
LYS263 MET264 TYR319 LEU321 TYR322 ASN323 
ILE324 ARG325 GLY326 ARG327 
3 54 0.31 15 22 PRO71 LEU72 ARG73 MET77 CYS132 LEU135 
ASP136 PHE139 LYS143 PRO144 LEU145 LYS146 
ARG147 SER148 ARG151 GLY152 MET155 





4 22 -0.01 18 19 ILE220 TYR223 GLY224 TYR227 LEU254 LYS263 
ILE266 VAL269 ILE270 ILE273 
 
Rhodoff (rhodopsin model from the oriental fruit fly) 
Site Size PLB Hyd Side Residues 
1 47 1.94 30 57 ARG131 VAL132 TYR136 SER139 LYS195 VAL201 
ALA202 HIS204 GLN216 ASN219 MET220 MET223 
TYR224 TRP280 TYR283 TYR284 CYS287 ARG305 
2 108 1.92 41 67 ILE86 ASP87 LEU90 ILE145 ASP148 ARG149 
ILE153 PHE159 TYR235 ILE238 ALA261 ARG264 
THR265 LYS267 MET268 THR269 ILE272 PHE326 
ASN327 ILE328 ARG329 
3 54 1.27 21 41 ILE62 GLY63 THR66 VAL67 LEU70 ILE71 SER82 
ASP87 LEU90 MET91 TYR323 GLY324 VAL325 
ASN327 ARG329 GLY330 LYS331 ASN333 ASN334 
4 48 0.90 25 40 LYS193 VAL194 HIS204 SER205 PHE206 PRO207 
LYS212 LEU213 GLN216 CYS287 PHE290 TRP291 









(Beta 2AR model from the oriental fruit fly) 
Site Size PLB Hyd Side Residues 
1 190 4.38 70 136 LEU107 GLU108 TRP111 VAL115 GLN116 TRP117 
ASP121 CYS124 ARG125 MET127 SER128 PHE129 
ARG131 VAL132 LEU135 GLN182 ILE185 HIS187 
LEU188 TYR197 CYS200 VAL201 PHE203 SER205 
PHE206 PRO207 THR208 GLU209 LEU210 HIS211 
TYR215 GLN216 ASN219 MET220 MET223 TYR283 
TYR284 MET286 CYS287 PHE290 TRP291 PRO302 
LEU303 ARG305 LYS306 PHE309 
2 95 0.96 28 53 ARG81 SER82 SER84 ILE86 ASP87 TYR239 ARG260 
ALA261 LYS263 ARG264 THR265 LYS267 MET268 
TYR323 PHE326 ASN327 ILE328 ARG329 GLY330 
3 64 0.79 23 40 GLU189 VAL194 TYR197 THR208 GLU209 LEU210 
HIS211 LYS212 LEU213 GLN216 PHE290 TRP291 
ASP293 LYS294 PRO295 SER296 ALA297 ASP298 
VAL300 PRO302 ARG305 
4 36 0.30 19 27 ILE62 GLY63 THR66 VAL67 LEU70 PRO320 LEU321 









Interproton distances from NMR (nm) used during Molecular dynamic simulations. Phote-
HrTH 150 mM SDS micelles, pH 4.5, 2mM peptide, Temp = 310 K referenced to DSS 
according to Wüthrich, K., NMR of Proteins & Nucleic Acids, p. 178, Wiley 1986) 
 
Number Resonances Value Upper Limit Lower Limit 
1 4PheH-2LeuHg 3.72257 4.46709 2.97806 
2 2LeuH-2LeuHg 3.40984 4.09181 2.72787 
3 3ThrHg2*-2LeuHda*5.91826   7.10191 4.73461 
4 6ProHa-2LeuHda* 4.89370 5.87244 3.91496 
5 3ThrHg2*-4PheHba4.90055 5.88066 3.92044 
6 4PheHba-4PheHbb 4.01776 4.82132 3.21421 
7 4PheH-4PheHba 2.47042 2.96450 1.97633 
8 6ProHga-4PheHba 4.18416 5.02100 3.34733 
9 7AspHba-4PheHba 3.85542 4.62651 3.08434 
10 4PheHba-4PheHe* 4.21901 5.06282 3.37521 
11 5SerH-4PheHba 2.98967 3.58760 2.39173 
12 3ThrHa-4PheHba 3.86036 4.63243 3.08828 
13 5SerHa-4PheHba 2.46959 2.96351 1.97567 
14 4PheHba-4PheHd* 2.94521 3.53426 2.35617 
15 3ThrHg1-3ThrHa 3.04423 3.65308 2.43539 
16 3ThrHa-4PheH 2.88589 3.46307 2.30871 
17 3ThrHa-6ProHa 3.85641 4.62769 3.08513 
18 3ThrHa-3ThrHb 2.68034 3.21641 2.14427 
19 3ThrH-3ThrHa 3.29356 3.95227 2.63485 
20 3ThrHg2*-1GluHga4.35194 5.22233 3.48155 
21 1GluHbb-1GluHga 3.97017 4.76421 3.17614 
22 5SerHbb-5SerHba 4.04949 4.85939 3.23959 
23 7AspHba-5SerHbb 3.76029 4.51235 3.00823 
24 5SerH-5SerHbb 3.30984 3.97181 2.64787 
25 5SerHa-5SerHbb 2.95008 3.54010 2.36006 
26 3ThrHg2*-1GluHgb4.95113 5.94136 3.96091 
27 1GluHbb-1GluHgb 3.99956 4.79947 3.19965 
28 8TrpH-8TrpHbb 3.56140 4.27368 2.84912 
29 8TrpH-5SerHg 4.05864 4.87037 3.24691 
30 8TrpHa-8TrpH 2.85458 3.42550 2.28366 
31 7AspHa-8TrpH 2.51479 3.01775 2.01183 
32 3ThrHb-8TrpH 3.77499 4.52998 3.01999 
33 8TrpH-6ProHa 4.42037 5.30445 3.53630 
34 8TrpH-7AspHbb 4.11011 4.93213 3.28809 
35 8TrpH-8TrpHba 2.44787 2.93745 1.95830 
36 3ThrHg2*-8TrpH 4.98005 5.97606 3.98404 
37 3ThrHg1-4PheH 3.32954 3.99545 2.66363 
38 3ThrHb-4PheH 3.28340 3.94007 2.62672 
39 6ProHa-4PheH 3.88625 4.66350 3.10900 
40 4PheH-2LeuHa 3.91957 4.70349 3.13566 
41 5SerHa-4PheH 2.82402 3.38883 2.25922 
42 1GluHba-4PheH 3.91823 4.70187 3.13458 
43 [66]-4PheH      2.53358 3.04030 2.02686 
44 [67]-6ProHa 4.06876 4.88251 3.25500 
45 7AspH-3ThrHg1 3.21520 3.85824 2.57216 





46 7AspH-8TrpHbb 2.90826 3.48992 2.32661 
47 7AspH-3ThrHb 2.50124 3.00149 2.00100 
48 7AspH-2LeuHbb 3.85558 4.62669 3.08446 
49 7AspH-7AspHba 3.73586 4.48303 2.98869 
50 7AspH-7AspHbb 3.25887 3.91064 2.60709 
51 7AspH-7AspHa 2.73808 3.28569 2.19046 
52 7AspHa-8TrpHbb 3.52949 4.23539 2.82359 
53 7AspHa-5SerHg 3.85507 4.62609 3.08406 
54 7AspHa-7AspHbb 3.13039 3.75647 2.50432 
55 3ThrH-[6AspHa] 3.67547 4.41056 2.94038 
56 6ProHa-6ProHbb 4.23142 5.07770 3.38513 
57 [69]-6ProHbb 3.29083 3.94900 2.63267 
58 5SerHg-6ProHbb 3.90086 4.68103 3.12069 
59 6ProHa-6ProHba 4.26548 5.11858 3.41239 
60 3ThrHg2*-6ProHba4.91487 5.89784 3.93189 
61 7AspHba-4PheHbb 3.09162 3.70995 2.47330 
62 7AspHba-6ProHa 4.01229 4.81475 3.20983 
63 7AspHba-5SerHba 2.26200 2.71439 1.80960 
64 5SerH-7AspHba 4.16331 4.99597 3.33065 
65 7AspHba-5SerHa 2.62832 3.15398 2.10265 
66 7AspHba-2LeuHbb 3.81678 4.58014 3.05342 
67 7AspHba-5SerHg 3.11629 3.73954 2.49303 
68 8TrpHa-5SerH 2.57080 3.08496 2.05664 
69 3ThrH-8TrpHa 3.43547 4.12256 2.74838 
70 3ThrHb-4PheHd* 4.55469 5.46563 3.64375 
71 1GluHba-4PheHd* 4.44558 5.33470 3.55647 
72 3ThrHg2*-6ProHga4.72130 5.66556 3.77704 
73 6ProHga-6ProHa 3.92018 4.70422 3.13615 
74 6ProHga-6ProHdb 3.46389 4.15666 2.77111 
75 6ProHga-8TrpHba 3.98401 4.78082 3.18721 
76 6ProHga-6ProHda 3.56610 4.27932 2.85288 
77 1GluHa-[70] 3.87125 4.64550 3.09700 
78 1GluH*-5SerHba 4.81621 5.77946 3.85297 
79 1GluH*-1GluHba 4.71241 5.65490 3.76993 
80 1GluHa-1GluH* 4.77503 5.73003 3.82002 
81 3ThrHg2*-1GluHa 4.80218 5.76261 3.84174 
82 1GluHa-6ProHa 4.07541 4.89049 3.26032 
83 1GluHa-1GluHba 3.87562 4.65074 3.10049 
84 3ThrHg1-4PheHbb 3.05079 3.66095 2.44063 
85 4PheHbb-5SerHba 2.97483 3.56980 2.37986 
86 1GluHba-4PheHbb 4.17370 5.00844 3.33896 
87 3ThrHg2*-1GluHba4.62476 5.54971 3.69981 
88 1GluHba-5SerHg 4.05882 4.87059 3.24706 
89 6ProHa-[71] 4.02729 4.83275 3.22183 
90 8TrpHba-4PheHz 3.76779 4.52135 3.01423 
91 8TrpHba-4PheHe* 3.41675 4.10010 2.73340 
92 3ThrHg2*-2LeuHa 4.29059 5.14871 3.43248 
93 3ThrHg1-2LeuHa 3.74595 4.49514 2.99676 
94 1GluHbb-2LeuHa 4.09061 4.90873 3.27249 
95 2LeuHa-2LeuHbb 3.17959 3.81550 2.54367 
96 2LeuH-2LeuHa 3.46526 4.15832 2.77221 
97 3ThrH-2LeuHa 2.45121 2.94145 1.96097 
98 3ThrHg1-6ProHda 3.97850 4.77420 3.18280 
99 7AspHbb-6ProHda 3.34034 4.00841 2.67228 





100 6ProHa-4PheHz 3.98217 4.77860 3.18574 
101 6ProHgb-6ProHa 4.12540 4.95048 3.30032 
102 6ProHa-4PheHa 4.25684 5.10821 3.40547 
103 3ThrHg1-3ThrHb 2.55894 3.07073 2.04715 
104 3ThrHb-5SerHg 4.04079 4.84895 3.23263 
105 3ThrHb-5SerHba 3.72490 4.46987 2.97992 
106 3ThrHb-4PheHe* 4.58505 5.50205 3.66804 
107 3ThrHb-6ProHa 4.06908 4.88290 3.25526 
108 3ThrH-3ThrHb 3.26538 3.91845 2.61230 
109 3ThrHb-2LeuHbb 2.82527 3.39032 2.26022 
110 3ThrHg2*-3ThrHb 5.01528 6.01834 4.01223 
111 5SerH-5SerHg 4.18477 5.02173 3.34782 
112 5SerH-6ProHa 3.38206 4.05847 2.70565 
113 5SerH-5SerHba 3.91947 4.70336 3.13558 
114 5SerH-5SerHa 2.46415 2.95698 1.97132 
115 5SerH-[72]  3.16133 3.79360 2.52906 
116 6ProHa-2LeuHdb* 5.27082 6.32499 4.21666 
117 5SerHa-5SerHba 2.73650 3.28379 2.18920 
118 5SerHa-2LeuH 3.17229 3.80675 2.53783 
119 5SerHa-6ProHa 2.80798 3.36957 2.24638 
120 3ThrH-5SerHa 3.33047 3.99656 2.66437 
121 1GluHbb-1GluHa 4.43330 5.31996 3.54664 
122 6ProHa-3ThrHb 3.97354 4.76824 3.17883 
123 2LeuH-3ThrH 3.41164 4.09397 2.72931 
124 2LeuHba-6ProH 3.16112 3.79334 2.52890 
125 5SerHg-5SerHba 3.17467 3.80961 2.53974 
126 6ProHa-5SerHg 4.14568 4.97482 3.31654 
127 3ThrHg1-5SerHg 2.91101 3.49322 2.32881 
128 7AspHbb-5SerHg 4.02260 4.82712 3.21808 
129 3ThrHg1-2LeuHbb 2.45663 2.94796 1.96531 
130 3ThrHg1-5SerHba 4.01698 4.82037 3.21358 
131 3ThrHg1-3ThrH 3.18049 3.81659 2.54439 
132 3ThrHg2*-7AspHbb4.90332 5.88399 3.92266 
133 3ThrHg2*-5SerHba5.02820 6.03384 4.02256 
134 3ThrHg2*-1GluHbb4.55216 5.46260 3.64173 
135 3ThrHg2*-3ThrH 4.64014 5.56817 3.71211 
136 3ThrHg2*-2LeuH 4.63556 5.56267 3.70845 
137 3ThrHg2*-2LeuHba4.69633 5.63559 3.75706 
138 3ThrHg2*-6ProHdb4.78140 5.73768 3.82512 
139 3ThrHg2*-2LeuHbb4.40272 5.28326 3.52218 
140 6ProHa-5SerHba 3.91832 4.70198 3.13466 
141 2LeuHbb-5SerHba 4.03364 4.84037 3.22691 
142 1GluHbb-2LeuHba 2.77387 3.32864 2.21910 
143 6ProHa-2LeuH 3.75188 4.50226 3.00150 
144 3ThrH-2LeuHbb 3.51083 4.21299 2.80866 
145 2LeuH-2LeuHbb 2.93991 3.52790 2.35193 
146 2LeuHbb-6ProHdb 4.26364 5.11637 3.41091 
147 2LeuHba-2LeuH 3.59980 4.31976 2.87984 
 
 
 
